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1.  TOTAL MOTHERS ATTENDING Totals 2013
Mothers who have delivered babies weighing >500 grams 8648
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1666  
Hydatidiform Moles * 39  
Ectopic Pregnancies 192  
Total Mothers Delivered 10314
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2013 
Maternal Deaths 3
3.  BIRTHS Totals 2013 
Singletons 8455 
Twins                                                                                                         181 
Triplets                                                                                                          8 
Quadruplets                                                                                                   0 
Total Babies Delivered weighing> 500 grams 8841
4.  OBSTETRIC OUTCOME Totals 2013
Spontaneous Vaginal Delivery 52% 
Forceps 6% 
Ventouse 11% 
Caesarean Section 31% 
Induction of Labour 29% 
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2013
Antepartum Deaths 42    
Intrapartum Deaths 0    
Stillbirths 42  
Early Neonatal Deaths 27
Late Neonatal Deaths 4
Congenital Anomalies 29         3
D U B L I N M AT E R N I T Y H O S P I TA L S
C O M B I N E D  C L I N I CA L  D ATA
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6.  PERINATAL MORTALITY RATES                                                      Totals 2013
Overall Perinatal Mortality Rate per 1,000 Births 7.8  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.5
Perinatal Mortality Rate Including Late Neonatal Deaths 8.2       
Perinatal Mortality Rate Excluding Unbooked Cases 7.1
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.0   
7.  AGE OF WOMEN
Nullips Multips             Total Mothers  Delivered>500g 
<20 yrs 195 24 219
20-24 yrs 595 355 950
25-29 yrs 905 953 1858
30-34 yrs 1211 1801 3012
35-39 yrs 640 1459 2099
40+ yrs 143 367 510
Total 3689 4959 8648
8.  PARITY
Totals 2012   % from Total Mothers  Delivered >500g 
Para 0 3689 42.7%
Para 1 2948 34.1%
Para 2-4 1910 22.1%
Para 5+ 101 1.2%
Total 8648 100% 
9. COUNTRY OF BIRTH & NATIONALITY AT DELIVERY - 2013
2012 % 2013 %
Irish 5693 64.36% 6318 73.06%
EU 1948 22.02% 1535 17.75%
NonEU 1188 13.43% 782 9.04%
Unknown 17 0.19% 13 0.15%
Total 8846 100.00% 8648 100.00%
4
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10. SOCIO-ECONOMIC GROUP - 2013
Socio-Group 2012 % 2013 %
1 622 7.19% 559 6.46%
2 2018 23.33% 1989 23.00%
3 1498 17.32% 1384 16.00%
4 506 5.85% 437 5.05%
5 603 6.97% 528 6.11%
6 344 3.98% 317 3.67%
7 2334 26.99% 2476 28.63%
8 1 0.01% 0 0.00%
9 2 0.02% 0 0.00%
10 918 10.62% 958 11.08%
TOTAL 9116 100.00% 8846 100.00%
11. BIRTH WEIGHT  
Weights Totals 2013      
500 - 999 gms 67
1,000 - 1,499 81
1,500 - 1,999 153
2,000 - 2,499 359
2,500 - 2,999 1152
3,000 - 3,499 2883
3,500 - 3,999 2865
4,000 - 4,499 1078
4,500 - 4,999 192
>5,000 11
Total 8841
12. GESTATIONAL AGE   
Nullips Multips Totals 2013 
<26 weeks 14 15 29
26 - 29 weeks + 6 days 35 29 64
30 - 33 weeks + 6 days 61 73 134
34 - 36 weeks + 6 days 180 200 380
37 - 41 weeks + 6 days 3392 4640 8032
42 + weeks 7 2 9
Total 3689 4959 8648
5
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13. PERINEAL TRAUMA AFTER ALL VAGINAL DELIVERIES (Numbers & Percentages)
Nullips Multips  Totals 2013
Episiotomy & Extended Episiotomy 1187 296 1483
First Degree Laceration 168 389 557
Second Degree Laceration 702 1107 1809
Third Degree Anal Sphincter/Mucosa 117 62 179
Fourth Degree 4 2 6
Other { Lacerations/Grazes not 241 573 814
requiring sutures}
Intact 143 1015 1158
Totals 2562 3444 6006
CS Deliveries not included in the above.
14.  THIRD DEGREE TEARS *  
Nullips Multips Totals 2013 
Occurring Spontaneously 44 51 95
Associated with Episiotomy 17 2 19
Associated with Forceps 21 3 24
Associated with Ventouse 30 7 37
Associated with Ventouse & Forceps 22 0 22
Associated with O.P. position 0 1 1
*Total 3rd Degree not listed as some women have a 3rd degree Tear with Both Episiotomy &
Instrumental Delivery.Table 13 has totals listed.
15.  PERINATAL MORTALITY IN ANTEPARTUM NORMALLY FORMED 
STILLBORN INFANTS
Nullips Multips Totals
Placental 5 5 10
Cord Accident 2 5 7
Infection 1 - 1    
Feto Maternal Haemorhage 2 - 2
Prematurity 3 1 4
Unexplained 1 4 5 
Total 14 15 29
Autopsy Totals
Autopsy Rate  16/29 55.2%
6
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16.  PERINATAL MORTALITY IN CONGENITALLY MALFORMED INFANTS
Nullips Multips      Totals 2013
CNS Lesions 2 5 7
Cardiac 1 4 5
Renal 1 1 2
Chromosomal 3 6 9           
Diaphragmatic Hernia 0 1 1
Other 1 4 5  
Totals 8 21 29
17.  EARLY NEONATAL DEATHS
Nullips Multips Totals 
Congenital 5 11 16
Prematurity / Infection 2 8 10
Placental 1 0 1
Unexpected 0 0 0
Totals 8 19 27
Full Autopsy 12/27
Autopsy Rate  44%
Overall Full Autopsy total for all Perinatal Deaths    33
Overall Autopsy Rate 47.8%
18.  HYPOXIC ISCHAEMIC ENCEPHALOPATHY
Grades Grade 1   Grade 2             Grade 3  
22 8 2
19.  SEVERE MATERNAL MORBIDITY
Nullips Multips Totals 
Massive Obstetric Haemorrhage     9 16 25
Emergency Hysterectomy 0 3 3    
Transfer To ICU/CCU 3 7 10
Uterine Rupture 0 1 1    
Eclampsia 0 0 0
Pulmonary Embolus 1 2 3
7
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20.  FINANCIAL INFORMATION: Non-capital income and expenditure account
For the year ended 31 December 2013
2013 2012
€'000 €'000
Cumulative non-capital deficit/(surplus) 
brought forward from previous year 1,035 136
Pay
Salaries 46,691 48,153
Superannuation and gratuities 3,636 4,624
Total Pay 50,327 52,777
Non-Pay
Direct patient care 5,126 5,100
Support services 4,977 4,379
Financial and administrative 3,430 3,253
Total Non Pay 13,533 12,732
Gross expenditure for the year 64,895 65,645
Income (19,464) (20,963)
Net expenditure for the year 45,431 44,682
HSE Funding notified for the year (45,351) (43,647)
Deficit for the year carried forward 
to following year 80 1,035
8
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The Master
10
I N T R O D U C T I O N
2013was another very busy year for the Rotunda Hospital.  Therecent trend of very high activity levels, coupled with asignificant reduction in budget allocation and headcount 
continued to pose a problem for the Hospital.  Looking back at
the figures over the years, the Hospital now looks after in excess of two and a
half thousand more women than it did ten years ago.  The fact that outcomes
remain as good as they are is a great tribute to the skill and dedication of the
staff of the Hospital. 
There were 11,121 patients registered for antenatal care, which was 1% less than
2012. We delivered 8841 babies greater than 500 grams to 8648 women. Over a ten
day period in early December, there were three 24 hour periods of time when there
were 47, 43 and 42 deliveries. This is a completely unacceptable level of activity,
given the resources available to the Hospital. Sadly, there were 3 deaths of mothers
delivered in 2013. The corrected perinatal mortality for the year was 4.0 per
thousand, which is very much in line with recent years.
There were 10 patients transferred from the Rotunda to the Mater HDU/ITU in
2013. This confirms the recent trend where we are seeing high complexity levels
within our obstetric population. It also highlights the fact that the hospital is
transferring its sickest patients by ambulance, due to the fact that we are not co-
located with an acute adult hospital and we have no immediate access to
intensive care facilities.  Given the issues highlighted around the deficiencies
within maternity services around the country, this is completely unacceptable
in a country that purports to have a modern health service.
Maternity services in Ireland became the focus of significant attention both
nationally and internationally following the tragic death of Savita
Halappanavar in Galway.  There was also significant media attention around
the new Protection of Life During Pregnancy Bill and the Oireachtas hearings at
the beginning of the year.  All of this attention has focused on the lack of
resources in relation to maternity services in this country.  There have been a
number of reports issued over the last ten years, however the inaction in
relation to implementing the recommendations of these reports has led to a
significant under-resourcing of services in relation to maternity and gynae care.
Despite representations to the HSE and to the Department of Health, little has
been done in relation to making any progress in improving infrastructure,
services or staffing levels in the maternity sector.  Our midwife to patient ratio
is too low and we require more consultants to staff our maternity units.  These
issues are compounded by increasing difficulty in attracting sufficient numbers
of good junior staff into the specialty.
2013 also saw the release of the long-awaited Higgins Report into the formation
of hospital groups.  The Rotunda is part of the RCSI Academic Hospitals Group,
covering most of the North-East region and North Dublin. The Higgins report
also recognised the unique relationship the Rotunda has with the Mater
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Hospital, and although the Mater is not in the same group as the Rotunda, the
report clearly indicates that the special relationship the Rotunda has with the
Mater should continue.
The hospital will continue to work with our new partners within the RCSI
Academic Hospitals Group and our long term ambition remains to be co-located
with a significant acute adult hospital partner on the Northside of the city.  In the
meantime the urgent clinical needs of the hospital must be addressed.  To this
end meetings have occurred over the year and early into 2014 with Dublin City
Council in an attempt to smooth the path for a West Wing Development, which
would address our most urgent clinical needs.  This development will include
additional labour ward rooms and theatre facilities in addition to new out-
patient facilities and additional postnatal beds.
One of our most significant clinical concerns is the growing waiting list for
gynaecology services.  There has been a huge increase in demand for access to
benign gynae services within the region.  The population of the region has
increased significantly, which in the first instance led to a big increase in
demand for maternity services, however this is now leading on to a 60%
increase in demand for gynae outpatient appointments.  The hospital, because
of its infrastructural deficits and the need to cope with the demand led
maternity services, cannot meet the current demand for benign gynaecology.
This problem has been exacerbated by the fact that the acute hospitals who do
some benign gynaecology are currently unable to facilitate significant amounts
of benign gynae surgery, due to bed issues; and the fact that our closest
neighbour, the Mater, now concentrate the majority of their gynae service on
gynae oncology.  The hospital has been working with the Special Delivery Unit
within the Department of Health to assist with dealing with waiting lists,
however work done to date has really only managed to clarify what the waiting
list to be seen in out-patients actually is.  A significant initiative will need to be
undertaken to assist clearing this waiting list for out-patient appointments.  In
addition the hospital will be working with partners within the North East
region to see if there is any way that spare capacity can be identified within the
regional hospitals.  A new West Wing Development will be beneficial, however
funding will be required for additional staff for this to succeed.
Over the course of 2013, the hospital hosted three high profile educational
meetings held, all of which were extremely well attended and feedback was
very positive. The first was a ‘Maternal Medicine Update’ meeting in March; the
second a ‘Fetal Monitoring’ study day in June. The Hospital was awarded a prize
for ‘Best Educational Meeting’ at the Irish Healthcare Awards, for ‘The Human
Cost; Cerebral Palsy secondary to Birth Asphyxia in the Term Infant’ which was
held in September.  The Hospital was also the focus of very favourable publicity
at the launch of the Sustainable Energy Ireland initiative, when Minister Pat
Rabbitte attended the Hospital in February of 2013.
The Bartholomew Mosse Charter Day Lecture was delivered by Professor Lisa
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Hornberger, visiting from Canada.  Unfortunately the usual Charter Day dinner
had to be postponed because of ongoing renovation work on the old front hall.  It
is hoped that this work will be completed in 2014.  The hospital hosted the usual
undergraduate students from RCSI and in addition a number of overseas
students did elective periods during the summer of 2013.  The hospital held its
annual Mini Medical school in October.  This was an extremely successful event
and my thanks to all of the staff who gave up their time to get involved in
teaching of all of the undergraduate students and the school children attending
the Mini Medical school.
The Friends of the Rotunda as usual provided huge support during the year for
research within the hospital and the annual Golf Classic which was again held
in Milltown helped to raise important funds.  My thanks to Sheila Thompson and
all of those who contribute hugely to this valuable resource for the hospital.
Over the course of the year the hospital management team again put in a huge
effort to bring the hospital in close to budget.  Great credit is due to Pauline
Treanor, Chris Kenny and the team for the work that they do in this area.
The Board of Governors continue to play a really important role in overseeing the
running of the hospital and my sincere thanks to all of those on the Board who
contribute hugely to, not just the General Board, but the various sub-committees
of the Board.  These individuals provide their services free of charge to the
hospital and have contributed hugely to the developing governance systems
that have been put in place over the last couple of years.  The hospital continues
to put in place clinical guidelines and perform gap analysis against national
guidelines.  Again my thanks go to all of those individuals who take part in this
onerous work.  The Clinical Audit Department continues to work extremely well
under the stewardship of Dr. Sharon Cooley who gets through a huge amount of
work with the assistance of her team.  Dr. Peter McKenna as Clinical Director has
put in a great deal of work on a variety of projects over the year and has been on
enormous assistance to me as Master.  For all of the work that he puts in, ably
assisted by Anne in the office, I am deeply grateful.
To all of my consultant colleagues and to all of the NCHDs in all specialities and
particularly to our midwifery colleagues, ably led by Margaret Philbin, our
Director of Midwifery, I am deeply grateful for the extraordinary level of
commitment that they bring to their jobs.  We work out of a facility which is no
longer fit for purpose and we are working very hard with the HSE and the
Department of Health to progress plans to deliver a west wing development to
address some of the most urgent clinical issues that we face.
I would particularly like to thank all of the heads of departments and all staff in
all areas for the hugely valuable work that they do in contributing to the life and
work of the hospital.  I would like to thank all of those who assisted in
I N T R O D U C T I O N
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compilation of the annual report and all of those who have contributed to the
significant number of quality initiatives that have happened in the hospital
over the year.   I would also like to wish Ann Frankish, our Chief Pharmacist,
well;  Ann retired after 26 years service, and we welcome Brian Cleary her
replacement.
Towards the end of 2013 the voluntary hospitals sector became the focus of
attention in relation to compliance around pay issues.  The hospital is
extremely concerned in relation to the reputational damage that this issue
may cause.  This hospital also has serious concerns in relation to the reputation
of the voluntary hospitals sector in this regard.  It is important that it is widely
understood the value that the voluntary hospital sector has played within Irish
Healthcare.  A significant number of the academic and research centres within
the country are housed within the voluntary hospital sector.  Many of the
leaders in Irish Healthcare work within these institutions.  Much of the
progress in terms of quality and efficiency within the Irish Health Service has
arisen within the voluntary hospital sector and voluntary hospitals have a
unique ability to respond to the needs of a constantly evolving population.  It is
vitally important that within the new hospital groups system that the value of
voluntary hospitals is not undermined and that the pivotal roles that they have
played within Irish Health Care is celebrated and harnessed for the future good
of the Irish Health System.
2014 promises to be another difficult year with similar budgetary challenges
and staffing issues being a serious concern across the country.  There are large
numbers of unfilled medical posts with reduced numbers of trainees making
applications for the specialty and difficulty recruiting for both medical and
midwifery and nursing positions which is a very serious concern for the
hospital and the service in general.
Lastly I would particularly like to single out Dr. Sharon Cooley for her assistance
with this report and also Mary and Anne in the Master’s office for the massive
effort they both put in to supporting the work that we do.
Dr. Sam Coulter-Smith.
Master.
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Y E A R S 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Babies
Born 6731 6804 7325 8456 8799 8912 8792 9319 9041 8841
Perinatal
Deaths 61 
+ 13 * 61 + 10* 50 + 13 * 66 + 10 * 64 + 7* 56+ 5* 69+5* 59+2* 66+2* 63+6*
Perinatal
Mortality
Rate
11 9.8 8.6 9.0 8.1 6.8 8.4 6.5 7.5 7.8
Mothers
Attending 7,290 7,518 8,036 9,290 9,655 9,709 9,594 10547 10397 10314
Maternal
Deaths 1 0 0 0 1 2 3 3 2 3
Caesarean
Section
%
26.6 25.6 27.7 27.1 26.2 28.5 27.9 29 29 31
Forceps/
Ventouse
%
16.5 15.3 16.8 17 20 19.8 20.5 19.4 18 17
Epidural
% 48 46.7 47 47 49 49.2 46.6 46 48 47
Induction
% 19 19 20 20 21 23.27 27 29 28 29
* Unbooked
16
C O M PA R A T I V E  R E S U L T S  F O R
1 0  Y E A R S
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S T A T I S T I C A L  S U M M A R I E S
1.  TOTAL MOTHERS ATTENDING Totals 2013
Mothers who have delivered babies weighing >500 grams 8648
Mothers who have delivered babies weighing <500 grams {including
miscarriages} 1666  
Hydatidiform Moles * 39  
Ectopic Pregnancies 192  
Total Mothers Delivered 10314
*This figure includes complete & Partial Hydatidform Moles 
2.  MATERNAL DEATHS Totals 2013
Maternal Deaths 3
3.  BIRTHS Totals 2013
Singletons 8652 
Twins                                                                                                         181 
Triplets                                                                                                          8 
Quadruplets                                                                                                   0 
Total Babies Delivered weighing> 500 grams 8841
4.  OBSTETRIC OUTCOME Totals 2013
Spontaneous Vaginal Delivery 52% 
Forceps 6% 
Ventouse 11% 
Caesarean Section 31% 
Induction of Labour 29% 
Breech Deliveries included in spontaneaous vaginal delivery
5.  PERINATAL DEATHS Totals 2013
Antepartum Deaths 42    
Intrapartum Deaths 0    
Stillbirths 42  
Early Neonatal Deaths 27
Late Neonatal Deaths 4
Congenital Anomalies 29          
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6.  PERINATAL MORTALITY RATES                                                      Totals 2013
Overall Perinatal Mortality Rate per 1,000 Births 7.8  
Perinatal Mortality Rate Corrected For Lethal Congenital Anomalies 4.5 
Perinatal Mortality Rate Including Late Neonatal Deaths 8.2       
Perinatal Mortality Rate Excluding Unbooked Cases 7.1 
Corrected Perinatal Mortality Rate Excluding Unbooked Cases 4.0   
7.  STATISTICAL ANALYSIS OF HOSPITAL POPULATION
AGE AT DELIVERY 2007 2008 2009 2010 2011 2012 2013
<20 4.7% 4.7% 3.8% 3.5% 3.0% 2.8% 2.5%
20-24 16.2% 14.8% 14.6% 13.1% 12.4% 11.6% 11.0%
25-29 24.7% 25.7% 24.7% 24.6% 23.6% 23.2% 21.5%
30-34 30.5% 30.2% 31.6% 31.6% 33.6% 34.8% 34.8%
35-39 19.9% 20.5% 21.3% 22.2% 22.5% 22.0% 24.3%
>=40 4.0% 4.1% 4.0% 5.0% 4.9% 5.5% 5.9%
PARITY 2007 2008 2009 2010 2011 2012 2013
0 46.9% 48.9% 47.3% 45.5% 45.5% 44.4% 42.6%
1 30.9% 29.3% 31.2% 32.3% 32.8% 34.1% 34.1%
2-4 20.8% 20.8% 20.4% 21.1% 20.7% 20.3% 22.1%
5+ 1.4% 1.0% 1.1% 1.1% 1.0% 1.2% 1.2%
BIRTHWEIGHT 2007 2008 2009 2010 2011 2012 2013
(grams)
500-999 0.8% 0.6% 0.5% 0.6% 0.5% 0.7% 0.8%
1000-1499 1.0% 1.1% 0.9% 0.7% 0.8% 1.0% 0.9%
1500-1999 1.6% 1.6% 1.6% 1.4% 1.6% 1.5% 1.7%
2000-2499 4.2% 3.7% 3.4% 4.0% 3.8% 4.0% 4.1%
2500-2999 13.0% 13.4% 13.6% 13.1% 13.8% 12.9% 13.0%
3000-3499 33.1% 33.0% 33.5% 32.1% 32.4% 31.5% 32.6%
3500-3999 31.7% 32.3% 34.4% 32.9% 33.0% 34.1% 32.4%
4000-4499 12.5% 12.2% 10.0% 12.7% 11.8% 12.2% 12.2%
4500-4999 2.2% 2.0% 1.9% 2.3% 2.1% 2.0% 2.2%
>5000 0.2% 0.3% 0.2% 0.2% 0.2% 0.1% 0.1%
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GESTATION 2007 2008 2009 2010 2011 2012 2013
(Weeks) 
<26 weeks 0.3% 0.3% 0.2% 0.3% 0.2% 0.3% 0.3%
26 - 29 weeks + 6 days 0.8% 0.6% 0.6% 0.6% 0.8% 0.7% 0.7%
30 - 33 weeks + 6 days 1.7% 1.5% 1.4% 1.4% 1.3% 1.5% 1.5%
34 - 36 weeks + 6 days 4.6% 4.1% 4.1% 4.3% 4.4% 4.4% 4.4%
37 - 41 weeks + 6 days 90.1% 90.9% 92.6% 92.8% 93.2% 93.0% 93.0%
42 + weeks 2.5% 2.5% 1.1% 0.6% 0.2% 0.2% 0.1%
19
51639 Rotunda Clinical Report 2013 301014 v5_Clinical Rep  30/10/2014  11:56  Page 19
NOTES ON PERINATAL MORTALITY
1. The overall rate applies to all babies weighing greater than or equal to 
500g who were stillborn or died in the first seven day of life (69).
2. The uncorrected perinatal mortality rate is calculated when unbooked (6) cases
are excluded.  Late bookers are considered as booked cases.
3. The corrected perinatal mortality rate is the uncorrected perinatal deaths
(63) less the number of congenital malformations (29 – 1 unbooked = 28) =
35.  This gives an uncorrected rate of 7.1 and a corrected rate of 4.0.
STILLBIRTHS
Stillbirths 42
Congenital Malformations 13
Placental 10
Cord 7
Extreme Prematurity 4
Feto Maternal Haemorrhage 2
Infection 1
Unexplained 5
F E T A L  L O S S
T h e  M a s t e r
20
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Congenital (13)
1. Age 21. Para 0.  Booked at 15 weeks gestation.  Ultrasound at booking
consistent with dates.  Plan for combined antenatal care.  No significant
medical or family history.  Anencephaly diagnosed at the anatomy scan at
23 weeks gestation.  Amniocentesis at 31weeks gestation.  Female
karyotype confirmed.  Spontaneous onset of labour at 32 weeks gestation
and a stillborn female infant weighing 0.86 kilograms delivery.  Post-
mortem declined.  Cause of death lethal fetal anomaly.
2. Age 40. Para 1.  One previous caesarean section.  Transfer of care from
Drogheda with gestational diabetes at 29 weeks gestation and fetal
superventricular tachycardia.  Tachycardia resolved using flexinide 100mg
three times a day. Significant fetal ascites and scalp oedema.  Subsequent
intrauterine fetal demise at 34 weeks gestation.  Caesarean section was
undertaken.  Stillborn male infant weighing 3.35 kilograms delivered.
Post-mortem performed.  Cause of death ascribed as fetal dysrhythmia.
3. Age 22. Para 0+1.  Booked at 14 weeks.  Medical history of depression.
Smoker – 10 cigarettes per day.  Booking bloods normal.  Anatomy scan at
21 weeks gestation showed evidence of anhydramnios, two vessel cord and
a pericardial effusion.  Bilateral renal agenesis diagnosed.  Antenatal care
in the Fetal Medicine Unit.  Spontaneous onset of labour at 32 weeks
gestation.  Assisted breech delivery of a stillborn female infant.
Subsequent post-mortem revealed evidence of sirenomelia, bilateral renal
agenesis and a confirmed female karyotype.  Cause of death lethal
congenital anomaly.
4. Age 25. Para 1+1.  One previous full normal delivery of a male weighing
4.05 kilograms and one first trimester loss.  No significant medical or
family history.   Booked at 13 weeks gestation and a cystic hygroma was
identified.  Referred to Prenatal Diagnosis.  Opted for invasive testing.
Normal female karyotype.  Hypoplastic left heart identified on ultrasound
at 20 weeks gestation with a large atrial septic defect and a dilated right
ventricle.  Follow-up in the Fetal Medicine Unit.  Intra-uterine fetal demise
diagnosed at 23 weeks gestation.  Labour induced.  Stillborn female infant
weighing 930g delivery.  Large septic cystic hygroma secondary to
congenital heart disease.  Fetal demise secondary to congenital anomaly.
5. Age 34. Para 1+1.  One previous first trimester loss and one emergency
section at 41 weeks of a liveborn male infant weighing 3.37 kilograms.
Indication for caesarean section was fetal distress.  Booked in Mount
Carmel Hospital.  Care transfer to the Rotunda due to a fetal diagnosis of a
left sided congenital diaphragmatic hernia.  The femur length was noted
to be small, less than the 5th centile and there was a two vessel cord. Forth-
nightly antenatal care visits.  Fetal demise was identified at 32 weeks
gestation.  Elective caesarean section undertaken at maternal request.
Stillborn male infant weighing 1.87 kilograms was delivered.  A limited
post-mortem was undertaken and confirmed the left sided fetal
diaphragmatic hernia.  Cyto-genetics unfortunately failed to grow and 21
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placental examination showed a hyper-coiled cord with an non-occlusive
thrombi.  Cause of death in the absence of a full post-mortem, placental
cause may have contributed to the death however anuploid and
additional anomalies cannot be excluded with a background history of a
left sided congenital diaphragmatic hernia.
6.  Age 28. Para 2.  Two previous full term normal deliveries of male infants
in 2010 and 2011 both normal weight.  Medical history of migraine.
Ultrasound at 12 weeks diagnosed anencephaly.  Hospital based antenatal
care.  Labour induced at 39 weeks gestation.   Stillborn female infant
weighing 2.33 kilograms.  Cause of death fetal anomaly.
7. Age 34. Para 1.  One previous term caesarean section for fetal distress in
another hospital at 41 weeks gestation. Male infant weighing 3.8
kilograms. History of postnatal depression.  Non-smoker.  Booked at 12
weeks gestation.  Ultrasound revealed singleton fetus consistent with
dates.  Planned for combined antenatal care.  VBAC discussed.  Anatomy
scan at 19 weeks gestation with sub-optimal views of the renal system.
Arrangements for re-scan.  Scan at 24 weeks was normal.  Polyhydramnios
noted at 32 weeks gestation.  Ultrasound performed and revealed a growth
restricted infant and a dilated right atrium, dilated loops of bowel and an
abnormal fetal posture.  Amniocentesis undertaken at 33 weeks.  Edwards
Syndrome diagnosed.   Hypertension in the latter half of pregnancy.
Intrauterine fetal demise at 40 weeks gestation.  Labour induced.  Stillborn
female infant weighing 2.16 kilograms.  Cause of death Edwards
Syndrome.
8. Age 32. Para 1.  Previous emergency caesarean section for failed induction.
Prior gestational diabetes.  Non-smoker.  Booked at 14 weeks gestation.
Occipital encephalcoele diagnosed on the anatomy scan at 21 weeks
gestation.  Intrauterine fetal demise at 23 weeks gestation.  Labour
induced and a stillborn male infant weighing 0.55 kilograms delivered.
Normal karyotype.  Cause of death lethal congenital anomaly.
9. Age 34. Primip.  Booked at 14 weeks gestation.  Medical history of
depression and scoliosis.  Non-smoker.  Plan for combined antenatal care.
Short long bones identified at the time of anatomy scan at 22 weeks
gestation, with no evidence of bowing or fracturing of the bone.
Amniocentesis undertaken.  Confirmed Trisomy 21.  Intrauterine fetal
demise at 27 weeks gestation.  Labour induced and stillborn male infant
weighing 1.29 kilograms was delivered.  No PM. Cause of death Trisomy 21.
10. Age 25.  Para 1+1.  Prior term emergency caesarean section for fetal distress
of a female infant weighing 3.86 kilograms and one spontaneous loss.  No
significant medical history, non-smoker.  Booked at 13 weeks gestation.
Ultrasound at booking revealed a singleton intrauterine pregnancy
consistent with dates.  Arrangements were made for combined antenatal
care.  Planned VBAC.  Normal anatomy scan at 22 weeks gestation.
Subsequent small for dates infant identified at 36 weeks gestation, with
an estimated fetal weight less than 5th centile and polyhydramnios.  
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Arrangement made for glucose tolerance test which was normal.
Subsequently presented to the Emergency Room at 37+5 weeks gestation
with decreased fetal movements and an intrauterine fetal demise was
diagnosed.  Induction of labour. Stillborn female infant delivered
weighing 1.82 kilograms.  Limited post-mortem performed.  Multiple fetal
abnormalities evident.  Placental karyotype showed 46XX additional (17)
(P13).  Placental examination revealed a dysmorphic infant with evidence
of intrauterine growth restriction and chronic utero placental
insufficiency and multi focal fetal thrombotic vasculopathy. Cause of
death Anuploidy.
11. Age 39. Para 1 +2.  One previous emergency caesarean section of a live
born male infant weighing 2.55 kilograms.  Two subsequent first trimester
losses.  History of hypertension in pregnancy and a family history of
congenital cardiac disease.  Booked at 10 weeks gestation.  First trimester
screening discussed.  Consultant led antenatal care.  Fall off in fetal
growth noted at 28 weeks gestation.  Intrauterine fetal demise at 30 weeks
gestation.  Labour induced.  Stillborn female infant weighing 1 kilogram
delivered.  Post-mortem revealed Trisomy 21 with congenital abnormal
myelopoiesis in the form a megakaryo blastic leukaemia.  Cause of death
congenital myelopoiesis secondary to Trisomy 21.
12. Age 36. Para 1 +2.  Two previous first trimester losses and one term vaginal
delivery of a female infant weighing 3.32 kilograms.  Past history of a
pituitary tumour.  Booked at 10 weeks gestation.  Non smoker.  Ultrasound
confirmed a singleton pregnancy consistent with dates.  Anatomy scan at
20 weeks gestation revealed an abnormal four chamber cardiac view and
abnormal cardiac vessel alignment.  Amniocentesis undertaken and
cardiology referral requested.  Fetal echo cardiography revealed a
completed AVSD with pulmonary atresia.  Poor fetal prognosis discussed.
Sinus bradycardia and subsequent intrauterine demise at 25 weeks
gestation.  Stillborn female infant weighing 1.03 kilograms delivered.
Cause of death cardiac anomaly. 
13. Age 35. Para 1.  One previous term delivery of a female infant weighing
3.65 kilograms.  Booked at 12 weeks gestation.  No significant medical
history.  Non-smoker.  Ultrasound revealed a singleton pregnancy
consistent with dates.  Arrangements for combined antenatal care.
Anatomy scan undertaken at 20 weeks gestation.  Oligohydramnios at the
time of the anatomy scan with an increased nuchal fold, absent stomach
bubble.  Dilated ureters.  Abnormal heart views.  Likely bladder outlet
obstruction diagnosed.  Feticide in another jurisdiction at 24 weeks
gestation.  Stillborn male infant was delivered weighing 0.625 kilograms.
Normal karyotype.  Cause of death feticide in another jurisdiction on the
basis of prenatal diagnosis of bladder outlet obstruction.
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Placental  ( 10 )
1. Age 21. Para 0.  Booked at 19 weeks gestation.  Ultrasound confirmed
gestational age.  No significant medical history.  Non-smoker.  Combined
antenatal care.  Normal anatomy scan at 21 weeks.  Presented to the
Emergency Room with decreased fetal movements at 37 weeks and
intrauterine fetal demise diagnosed.  Labour induced and a stillborn male
infant weighing 2.94 kilograms was delivered.  Negative for thrombophilia,
normal thyroid function test, normal haemoglobin A1C, negative Torch
screen.  Post-mortem performed.  Excluded congenital anomaly.  Evidence of
hypoxia was present.  Placenta showed delayed villous maturation and a low
grade ascending infection.  
2. Age 32. Para 2. Previous emergency caesarean section at term, followed by
stillborn assisted breech at 29 weeks. Booked at 12 weeks.  Normal anatomy
scan at 18 weeks. Serial scans performed. Normal growth and dopplers at 20,
23 and 27 weeks. Presented at 28 weeks with vaginal bleeding. Scan
confirmed no fetal heart. Assisted breech delivery of a male infant weighing
1.06kgs. Blood pressure elevated postnatally, requiring treatment.
Thrombophilia screen negative. Placental histology showed features of
severe chronic uteroplacental insufficiency. PM declined. Cause of death:
chronic uteroplacental insufficiency.
3. Age 28. Para 0.  Referred from Mullingar Hospital at 25 weeks gestation with
dichorionic diamniotic twins, both of whom showed evidence of severe
growth restriction.  Weekly follow-up in the Fetal Medicine Department.
Intrauterine fetal demise of twin I at 26 weeks gestation.  Subsequent demise
of twin II at 28 weeks gestation.  Twin I weighed 210g at delivery and twin II
weighed 720g at delivery. PM performed.  No evidence of congenital anomaly
in either infant.  Cause of death ascribed to both infants as chronic utero
placental insufficiency.   Serological investigations negative.
4. Age 34.  Para 3.  Booked at 12 weeks gestation.  Prior history of preterm births.
First pregnancy induced at 34 weeks gestation and a vaginal delivery of
female infant weighing 2.35 kilograms.  Reason for induction pre-eclampsia.
In second pregnancy laboured spontaneously at 32 weeks and 6 days, twin
girls, twin I – 1.8 g, normal delivery.  Twin II weighed 1.75 kilograms and was
an emergency caesarean section.  VBAC discussed at booking.  Commenced
on low dose aspirin.  Shared antenatal care with consultant review at each
visit.  Normal fetal growth throughout the pregnancy.  Attended the
Emergency Department at 36 weeks gestation with a history of decreased
fetal movement and intrauterine fetal demise was diagnosed.  Labour was
subsequently induced.  Stillborn female infant delivered weighing 2.92
kilograms.  Post-mortem excluded congenital anomalies.  Placenta showed
evidence of multi focal mild to moderate villitis.  Thrombophilia screen, Torch
screen, thyroid function tests and haemoglobin A1C all normal.  Cause of
death placental villitus.
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5. Age 22. Para 0.  Unbooked. Presented to the Emergency Room at 24 weeks
gestation with abdominal pain.  Intra-uterine fetal demise diagnosed.
Subsequent induction of labour and a stillborn female infant weighing 870g
was delivered.  Consented to limited post-mortem examination.  The infant
was negative for external congenital malformations.  Cyto-genetics 46xx
consistent with female karyotype.  Placental examination showed evidence
of severe chronic utero-placental insufficiency with accelerated villous
maturation and significant infarction.  Cause of death likely placental
disease.
6. Age 25. Para 2+1.  Two previous full term deliveries of appropriately grown
infants and a first trimester loss in 2012.  Past history of postnatal
depression.  Smoked 20 cigarettes a day at booking.  Booked at 12 weeks
gestation.  Dates consistent with scan findings.  Booked for Midwifery Led
Care.  Transferred to Consultant Led Care at 33 weeks gestation due to
maternal history of anaemia with a haemoglobin of 8g per litre.  Normal
booking bloods.  Haemoglobin 10g per litre at booking.  Normal anatomy
scan at 21 weeks.  Presented to the Emergency Room at 37 weeks with
concealed abruption and intrauterine fetal demise.  Stillborn male infant
weighing 2.17 kilograms delivered. Significant quantity of clots delivered
with the placenta consistent with concealed abruption.  Post-mortem
declined.  Placental examination showed evidence of a retro-placental
haemorrhage associated with placental infarction and ascending infection.
Cause of death placental abruption.
7. Age 30. Para 1+1.  Previous emergency caesarean section for a non-
reassuring CTG in early labour.  Delivery of a female infant weighing 2.37
kilograms.  History of anxiety.  Non-smoker.  Booked at 15 weeks gestation.
Ultrasound consistent with dates.  Combined antenatal care.  Vaginal birth
after sections discussed and plan for same.  Noted to be large for dates at
term.  Referred for ultrasound.  Intrauterine fetal demise diagnosed.  Labour
induced and still born male infant delivered, weighing 2.54 kilograms.  Post-
mortem performed.  Excluded congenital anomalies.  Delayed villous
maturation on placental examination.  Coagulation screen profile
haemoglobin A1 screen normal.  Normal thyroid function test.  Cause of
death delayed villous maturation in the placenta.
8. Age 35. Para 0.  Booked at 15 weeks gestation.  No significant medical history.
Smoker of 10 cigarettes per day.  Ultrasound at 15 weeks showed a mismatch
in dates with a crown rump length of approximately 7 weeks.  EDD assigned
on ultrasound.  Normal anatomy scan at 22 weeks gestation.  Sudden onset
of abdominal pain at 29 weeks gestation.  Attended the Emergency Room
and an intrauterine fetal demise was diagnosed.  Labour was induced and a
stillborn male infant weighing 1.4 kilograms was delivered.  Placental
examination showed evidence of retroplacental haemorrhage.  Post-
mortem performed and was negative for congenital malformation.  Cause of
death placental abruption.
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9. Age 40. Para 1+3.  Previous term assisted delivery of a live born male infant.
Two previous miscarriages and one previous molar pregnancy.  Non smoker.
Booked at 12 weeks gestation for hospital based care.  Presented at 35 weeks
gestation with decreased fetal movements for the preceding two days.
Intrauterine fetal demise diagnosed.  Labour was induced and a stillborn
female infant was delivered weighing 2.5 kilograms.  Post mortem -excluded
congenital anomaly.  Placental history showed evidence of a multi-focal
chronic villitis and intervillitis suggestive of fetal thrombotic vasculopathy
and a hypocoiled cord.  Cause of death placental disease.
10. Age 36. Para O.  Later booker at 24 weeks gestation, uncertain dates. Non-
national.  Non-smoker.  No significant medical history.   Anatomy scan at 26
weeks gestation showed no obvious fetal anomaly.  Presented the clinic at 27
weeks gestation with no fetal movements.  Intrauterine fetal demise
diagnosed.  Induction of labour.  Stillborn male infant weighing 1.01 kilograms
delivered.  Normal haemoglobin A1C.  Normal thyroid function.  Kleihauer
negative.  Placental exam showed evidence of chronic utero-placental
insufficiency with a large utero placental haemorrhage.  Post-mortem
performed.  No obvious congenital anomaly.  However mosaic karyotype
identified on placental karyotyping.  Possible placental mosaicism requiring
referral for genetic counselling and karyotyping.  Hypocoiled cord.  Cause of
death retroplacental haemorrhage.   Genetic referral for the couple to exclude
a balanced translocation and possible recurrence.
Cord  (7 )
1. Age 38. Para 2.  Two previous elective caesarean sections at term for breech
presentation. Pregnancy induced hypertension in both pregnancies,
however no anti hypertensives required.  Non smoker.  Booked at 11 weeks
gestation.  Combined antenatal care.  Plan for elective caesarean section at
term.  Normal anatomy scan at 20 weeks gestation.  Presented at 28 weeks
gestation with decreased fetal movements for the preceding 3 to 4 days.
Intrauterine fetal demise diagnosed.  Anhydramnios noted at the time of
diagnosis.  Labour induced and a stillborn male infant was delivered
weighing 0.87 kilograms.  Post-mortem excluded congenital anomalies.
Hypercoiled cord with a true knot in the cord identified.  Normal other
post-mortem bloods.  Cause of death cord accident.
2. Age 32. Para 0.  Booked at 16 weeks gestation.  EDD assigned based on
ultrasound due to a five week discrepancy.  Non-smoker.  No significant
medical history.  Family history of muscular dystrophy.  Combined
antenatal care.  Admitted to the hospital with a non-substantial
antepartum haemorrhage at 39 weeks gestation and intra-uterine fetal
demise was diagnosed.  Labour induced.  Stillborn male infant delivered
weighing 3.35 kilograms.  Thrombophilia screen negative.  Torch screen
negative.  Normal thyroid function test and normal haemoglobin A1C.
Post-mortem performed.  No evidence of congenital anomalies.  Placental
examination revealed evidence of a cord accident with a tight nuchal cord
and non occlusive thrombo in the umbilical vein with additional thrombi
in larger stem vessels consistent with a cord accident.26
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3. Age 29. Para 1 +2.  Previous elective caesarean section at term and two first
trimester losses.  Past history of dermatitis.  Smoker – 10 per day.  Booked
at 12 weeks gestation.  VBAC discussed.  Singleton uterine pregnancy noted
at booking consistent with dates.  Normal anatomy scan at 20 weeks
gestation.  Combined antenatal care.  Presented at 38 weeks with
decreased fetal movement and intrauterine fetal demise diagnosed.
Induction of labour.  Stillborn male infant weighing 3.8 kilograms
delivered.  Placental examination showed a tight true knot in the cord
with evidence of circulatory obstruction.  Normal thyroid function.
Normal haemoglobin.  Normal coagulation profile.  Post-mortem declined.
Cause of death – true knot in the cord, cord accident.
4. Age 35. Para 1+2.  History of two first trimester losses in 2002 and 2004 and
an emergency caesarean section at 41 weeks of a liveborn female infant
weighing 3.41 kilograms.  Booked at 16 weeks gestation.  On prophylactic
innohep due to a strong family history of venous thrombosis and the
patient’s own additional risk factors which would include pregnancy and
morbid obesity.  Had presented with calf pain to a General Hospital early
in pregnancy and commenced on innohep prior to her first visit.  Normal
anatomy scan at 23 weeks gestation.  Presented with decreased fetal
movements at 27 weeks gestation and intrauterine fetal demise was
confirmed.  Labour was subsequently induced and a stillborn female
infant weighing 0.87 kilograms was delivered.  Post-mortem showed no
evidence of congenital anomalies but showed evidence of cord accident
with an occlusive thrombus in the umbilical artery and an increased
coiling index.  Cause of death cord accident.
5. Age 24. Para 2.  Unbooked. Booked in another jurisdiction.  Diagnosed with
an intrauterine fetal demise at 35 weeks.  Patient was involved in a road
traffic accident two weeks prior to the intrauterine fetal demise.  Decided
to travel home to be with family.  Stillborn male infant born before arrival
in the hospital.  Male infant weighing 2.42 delivered.  Post-mortem
performed.  No obvious external congenital malformations.  Placental
histology showed evidence of an increased coiling index in the umbilical
cord with a non-occlusive thrombus in the umbilical artery and fetal stem
vessels.   Negative Torch screen.  Normal thyroid function screen.  Normal
haemoglobin A1C.  Cause of death cord accident.
6. Age 21. Para 0.  Medical history of migraine and asthma.  Smoker of up to
10 cigarettes a day.  Booked at 14 weeks gestation for combined antenatal
care.  Normal anatomy scan at 20 weeks gestation.  Presented to the
Emergency Room at 38 weeks gestation with no fetal movements.
Intrauterine fetal demise diagnosed.  Labour induced.  Stillborn female
infant delivered weighing 2.67 kilograms.  Placental examination showed
a hyper-coiled cord and evidence of obstruction with the fetal circulation.
Post-mortem was negative for congenital malformation.  Cause of death
cord accident on a background of delayed villous maturation.
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7. Age 25. Para 1.  One previous term uncomplicated vaginal delivery of a male
infant weighing 2.8 kilograms.  No significant medical history. Smoked 10 a
day at booking.  Booked at 14 weeks gestation.  Singleton pregnancy
consistent with dates.  Plan for combined antenatal care.  Normal anatomy
scan undertaken during the pregnancy. Failed to attend for antenatal care
after 34 weeks gestation. Presented at 38 weeks and 6 days gestation in early
labour.  Intrauterine fetal demise diagnosed.  Post-mortem declined.
Haemoglobin A1C normal.  Thyroid function normal.  True knot identified in
the cord.  Cause of death cord accident.
Extreme Prematur ity  (4 )
1. Age 38.  Para 0.  Admitted to another Hospital at 22 weeks with PPROM and
transferred to the Rotunda in the fetal interest.  Anhydramnios and a
breech presentation of a 500g infant identified on transfer.  Subsequent
onset of labour.  Vaginal delivery of a stillborn female infant weighing
520g.  Post-mortem declined.  Normal haemoglobin A1C.  Normal thyroid
function.  Negative Torch screen.  Placental examination showed evidence
of chorioamniotis.  Cause of death fetal prematurity due to a gestation of 23
week and 4 days.
2. Age 32. Para 0+1. Previous miscarriage. Booked at 13 weeks gestation. No
past history of note. O negative. Scan confirmed dates. Anatomy scan at 21
weeks showed funnelling of the cervix.  Considered for rescue cerclage;
however PPROM prior to procedure. Commenced on antibiotics. Proceeded
to labour within 24 hours. Spontaneous vaginal delivery of stillborn  male
infant weighing 0.6kgs. Required manual removal of placenta. PM
declined. Placental examination revealed evidence of ascending infection
with PHS group B isolated from placenta. Cause of death: extreme
prematurity.
3. Age 33. Para 2+2.  Two previous term normal deliveries of female infants
weighing 3 and 3.5 kilograms and two first trimester losses.  No significant
medical history.  Non-smoker.  Booked at 14 weeks gestation.  Normal
anatomy scan at 23 weeks gestation.  PPROM at 23 weeks and 3 days
gestation.  Subsequent spontaneous vaginal delivery of a stillborn female
infant weighing 0.59 kilograms.  Post-mortem performed in conjunction
with routine post-mortem investigations.  Placental examination revealed
evidence of ascending infection and acute suprative chorioamnionitis.
Post-mortem showed evidence of fetal pneumonia.  Cause of death extreme
prematurity complicated by fetal pneumonia and chorioamnionitis.
4. Age 29. Para 0.  Non-smoker.  Past history of sexually transmitted infection,
successfully treated.  Booked at 13 weeks gestation for combined antenatal
care.  Normal anatomy scan at 20 weeks gestation.  Preterm, pre-viability
rupture of the membranes at 23 weeks gestation.  Stillborn male infant
delivery weighing 0.58 kilograms.  Post-mortem declined.  Cause of death
prematurity. 
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Feto  Maternal  Haemorrhage  (2 )
1. Age 27.  Para 0.   Booked at 15 weeks for combined antenatal care.  Past
medical history of migraine with nil else of note.  Non-smoker.  Normal
anatomy scan at 20 weeks.  Routine antenatal care.  Presented at 40 weeks
with decreased fetal movement.  Labour induced.  Stillborn male infant
weighing 3.6 kilograms. Post-mortem revealed no evidence of congenital
malformation, however evidence of a massive feto-maternal haemorrhage.
Kleihauer taken on the day of delivery showed evidence of a feto-maternal
haemorrhage in excessive of 200 mls.  Placental examination showed
evidence of inter-villous haemorrhage consistent with fetomaternal
haemorrhage.  Cause of death massive feto maternal haemorrhage.
2. Age 31. Para 0+1.  Previous termination of pregnancy.  No significant medical
history.  Non-smoker.  Booked at 13 weeks gestation.  Dates assigned based
on ultrasound.  Plan for combined antenatal care.  Uneventful antenatal
care.  Presented at 39 weeks gestation with decreased fetal movements and
intrauterine fetal demise diagnosed.  Labour induced and stillborn male
infant weighing 3.24 kilograms delivered.  Postnatal investigations revealed
a post Khleiheur with a feto-maternal haemorrhage of approximately 94
mls.  Placental histology showed evidence of feto-thrombotic vasculopathy.
Cause of death feto-maternal haemorrhage.
Infect ion  ( 1 )
1. Age 22.  Para 0+1.  Previous termination of pregnancy in the first trimester.
Late booker at 26 weeks gestation.  Non national, limited English. No
significant medical history.  Smoker - 10 cigarettes a day.  Ultrasound
revealed singleton fetus consistent with dates.  One subsequent visit to the
hospital at 29 weeks gestation.  Failed to attend glucose tolerance test.
Subsequently attended the emergency room at 31 weeks gestation with
decreased fetal movements and intrauterine fetal demise diagnosed.
Labour induced and stillborn female infant weighing 1.62 kilograms was
delivered.  Limited post-mortem undertaken.  It was negative for any
external congenital malformations.  Placental karyotype showed a normal
karyotype.  Histology was strongly suggestive of a suprative
chorioamnionitis as being the cause of the fetal death.  Thrombophylia
screen normal.  Thyroid function test normal.  Haemoglobin A1C.  Cause of
death acute suprative chorioamnionitis.
Unexplained  (5 )
1. Age 27.  Para 1.  Previous full term assisted deliveryof a live born female
infant weighing 3.33 kilograms.  Past history of Bells palsy.  Body mass
index of 18.  Non-smoker.  Booked at 13 weeks gestation.  Ultrasound
revealed singleton fetus consistent with dates.  Plan for combined
antenatal care.  Booking bloods normal.  Regular hospital review.  Presented
to the Emergency Room in early labour at 39 weeks gestation and
intrauterine fetal demise diagnosed.  Subsequent vaginal delivery of a
stillborn female infant weighing 3.85 kilograms.  Post-mortem declined.
Normal haemoglobin A1C.  Normal thyroid function.  Negative Torch
screen.  Normal placental histology.  Cause of death unexplained.
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2. Age 36. Para 1.  Previous elective caesarean section at term for a breech
presentation of a female infant weighing 3.53 kilograms.  Medical history
of migraine.  Non-smoker.  Booked at 12 weeks gestation.  Ultrasound
revealed a singleton pregnancy consistent with dates.  Plan for combined
antenatal care.  Normal anatomy scan at 20 weeks gestation.  Presented to
the Emergency Room with migraine and dyspoenea.  Referred up to the
Mater at 40 weeks gestation for cranial imaging due to severe headaches
and blurred vision.  Normal cranial imaging and normo-tensive therefore
discharged.  Booked for elective caesarean section at 41 weeks if there was
no spontaneous labour.  Presented at 41 weeks for section and intrauterine
fetal demise diagnosed.  Caesarean section undertaken at maternal
request and a stillborn female infant weighing 3.73 kilograms was
delivered.   Post-mortem excluded congenital anomaly.  Placental
examination showed evidence of diffuse delayed villous maturation.
Glucose tolerance test negative.  Torch screen negative.  Thrombophilia
screen negative.  Cause of death unexplained.  
3. Age 27. Para 0+1.  One previous termination in the first trimester.
Unbooked.  Presented at 38 weeks gestation with decreased fetal
movements and an intrauterine fetal demise diagnosed.  Labour induced
and a stillborn female infant weighing 1.54 kilograms delivered.  Post-
mortem investigation showed a negative Torch, negative Kleihauer,
normal thyroid function tests and a normal haemoglobin A1C.  Post-
mortem was negative for congenital anomalies.  Cause of death
unexplained.
4. Age 36. Para 2+1.  Two previous term deliveries of growth restricted
infants weighing between 2 and 2.5 kilograms.  Smoker of 10 per day.  No
significant medical history.  Booked at 13 weeks gestation.  Normal
anatomy scan at 21 weeks gestation.  Presented at 26 weeks with decreased
fetal movements and intrauterine fetal demise diagnosed.  Labour
induced and still born female weighing 0.76 kilograms delivered.  Post-
mortem declined.  Placental examination showed evidence of sub chorial
haemorrhage, thyroid antibodies present in the thyroid function test.
Cause of death unexplained.
5. Age 39. Para 1.  Previous emergency caesarean section for fetal distress of
a live born female infant weighing 3.39 kilograms.  Gestational diabetes in
that pregnancy.  History of secondary infertility.  Non-smoker.  Booked at
13 weeks gestation with a di-chorionic di-amniotic twin pregnancy.
Hospital based antenatal care.  Normal anatomy scan at 20 weeks.  Intra-
uterine fetal demise of twin II at 26 weeks gestation.  Subsequent
caesarean section at 33 weeks gestation for antepartum haemorrhage.
Stillborn female infant weighing 0.65 kilograms delivered and another
female infant weighing 2.87 kilograms delivered, with Apgars 7 at 1 and 9
at 5.  Cause of death unexplained.
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EARLY  NEONATAL  DEATH
Neonatal  Deaths 27
Congenital Malformations 16
Extreme Prematurity           10
Abruptio Placenta 1
Congenital  Malformation  ( 16 )
1.  Age 36. Para 0+1. Past history of hypothyroidism. Booked at 12 weeks.
Anatomy scan at 20 weeks revealed complex cardiac defect.
Amniocentesis confirmed trisomy 18.  Caesarean section performed at 38
weeks at maternal request. Female infant, 1.77kgs. Apgars 5 at 1, 7 at 5.
Baby died day 1 post-delivery. No PM. Cause of death: trisomy 18.
2. Age 33. Para 2+1.  Two previous spontaneous vaginal deliveries at term
and one 13 weeks loss.   Booked at 30 weeks; referred from another
hospital following scans which suggested renal abnormality.  Scan
confirmed megacystis, bilateral dilated ureters, severe hydronephrosis
and anhydramnios. Had amnio-infusion and bladder shunt inserted.
Advised of lethal prognosis. Followed up in Fetal Medicine department.
Laboured spontaneously at 36 weeks. Baby born before arrival.  Male
infant 2.97kgs.  Apgars 5 at 40 minutes. Baby died at 4 hours of age.  PM
declined. Cause of death: lethal renal congenital malformation.
3. Age 33. Para 3. Unbooked. Visiting Dublin from Belfast.  Known multiple
congenital anomalies: meningomyelocele, diaphragmatic hernia,
ventriculomegaly, polyhydramnios. PPROM while visiting Dublin at 38
weeks gestation. Had planned elective caesarean section in Belfast.
Delivered by elective caesarean section. Female infant 4.62kgs. Apgars 1 at
1, 1 at 5. Pronounced dead at 2 hours. No PM. Cause of death: multiple
congenital abnormalities, spina bifida, diaphragmatic hernia and gross
hydrocephalus.
4. Age 37. Nulliparous. Transferred from another hospital following
diagnosis of suspected complete heart block, at 23 weeks gestation.
Reviewed by cardiac team at combined Rotunda/Coombe Cardiac Clinic.
Growth restriction with oligohydramnios noted at 29 weeks. Followed in
Fetal Medicine department. Poor cardiac contractility noted, with poor
biophysical score at 35 weeks. Elective caesarean section at 36 weeks. Male
infant 2.14kgs. Apgars 3 at 1, 7 at 5. Baby transferred to NICU; RIP day 1 post
delivery. Coroner’s post-mortem. Cause of death: Multiple dysmorphic
features, low-set ears, short neck, bilateral syndactyly and clinodactyly,
bilateral talipes. Heart: biventricular hypertrophy leading to congenital
arrhythmia.  Karyotype normal. Cause of death: congenital cardiac
abnormalities.
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5.  Age 33. Para 0+2. Two spontaneous early losses. Booked at 12 weeks
gestation. BMI 38.6. Poor attender.  Anatomy scan at 31 weeks revealed complex
CNS abnormality. Referred to Fetal Medicine department. Confirmed large
encephalocele. Also cardiac enlargement in rotation. Followed in Fetal
Medicine department. Spontaneous vaginal delivery of a male infant weighing
3.86 kg at 39 weeks gestation. Apgars 2 at 1, 0 at 5. Baby RIP day 1.  PM declined.
Cause of death: lethal CNS abnormality.
6. Age 20. Para 1. Previous Ventouse delivery at term. Late booker at 23 weeks.
Scan suggestive of CNS and renal abnormalities. Referred to Fetal Medicine
department. Multiple abnormalities including holoprosencephaly, complex
cardiac issues and ambiguous genitalia, short femur, renal pyelectasis and
rocker-bottom feet. Rescan at 31 weeks suggestive of hypoplastic left heart,
ventriculomegaly. Amniocentesis declined. Reviewed in combined
Rotunda/Coombe Cardiac Clinic. Confirmed hypoplastic left heart. Elective
caesarean section performed at 39 weeks. Indeterminate sex, weight 2.89kgs.
Apgars 2 at 1, 2 at 5. Early neonatal death. Post-mortem performed.  Cause of
death: multiple congenital malformations. 
7. Age 34. Para 1. Previous emergency caesarean section at term. Booked at 11
weeks. Anatomy scan at 20 weeks revealed facial abnormalities. Follow up
scans in the Fetal Medicine department confirmed possibility of cleft lip and
palate, with microcephaly, fused thalami and possible cardiac abnormality.
Amniocentesis performed. Diagnosis: monosomy of distal arm of chromosome
13q. Laboured spontaneously at 37 weeks; spontaneous vaginal delivery. Female
1.42kgs. Apgars 2 at 1, 2 at 5. No resuscitation. Baby pronounced dead at 1 hour.
PM declined. Genetic counselling organised. Cause of death: lethal
chromosomal abnormality.
8. Age 31. Para 3.  Three previous postdates deliveries of live born infants weighing
between 3.4 and 3.66 kilograms.  No significant medical history.  Non-smoker.
Booked at 14 weeks gestation.  Planned combined antenatal care.  Anencephaly
diagnosed on anatomy scan at 22 weeks gestation with poor fetal views due to
maternal habitus.  Fetal Medicine follow-up.  Induction of labour at 40 weeks
gestation.  Live born female infant was delivered weighing 1.84 kilograms.
Apgars 1 at 1 and 0 at 5.  Early NND.  PM declined.  Cause of death lethal
congenital anomaly.    
9. Age 38. Para 2.  Two previous term deliveries of live born female infants.
Booked in Kilkenny Hospital with dichorionic diamniotic twins.  Referred for
fetal assessment review due to numerous structural abnormalities identified
in twin I.  Suspected Trisomy 18 for twin I.  Reviewed in the Fetal Medicine Unit
at 23, 27, 31, 35 and 37 weeks gestation.  Elective caesarean section undertaken at
37 weeks gestation.  Live born female infant delivered weighing 1.3 kilograms.
Apgars 6 at 1 and 6 at 5.  And a live born male infant was delivered weighing 3.9
kilograms.  Apgars 9 at 1 and 10 at 5.  Neonatal death of twin I within the first
24 hours, with a suspected diagnosis of Trisomy 18.  Post-mortem declined.
Likely cause of fetal demise.  Lethal congenital anomaly.
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10.  Age 39. Para 3+4. Black African.  Three previous caesarean sections at 39, 40
and 29 weeks.  HIV positive.  Previous LLETZ. Booked at 14 weeks.  Attended
DOVE Clinic. Standard antiretrovirals. 20 week anatomy scan revealed
significant growth restriction <5th centile for all parameters, with likely
congenital cardiac abnormality.  Fetal medicine referral confirmed cardiac
malformation.  Amniocentesis performed.  Diagnosis at 27 weeks: Trisomy
18.  Followed in Fetal Medicine department.  Elective caesarean section at 38
weeks. Male infant 1.76kgs. Good apgars at delivery;  however RIP day 3. PM
declined. Cause of death: Trisomy 18, Edwards Syndrome.  This patient
conceived later in the year and miscarried requiring an ERPC. She died
following collapse several weeks later. Coronors PM awaited.
11. Age 37. Gravida 5, para 4.  Booked in another Hospital and transferred to the
Rotunda at 12 weeks gestation with a fetal diagnosis of a cystic hygroma.
History of a cystic hygroma in a previous pregnancy with a normal fetal
outcome.  Extensive cystic hygroma noted on ultrasound with fetal talipes.
Normal karyotype identified on amniocentesis.  Fetal echo cardiology
arranged for 22 weeks gestation.  Generalised fetal hydrops noted at this time
point.  Negative infection screen and a normal echo. Placenta was noted to be
low lying at 22 weeks gestation and centrally covering the cervix.  Maternal
Balentine syndrome developing at 24 weeks gestation with significant
maternal oedema, dyspnoea, proteinuria and  hypertension.  Deterioration in
the maternal condition with evidence of maternal heart failure with bilateral
plural effusions and pulmonary oedema and hypertension.   Imminent risk to
the mother, necessitating hysterotomy.  Live born female infant weighing
900g delivered.  Neonatal death day 1.  PM performed.  Cause of death non
immune hydrops of unknown aetiology.  Massive haemorrhage at the time of
delivery necessitating hysterectomy.  Discharged home on Labetalol 200mg
on day 5 post-operatively.  
12. Age 17. Primagravid.  Booked at 11 weeks. Smoker - 10 per day. Anatomy scan
at 20 weeks revealed thickened nuchal fold, unilateral talipes. Repeat scan in
Fetal Medicine department revealed ventriculomegaly and hydronephrosis.
Amniocentesis performed; normal karyotype. Patient presented at 22 weeks
with vaginal bleeding and crampy abdominal pains. Proceeded to labour.
Assisted vaginal breech delivery. Male infant, 0.5kgs. Apgars 1 at 1, 1 at 5. Baby
pronounced dead shortly after delivery. Post-mortem confirmed bilateral
ventriculomegaly, bilateral pyelectasis, bilateral talipes, bilateral rocker-
bottom feet; however cytogenetics was normal. Cause of death: extreme
prematurity with a number of associated congenital malformations.
13. Age 36. Para 3+4.  Two previous term deliveries, one live born male infant
weighing 3 kilograms and one emergency caesarean section at 39 weeks of
a live born male infant weighing 2.66 kilograms.  Then a subsequent fresh
still birth at 24 weeks gestation.  Past history of pancreatitis, anaemia,
hepatitis C, depression, oesophageal varices, on Methadone maintenance
therapy, heavy smoker at booking.  Booked at 15 weeks gestation.
Encephalocele noted at 20 weeks gestation.  For Fetal Medicine follow-up.
Preterm pre-labour rupture of the membranes at 34 weeks gestation with a
subsequent vaginal delivery of a live born female infant weighing 1.54
kilograms.  Apgars 2 at 1 and 2 at 5.  Early neonatal death.  PM declined.
Cause of death lethal congenital anomaly. 
51639 Rotunda Clinical Report 2013 301014 v5_Clinical Rep  30/10/2014  11:57  Page 33
14. Age 24. Nulliparous. No relevant past history. Booked at 12 weeks gestation.
Anatomy scan at 20 weeks showed oligohydramnios. No history of PPROM.
Referred to Fetal Medicine department. Rescan at 24 weeks revealed significant
growth restriction with multiple structural abnormalities, including cleft lip,
rocker-bottom feet, unusual cardiac anatomy. An amniocentesis was
performed and sample sent for karyotyping. Result: Trisomy 13. Followed in the
Fetal Medicine department. Admitted at 35 weeks with pre-eclampsia
requiring antihypertensive treatment. Induction of labour at 36 weeks.
Spontaneous vaginal delivery. Male infant 1.31kgs. Poor apgars at delivery. Baby
pronounced dead after 30 minutes. Cause of death: chromosomal, trisomy 13.
15. Age 30.  Para 1. One previous term uncomplicated vaginal delivery of a live
born female infant weighing 3.57 kilograms.  No significant medical history.
Non smoker.  Booked at 13 weeks gestation. Recurrent episodes of vaginal
bleeding.   Hospital based care.  Alobar holoprosencephaly noted on the
anatomy scan at 20 weeks gestation.  Cleft lip and a midline facial defect
noted.  Normal karyotype on amniocentesis.  Subsequent spontaneous onset
of labour at 32 weeks gestation with a background history of PPROM for the
preceding four days.  Assisted breech delivery of a live born female infant
weighing 1.81 kilograms.  Apgars 2 at 1 and 2 at 5.  Early neonatal death.  PM
peformed.  Cause of death lethal congenital anomaly.
16.  Age 27.  Para 1 Previous full term delivery.  No medical history of noted.
Booked at 12 weeks.  Routine antenatal care.  Anatomy scan at 21 weeks
showed no obvious fetal abnormalities.  Reviewed at 27 and 30 weeks with
breech presentation.  Scan at 33 weeks revealed evidence of fetal hydrops with
bilateral hydrothorax and mediastinal shift.   Delivered by caesarean at 34
weeks gestation.  Male infant weighing 2 kilograms.  Good Apgar scores.
Transferred to NICU.  NND day 2.  Post-mortem revealed brocho-pulmonary
sequestration causing severe fetal hydrops.
Extreme Prematur ity  ( 10 )
1. Age 36. Para 1. Previous Ventouse delivery at term. Booked at 13 weeks.
Monochorionic, diamniotic twins. Followed with serial scans. Twin-to-twin
transfusion syndrome diagnosed at 23 weeks. Fetoscopic laser ablation
performed. Substantial antepartum haemorrhage of 500 mls at 23 weeks and
3 days, followed by spontaneous rupture of membranes and cord prolapse.
Twin 1: assisted breach delivery, 0.39kgs. Twin 2: spontaneous vaginal delivery,
male infant, 0.61kgs. No resuscitation. PM declined. Cause of death: extreme
prematurity following twin-to-twin transfusion syndrome and laser ablation.
2. Age 27. Nulliparous. Booked at 14 weeks. 20 week anatomy scan negative for
malformations; suggestive of low-lying placenta. Poor attender. Scanned at
24 weeks; suggestive of oligohydramnios. History suggestive of PPROM.
Admitted for observation. Laboured spontaneously at 24 weeks gestation.
Forceps delivery. Male infant 0.51kgs. Apgars 0 at 1, 1 at 5. PM declined. Cause
of death: extreme prematurity. Placental examination showed evidence of
ascending infection with maternal and fetal response, with evidence of
retroplacental haemorrhage and acute supperative chorioamnionitis.
34
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3. Age 41. Para 1. Previous emergency caesarean section at 36 weeks,
complicated by pre-eclampsia. Past history of depression. Booked at 19
weeks. BMI 30.42. Hypertensive at booking. Referred to Mental Health
Liaison team. Anatomy scan at 24 weeks revealed evidence of growth
restriction. Followed with serial ultrasounds and dopplers. Absent end
diastolic flow from 25 weeks; reversed end diastolic flow noted at 27 weeks.
Delivered by emergency caesarean section of a male infant weighing .75kgs
at 27 weeks gestation.  Apgars 4 at 1, 6 at 5. Baby transferred to NICU. RIP day
2. Coroner’s PM: extreme prematurity with RDS.
4&5. Age 37. Para 2+1.  Two previous term caesarean sections and a previous
first trimester loss.  Referred from Mullingar Hospital at 20 weeks
gestation with monochorionic diamniotic twins and twin to twin
transfusion syndrome stage II.  Amnio reduction undertaken and
subsequent fetoscopic laser for twin to twin transfusion syndrome stage
III.  Maternal pyrexia and pre-term pre-labour rupture of membranes.
Variation in maternal condition requiring delivery of the infants at 23
weeks gestation.  Male infants delivered weighing 0.58 and 0.51 kilograms
by hysterotomy.  Both twin died within an hour. PM declined.   Cause of
death prematurity complicated by twin to twin transfusion syndrome and
ascending infection.  Patient discharged home well day 6 postnatally
6. Age 36. Para 1+1.  Unbooked.  Presented at 26 weeks. 
Monochorionic/diamniotic twins.  Antenatal care elsewhere. Regular
pains. Cervix 9cms dilated.  Emergency caesarean section performed.
Twin I breech presentation, female 890gms, Apgars 2 at 1, 5 at 5, 9 at 10.
Twin II female 850gms, apgars 3 at 1, 4 at 5, 6 at 10. Both babies transferred
to NICU. Twin 1 RIP day 1; extreme prematurity. PM negative for congenital
malformations. Cause of death: extreme prematurity. Twin II grade 4 IVH;
care withdrawn day 16.  No PM.  Placental histology confirmed
monochorionic diamniotic placentation. No evidence of vilitus
intervilicitis infarction or retroplacental haemorrhage. Cause of death:
extreme prematurity
7. Age 34. Para 2+1.  One previous termination, one previous spontaneous
vaginal delivery and a subsequent emergency caesarean in her last
pregnancy in 2007.  Medical history of hepatitis C.  Booked at 21 weeks
gestation.  Uncertain of LMP.  Estimated date of delivery assigned based on
ultrasound at booking.  Emergency room presentation at 24 weeks with
vaginal bleeding and a diagnosis of a revealed abruption.  Emergency
classical caesarean section at 24 weeks and a live born male infant
weighing 640g delivered.  Apgars 7 at 1, 8 at 5 and 8 at 10.  Intubated and
transferred to the special care baby unit.  Early neonatal death.  Total
maternal blood loss 3.5 litres.  Seven units of blood transfused, two units of
fibrinogen and four units of octoplas.  Discharged home well on day 7 post
caesarean section with arrangements for follow-up.
35
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8. Age 35 year old. Nulliparous patient. Transferred from another hospital at
18 weeks gestation following a diagnosis of PPROM at 17 weeks. Admitted
for monitoring and observation. Followed in the Fetal Medicine
department. Emergency caesarean section at 26 weeks with suspected
chorioamnionitis. Male infant 0.86kgs. Apgars 0 at1, 4 at 5, 6 at 10. Baby RIP
day 3. Day 4 post-delivery, significant pulmonary hypoplasia. PM declined.
Placental examination confirmed evidence of ascending infection. Cause of
death: extreme prematurity and pulmonary hypoplasia.
9.&10.Age 37. Para 1.  Previous preterm vaginal delivery at 36 weeks gestation of a
live born female infant weighing 2.84 kilograms.  No significant medical
history.  Non-smoker.  Booked at 12 weeks gestation with a monochorionic
diamniotic pregnancy.  Chorionicity confirmed and arrangements made for
hospital based care according to the monochorionic twin pregnancy
protocol.  Normal anatomy scan at 21 weeks gestation.  Presented at 23 weeks
gestation with both infants having been born prior to arrival in the hospital.
The first infant was a male infant weighing 0.62 kilograms and the second
was a male infant weighing 0.517 kilograms.  Twin I Apgars of 2 at 38 minutes
of age.  Twin II RIP in the immediate postnatal period.  Twin I RIP died day 2.
Twin II Coroners PM.  Twin I no pm. Cause of death extreme prematurity.  
Abruptio  P lacenta  ( 1 )
1. Age 31. Nulliparous.  Seen in the Diabetic Clinic.  History of insulin
dependent diabetes and hypothyroidism.  Anatomy scans at 20 weeks
negative for malformations.  Regular attender at the clinic.  Admitted at 34
weeks with suspected pre-eclampsia.  Commenced on Labetalol.  Induction
of labour planned for 37 weeks, but reduced fetal movements reported at
36+3 weeks.  Non-reassuring CTG.  Emergency caesarean section
performed.  Male infant weighing 2.84 kilograms delivered.  Apgars 0 at 1,
2 at 5 and 3 at 10 minutes.  Neonatal death on day 2.  At time of caesarean
section placenta abruption noted with estimated blood of 1000mls.
Coroners post-mortem examination confirmed placental abruption.
Negative for congenital malformations.  Three months postnatally patient
required coronary artery stents.  
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MATERNAL MORTALITY 3
M a t e r n a l  M o r t a l i t y  
T h e  M a s t e r
1.  Age 37. Para 4.  Past history of depression and intellectual disability.  Late
booker at 37 weeks.  Breech presentation.  Unsuccessful ECV at 39 weeks.
Booked for planned elective caesarean section.  Uneventful delivery and
postnatal care.  Routine thrombo-phrophylaxis.  Seen by Mental Health
Liaison team and follow-up organised with GP and Community teams.
Forty-seven days postpartum patient taken to general hospital by
ambulance with difficulty breathing, suffered cardiac arrest in transit and
pronounced dead on arrival in A&E Department.  A Coroners PM was
performed.  Cause of death acute pulmonary embolus and sub-acute
pulmonary embolus due to deep vein thrombosis of the leg and pelvic veins.
2.  Age 34. Para 3+1.  Two previous caesarean sections. Booked at 10 weeks.  Early
scan revealed oligohydramnios.  Follow-up by the Fetal Medicine
Department.  Continued oligohydramnios with a low lying globular
placenta.  Delivered by emergency caesarean section at 26 weeks.  Female
infant weighing 0.89 kilograms.  Placenta acreta.  Per-operative blood loss
1200 mls.  Post-operatively transferred to High Dependency.  Maternal
collapse day 1 post delivery.  Patient resuscitated, intubated and transferred
to the Mater Intensive Care Unit, where she deteriorated steadily over
several days and died day 4 post delivery. Coroner’s post mortem: cause of
death massive pulmonary embolism.
3. Age 39.  Four previous caesarean sections and four TOPs.  Past history of
neonatal death from Trisomy 18.  HIV positive.  Presented at 9 weeks
gestation.  Scan confirmed no fetal heart.  Diagnosed silent miscarriage.
ERPC under ultrasound guidance.  Presented to Emergency Room five days
post ERPC with significant headache, gradually getting worse.  Patient
referred to the Mater Hospital for assessment.  Patient was admitted to
Connolly Hospital some days later having collapsed.  Coroners PM.  Report
awaited.
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WHO Definitions:  
Direct obstetric deaths are those resulting from obstetric complications of the
pregnant state {pregnancy, labour and the puerperium} from interventions,
omissions, incorrect treatment or from a chain of events resulting from the
above.  
Indirect obstetric deaths are those resulting from previous existing disease or
disease that developed during pregnancy and which are not due to direct
obstetric causes, but are aggravated by the Physiologic effects of pregnancy.  
Dr. Sam Coulter Smith
Master
Maternal Mortality   
Year Total Total Number of Mothers Attending      
2004 1 7290
2005 0 7518
2006 0 8036
2007 0 9290
2008 1 9655
2009 2 9709
2010 3 9594
2011 3 10547
2012 2 10397
2013 3 10514
Total 15 92550
Maternal Mortality Rate       16.2/100,000
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The Rotunda continued to prospectively monitor severe maternal morbidity
during 2013. 
In total there are 40 patients reported on and 53 events. The incidence of severe
morbidity for 2013 was 0.46%. The incidence of severe maternal morbidity events
was 0.61%.
Similar to 2012 there were no episodes of eclamptic seizure. Our number of cases
with major obstetric haemorrhage rose in 2013 (from 18 to 25). This is similar to the
incidence in 2011. The number of cases requiring hysterectomy in 2013 was three
which is more than halved when compared with 2012. All of our caesarean
hysterectomies were in cases complicated by placenta praevia or placenta percreta.
Our number of cases requiring transfer for intensive care or coronary care
management was ten. This includes five of our patients that required delivery in
the Mater Misercordiae hospital. 
In line with previous years we report “near-miss” cases for prompt identification
of learning points for all providing maternity care in Ireland.
Major Maternal Morbidity Number Number
of cases 2012 of cases 2013
Transfusion more than 5 units 
or Estimated Blood loss more 
than 2.5L or Treated 
for coagulopathy 18 25
ICU/CCU Transfer 15 10
Peripartum hysterectomy 7 (6 Rotunda and 
one in the Mater) 3
Pulmonary oedema or acute 
respiratory dysfunction 3 3
Pulmonary embolism 2 3
Renal or liver dysfunction 3 2
Uterine rupture 1 1
Anaesthetic issue 1 1
Coma 0 1
Cardiac arrest 2 1
Status epilepticus 0 0
Septicaemic shock 3 0
Cerebrovascular accident 0 0
Eclampsia 0 0
Maternal deaths 2 3
S E V E R E  M A T E R N A L  M O R B I D I T Y
D r .  S h a r o n  C o o l e y  &  D r .  M i c h a e l  G e a r y
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Massive  Obstetr ic  Haemorrhage  (25 )
1.  Age 24. Para 2+2.  Non-national.  Booked at 12 weeks gestation with a history
of two previous emergency caesarean sections and two previous
miscarriages.  Additional medical history of sickle cell trait and anaemia.
Posterior placenta praevia identified.  Admitted with abdominal pain at 36
weeks gestation with a background history of urinary tract infection.
Antepartum haemorrhage.  Emergency caesarean section undertaken at 36
weeks and 6 days gestation.  Live born male infant weighing 3.335 kilograms.
Apgars 9 at 1, 10 at 5 and 10 at 10.  Total blood loss 2500 mls inter-operatively,
requiring transfusion of two units of packed red cells.  Discharged home well
on day 5 postnatal.  Failed to attend for postnatal review at 6 weeks.
2. Age 29. Para 0.  Known history of infertility.  Investigated in another
hospital and diagnosised as having a bicornuate uterus.  Spontaneous
pregnancy.  Booked at 11 weeks gestation and notes were requested from the
referring hospital.  Pregnancy identified in the left horn of the uterus at 8
weeks gestation.  Subsequently referred as an emergency from a General
Hospital with a haemo-peritoneum at 15 weeks gestation and maternal
collapse.  Laparotomy undertaken, ruptured uterine horn identified and loss.
Uterus repaired.  Total blood loss 2.6 litres.  Total blood transfused 6 units,
one gram of fibrinogen and two units of octoplas.  Uneventful post-operative
recovery and discharged home day 6 with arrangements for follow-up.
3. Age 37. Para 2.  Booked at 13 weeks gestation with a history of a previous
emergency caesarean section and a subsequent VBAC. No significant
medical history.  Hospital based antenatal care.  Subsequent spontaneous
rupture of membranes at 40 weeks gestation.  Pains failed to establish and
an elective caesarean section was done thereafter.  Live born male infant
weighing 3.9 kilograms, Apgars 9 at 1 and 10 at 5.  Patient was returned to
theatre from the recovery room with hypotension and a retro-peritoneal
haemorrhage was identified and the abdominal cavity was packed. Total
blood loss 3.3 litres.  Subsequent return to theatre and left uterine artery
ligated.  Total blood transfused 5 units of packed red cells, 6 units of FFP and
2 pools of platelets. Discharged home day 8 post caesarean section.
4. Age 28. Para 0.  Booked for midwifery led care at 12 weeks gestation.
Induction of labour at 41 weeks and 1 day secondary to maternal
hypertension.  Prostaglandin induction with a 7 hour labour.  Ventouse-
assisted vaginal delivery in theatre of a male infant weighing 4.48 kilograms.
Apgars 9 at 1 and 10 at 5.  Subsequent atonic uterus and 2.7 litre blood loss.
Transfused two units of packed red cells in the immediate post partum
period.  High dependency care.  Discharged home well day 3 postnatal.
5. Age 30. Para O+0.  Spontaneous onset of labour at 40 weeks gestation with
no antenatal risk factors.  IVF pregnancy.  Syntocinon to augment progress
in labour.  A failed instrumental at full dilation.  Emergency caesarean
section.  Live born male infant weighing 4.37 kilograms, Apgars 9 at 10, 10 at
5.  Atonic uterus and subsequent 2.5 litre blood loss.  Two units of packed red
cells transfused.  Discharged home well day 5 postnatal.
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6. Age 39. Para 1.  History of bilateral oophrectomy for ovarian cancer.  Donor
egg.  Booked at 13 weeks gestation.  Combined antenatal care.  Induced at 40
weeks gestation.  Spontaneous vaginal delivery.  Subsequent vaginal wall
tear and atonic uterus and 2.5 litre blood loss.  Four units of cross matched
blood transfused, 3 grams of fibrinogen and 3 units of octoplas.  Intra-
uterine balloon tampenade.  Balloon removed day 1 postnatal.  Discharged
home well day 3 post delivery.
7. Age 25. Para 0.  Booked for antenatal care at 11 weeks gestation in England
where a DCDA pregnancy was diagnosed.  Antenatal care was provided
between the Rotunda Hospital Dublin and London with subsequent return
for hospital based care in Dublin from 30 weeks gestation.  Induced at 37
weeks for pregnancy induced hypertension.  Vaginal delivery of a male
infant weighing 2.58 kilograms, Apgars 9 at 1 and 9 at 5, and a female infant
weighing 1.98 kilograms, Apgars 9 at 1 and 10 at 5.  Subsequent retained
placenta requiring a manual removal of placenta in theatre and an atonic
uterus requiring a return to theatre.  RUSHE balloon inserted.  Total blood loss
two litres.  Total blood transfused 4 units of cross matched blood, 4 grams of
fibrinogen, 2 pools of platelets and 4 units of octoplas.  Postnatal period
complicated by pulmonary oedema and acute renal failure.  Multi-
disciplinary high dependency care provided.  Blood pressure stabilised and
renal function and respiratory function improved over the 8 days postnatally.
Discharged home well day 8, with arrangements for further follow-up.
8. Age 37. Para 4.  Referred from another hospital, with a fetal cystic hygroma
at 15 weeks gestation.  Amniocentesis undertaken at 17 weeks gestation
confirmed a normal female karyotype.  Severe hydrops fetalis.  At 22 weeks
gestation maternal condition deteriorated with significant proteinuria,
dyspnoea, fetal oedema.  Admitted for stabilisation with a suspected
diagnosis of Ballantyne syndrome.  Delivered mandated in the maternal
interest at 22 weeks gestation.  Known low lying placenta.  Hysterotomy
undertaken.  Four litre intra-operative blood loss.  Difficulty with
haemostasis despite numerous conservative measures. Hysterectomy
undertaken.  Total blood loss 4 litres.  Transfused with 4 units or cross
matched blood and 1 unit of octoplas.  Discharge home well on day 5
postnatally.
9. Age 37. Para 4 +2.  Previous emergency caesarean section.  Pre-eclampsia in
first pregnancy, followed by subsequent 3 term vaginal births after section
and two miscarriages.  Morbid obesity with a body mass index of 38 at
booking.  Booked at 15 weeks gestation.  Normal glucose tolerance test.
Subsequent spontaneous onset of labour at 40 weeks gestation, precipitous
labour and a live born male infant weighing 3.51 kilograms was delivery,
Apgars 9 at 1 and 10 at 5.   3.6 litre primary postpartum haemorrhage
secondary to uterine atony.  Examination under anaesthetic in theatre and
intra-uterine balloon tampenade in conjunction with oxytocics.
Transfused 2 units of packed red cells, 2 units of octoplas and 1 unit of
fibrinogen concentrate.  High dependency care.  Discharged home well on
day 5 postnatal.
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10. Age 39. Para 11.  Booked at 12 weeks gestation for combined antenatal care.
Maternal Parvo virus during the first month of pregnancy.  Routine follow-
up in the Fetal Medicine Unit for the following 10 weeks with no evidence
of fetal anaemia.  Presented to the emergency room at 35 weeks gestation
with pains.  Bradycardia and suspected placental abruption.  Live born male
infant weighing 2.70 kilograms.  Apgars 3 at 1, 6 at 5 and 7 at 10.  Cord pH 6.9.
Placental abruption confirmed at emergency caesarean section.  Extension
of the uterine angle at caesarean section and a subsequent 1.8 litre blood
loss requiring 2 units of packed red cells and 2 units of fresh frozen plasma.
High dependency care and discharged home day 6 post caesarean section. 
11. Age 32. Primip.  Booked at 13 weeks gestation.  Body mass index of 37.
Combined antenatal care with a normal glucose tolerance test at 28 weeks.
Presented in spontaneous labour at 40 weeks gestation.  Emergency
caesareans section for failure to advance at 3 centimetres dilatation.
Lateral extension of the caesarean uterine incision with a subsequent 2.5
litre blood loss.  Four units of packed red cells transfused and care post-
operatively in the high dependency unit.  Discharged home well on day 5
postnatal.
12. Age 33. Para 2.  Booked at 12 weeks gestation with confirmed dates.  Two
previous caesarean sections.  Hospital based antenatal care.  Low lying
placenta noted at 20 weeks.  Elective caesarean section at 38 weeks.  Live
born female infant weighing 3.01 kilograms delivered.  Apgars 9 at 1 and 10
at 5.  Four litre intra-operative blood loss with a morbidly adherent
placenta.  Partial separation of the placenta.  High dependency care post-
operatively.  Discharged home well day 6 post operatively with
arrangements for follow-up.  Total blood loss four litres.  Three units of red
cells transfused and two units of octoplas.
13. Age 40. Primip.  Booked at 15 weeks gestation.  ICCSI pregnancy.  Known
uterine fibroids.  Medical history of hyperthyroidism, asthma.  Combined
antenatal care.  Spontaneous onset of labour at 40 weeks gestation.
Ventouse-assisted delivery of a live born female infant weighing 3.18
kilograms.  Apgars 9 at 1 and 10 at 5.  Primary post-partum haemorrhage of
3 litres requiring transfer to theatre.  Retained placental tissue removed.
RUSHE balloon tamponade.  In total 8 units of blood transfused.  One pool
of platelets and three units of octoplas.  Discharged home well day 6
postnatal.
14. Age 33. Para 0.  Booked at 11 weeks gestation.  Combined antenatal care.  No
significant medical history.  Induced for post dates at 41 weeks and 4 days
gestation.  Emergency caesarean section at full dilatation for high
presenting part and failure to advance in the second stage.  Primary post-
partum haemorrhage secondary to uterine atony.  Total blood loss 3.5 litres.
Two units of red cells transfused, four units of fresh frozen plasma and two
grams of fibrinogen.  Discharged home well day 6 postnatally.
42
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15. Age 39. Para 1+1.  Previous emergency caesarean section at full dilatation for
failed instrumental.  Booked at 13 weeks gestation.  Dates assigned.  Hospital
based care.  Placenta praevia noted at 20 weeks gestation.  Admitted with an
antepartum haemorrhage at 31 weeks gestation.  No subsequent blood loss
thereafter.  Elective caesarean section at 37 weeks gestation for placenta
praevia.  800 ml intra-operative loss.  Subsequent post-partum haemorrhage.
Total blood loss 2.5 litres.  Four units of blood transfused.  No additional blood
products required.  Discharged home well on day 5.
16. Age 34. Para 2+1.  One previous termination, one previous spontaneous
vaginal delivery and a subsequent emergency caesarean in her last
pregnancy in 2007.  Medical history of hepatitis C.  Booked at 21 weeks
gestation.  Uncertain of LMP.  Estimated date of delivery assigned based on
ultrasound at booking.  Emergency room presentation at 24 weeks with
vaginal bleeding and a diagnosis of a revealed abruption.  Emergency
classical caesarean section at 24 weeks and a live born male infant weighing
640g delivered.  Apgars 7 at 1, 8 at 5 and 8 at 10.  Intubated and transferred to
the special care baby unit.  Early neonatal death.  Total maternal blood loss 3.5
litres.  Seven units of blood transfused, two units of fibrinogen and four units
of octoplas.  Discharged home well on day 7 post caesarean section with
arrangements for follow-up.
17. Age 29. Para 1.  One previous term assisted vaginal delivery in 2010.  Booked
for midwifery led care at 14 weeks gestation.  Presented at 40 weeks with
decreased fetal movements.  Induction of labour undertaken for same.
Spontaneous vaginal delivery of a live born female infant weighing 3.87
kilograms.  Apgars 9 at 1 and 10 at 5.  Subsequent primary and secondary
postpartum haemorrhage.  Estimated blood loss in the immediate 24 hours
following delivery 1.6 litres.  Subsequent blood loss and re-admission with a
secondary postpartum haemorrhage requiring re-examination under
anaesthetic and removal of placental tissue.  In total two units of cross
matched blood transfused, two grams of fibrinogen and two units of octoplas.
Fourteen days between the primary and secondary postpartum
haemorrhage.  Discharge home well six days after her second admission. 
18. Age 28. Para 2+1.  Booked at 12 weeks gestation. Past history of a previous
miscarriage in 2002, spontaneous vaginal delivery of a liveborn female
weighing 3.06 kilograms in 2005 and an emergency caesarean section for
placental abruption at 28 weeks gestation of a liveborn male infant.  Medical
history of anaemia and depression, recurrent urinary tract infections and
was methadone maintenance therapy at booking.  Smoker in excess of 20 per
day.  Hospital based care.  Old notes requested from the maternity hospital
where she delivered previously.  Poor attender for antenatal care.  Presented
with a significant antepartum haemorrhage at 31 weeks and 4 days gestation.
Admitted for steroids.  Subsequent suspected abruption and a category I
emergency caesarean section undertaken.  Liveborn male infant weighing
1.83 kilograms with Apgars 6 at 1 and 9 at 5.  Placental abruption confirmed.
2.7 litre loss at the time of closure at section.  Hypovolemic and tachycardiac
post-operatively requiring a return to theatre.  Total blood loss 6 litre.  Seven
units of cross matched blood, two grams of fibrinogen and four units of
octoplas administered.  Discharged home day 5 post section.
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19. Age 45. Para 1.  Booked at 20 weeks gestation.  Mono-chorionic diamniotic
twins.  Normotensive at booking.  Body mass index of 33.  Large mid-line
periumbilical hernia.  Previous gastric band surgery.  Pre-eclampsia in first
pregnancy 13 years previously.  On labetalol at booking and aspirin.
Hospital based care.  Static fetal growth at 36 weeks gestation.  Labour
induced.  Spontaneous vaginal delivery of twin I weighing 2.31 kilograms,
Apgars 9 at 1 and 10 at 5 and spontaneous vaginal delivery of twin II
weighing 2.62, Apgars 9 at 1 and 10 at 5.  Primary postpartum haemorrhage
of 3 litres.  Transferred to theatre for examination under anaesthetic and
RUSHE balloon insertion.  Total blood loss of 3 litres.  Four units of blood
transfused.  Discharged home well on day 3 post delivery.
20. Age 39. Primip.  Booked at 18 weeks gestation, fetal size consistent with
gestation.  Combined antenatal care.  No significant medical history.
Normal body mass index.  Smoker of 10 cigarettes per day.  Spontaneous
onset of labour at 38 weeks gestation.  Failed instrumental at full dilatation
and subsequent emergency caesarean section.  Primary postpartum
haemorrhage requiring return to theatre three hours post section for
laparotomy.  Total blood loss 4.3.   Required 2 units of O negative blood, 3
units of cross matched blood, 2 units of fibrinogen, 1 pool of platelets and 7
units of octoplas.  Post-natal period complicated by sub-acute ileus.
Discharged home on day 7 postnatal.
21. Age 30. Para 0+3.  Booked at 14 weeks gestation.  No significant medical
history.  Midwifery led care with a plan for a home birth.  Transferred to
hospital in spontaneous labour at 41 weeks + 1 day gestation due to
prolonged rupture of membranes for oxytocin augmentation.  Emergency
caesarean section at full dilatation for fetal bradycardia, followed by a
return to theatre four hours later with maternal hypotension and
tachycardia.  Midline laparotomy with consultant vascular surgeon in
attendance.  Re-suturing of uterine angle.  Spleen and liver explored.  No
definitive cause of blood loss identified.  Total blood loss 5 litres.  Total blood
transfused 1 unit of O negative blood, 6 units of cross matched blood, 3 units
of fibrinogen, 2 pools of platelets and 6 units of octoplas.  Discharged home
will on day 8 postnatal.
22. Age 34. Para 3.  Booked at 11 weeks gestation.  Routine anatomy scan at 20
weeks showed evidence of short long bones and talipes.  Subsequent Fetal
Medicine review and follow-up.  Past medical history of postnatal
depression but nil else of note.  Three previous full term appropriately
grown infants.  Normal karyotype at amniocentesis.  Induction of labour at
36 weeks due to intrauterine growth restriction.  Subsequent emergency
caesarean section at full dilatation.  Live born male infant delivered
weighing 2.36 kilograms.  Apgars 9 at 1 and 10 at 5.  Intra-operative blood
loss 3.5 litres in total.  Units of blood transfused.  Mother and baby
discharged home well on day 5 for follow-up with the geneticist.
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23. Age 31. Para 3+3.  Booked at 15 weeks gestation.  Prior history of an assisted
vaginal delivery, two caesarean section and 3 first trimester losses.  Pregnancy
induced hypertension in the last pregnancy.  Family history of venous
thromboembolism.  Normotensive on booking.  Placenta noted to be anterior
and low lying covering the cervix at 20 weeks gestation with loss of the
bladder uterine interface.  Possibility of placenta accreta or percreta.  No
bleeding.  Managed as an outpatient with arrangements for review at 24 and
28 weeks and anaesthetic follow-up.  Seen in the clinic at 24, 28, 30 and 31
weeks.  Presented to the Emergency Room at 31 weeks and 1 day with a non-
substantial antepartum haemorrhage.  Admitted.  Continuing light vaginal
bleeding.  Significant antepartum haemorrhage at 33 weeks gestation
requiring emergency caesarean section.  Live born female infant weighing
2.39 kilograms delivered.  Apgars 2 at 1, 6 at 5 and 9 at 10 minutes.  Classical
caesarean section undertaken.  Placenta left insutu.  Two litre postpartum
haemorrhage in the immediate post-operative period.  Patient returned to
theatre for a sub-total hysterectomy.  Stabilised and transferred to the Mater
Intensive Care Unit post-operatively.  Total blood loss six litres.  Ten units of
crossed matched blood, 4 grams of fibrinogen, 2 pools of platelets and 8 units
of octoplas transfused.  Transferred back to the Rotunda day 2 post-
operatively.  Post-natal recovery complicated by bilateral pneumonia emboli
ileus.  Wound infection on day 13.  Discharged home day 19 post-operatively
with follow-up arranged for two weeks and 6 weeks post natal.
24. Age 22. Para 2+1.  Two previous term deliveries.   Booked at 11 weeks gestation.
Combined antenatal care.   Normal anatomy scan at 21 weeks gestation.
Spontaneous onset of labour at 40 weeks gestation.  Live born male infant
weighing 4.62 kilograms delivered.  Apgars 9 at 1 and 10 at 5 minutes.
Subsequent postpartum haemorrhage secondary to a retained placenta.
Total blood loss 3 litres.  Four units of blood transfused, 2 grams of fibrinogen
and 3 units of octoplas.  RUSHE balloon inserted in theatre. Discharged home
well day 3 postnatal.
25. Age 37. Para 1+1. Presented to the emergency room at 6 weeks gestation with
a sudden onset of lower abdominal pain and shoulder tip pain, on a
background history of two years of infertility.  No significant medical history.
Collapse on admission. Pelvic examination and abdominal ultrasound
suggestive of a right-sided ectopic, with a haemoperitoneum identified.
Patient stabilised and transferred to theatre for emergency laparotomy and
right salpingectomy. Left tube appeared normal. Total blood loss 2 litres. Total
blood transfusion of 4 units of packed red cells and 6 units of octoplas.
Discharged home well on day 4 post laparotomy, with arrangements for
follow up for serial bHCG.
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Transferred  to  Mater  ( 10 )
1. Age 32. Para 2.  Two previous term deliveries.  Booked at 12 weeks gestation.
Combined antenatal care.  Admitted at 33 weeks gestation to the Intensive
care unit in the Mater Hospital with Streptococcal pneumonia. Lower
sector caesarean section at 33 weeks and 5 days gestation.  Live born female
infant weighing 2.17 kilograms.  Apgars 7 at 1 and 10 at 5.  Total intra-
operative blood loss 780 mls.  Postnatal recovery in the Mater Hospital.
2. Age 30, para 0+1, with a previous second trimester loss at 21 weeks
gestation in 1999. Maternal history of congenitally corrected transposition
of the great arteries and tricuspid regurgitation. Booked at 9 weeks
gestation for multidisciplinary hospital-based care, in view of the cardiac
history. On carvedilol 3.125mgs twice daily at booking. Severe tricuspid
regurgitation prior to pregnancy. Consultant-led care, with cardiology and
anaesthetic input. Elective caesarean section in the Mater Hospital at 35
weeks gestation, of a liveborn male infant, weighing 2.6kgs; apgars 9 at 1,
10 at 5. Discharged home well on day 5 postnatally, for cardiac follow up.
3. Age 29, para 0. Booked at 12 weeks gestation. Past history of Crohn’s
disease, pernicious anaemia and a bowel resection in 1999, with dilatation
of a bowel stricture in 2006.   Booked for combined antenatal care.  Midline
laparatomy and a bowel stoma noted.  Normal anatomy scan at 20 weeks
gestation.  Presented at 36 weeks gestation with a prolapsed stoma.
Emergency caesarean section at 36 weeks gestation in the Mater Hospital
and a liveborn male infant weighing 2.54 kilograms was delivered.  Apgars
9 at 1 and 10 at 5.  Discharged home well day 6, postnatally.
4. Age 35. Para 1.  Previous caesarean section.  Transferred  from the Coombe
Women and Infants University Hospital at 33 weeks  and 6 days with
maternal history of a heart and lung transplant in 2007 and a renal
transplant in 2009.  Transfer was indicated in maternal interest due to
superimposed pre-eclampsia and pre-term pre-labour rupture of
membranes and deterioration in the maternal condition.  Emergency
caesarean section undertaken in the Mater Hospital of a liveborn female
infant weighing 2.34 kilograms.  Apgars 5 at 1 and 7 at 5.  Uneventful
postnatal recovery.  Patient was discharged on day 6 postnatal.
5. Age 37. Para 2.  Two previous term uncomplicated deliveries in 2007 and
2008 of liveborn male infants weighing 4.2 and 3.9 kilograms.  Medical
history of maternal super ventricle tachycardia in 2012 and pulmonary
sarcoidosis.  Transferred from Limerick Hospital at 33 weeks gestation
with a dichorionic diamniotic twin pregnancy and recurrent episodes of
maternal fast atrial fibrillation despite the use of beta blockers.
Transferred to the care of Cardiology in the Mater Hospital.  Cardio version
undertaken in the Mater Hospital.  Discharge home day 4 post cardio
version to continue care in the referring hospital. 
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6. Age 29. Para 1.  One previous precipitous delivery in 2011 of a liveborn infant.
Medical history of cardio myopathy with myocardio fibrosis and arrhythmia
refractory true oblation.  Booked in the Coombe Women’s and Infants
University Hospital.  On Methoprolol 50mg twice daily and Flecainide 50mg
twice daily.  Transferred from the Coombe Women’s and Infants University
Hospital to the Rotunda at 31 weeks gestation with a growth restricted infant
and intermittent absent end diastolic flow.  Estimated fetal weight at
transfer was 1.35 kilograms.  Delivery required in the fetal interest.  Elective
caesarean section undertaken in the Mater Misericordiae Hospital due to the
maternal cardiac condition at 31 weeks gestation.  Live born female infant
was delivered weighing 1.38 kilograms .  Apgars 8 at 1 and 9 at 5.   Transferred
back from the Mater to the Rotunda in the early postnatal period.  Maternal
heart rate well controlled on Flecainide 50mg twice daily and Methoprolol
50mg twice daily over the postnatal period.  Discharged home with
arrangements for cardiac follow-up day 4 post section.
7. Age 33. Para 0.  Maternal history of anxiety.  Booked at 15 weeks gestation.
Combined antenatal care.  Presented in spontaneous labour at 40 weeks and
3 days gestation.  Maternal collapse at full dilatation and maternal (assist a
lay?) requiring cardiac compression for a period of three minutes.  Assisted
vaginal delivery of a live born male infant weighing 3.6 kilograms.  Apgars 9
at 1 and 9 at 5.  Atonic postpartum haemorrhage of 1 litre.  Provisional
diagnosis of possible eclamptic seizure or under lying cardiac disease.
Maternal pulse irregular.  R         and tachycardia noted in the early postnatal
period.  Runs of atrial fibrillation.  Transferred to the Coronary Care Unit in
the Mater Hospital for further investigations on day 1 postanatally.
8. See Massive Obstetric Haemorrhage (3)
9. See Massive Obstetric Haemorrhage (23)
10. See Master’s Report on Maternal Deaths (2).
Per ipar tum Hysterectomy (3 )
1. Age 34. Para 3.  Three previous caesarean sections.  History of pre-eclampsia
in pregnancies.  Known HIV positive.  Non-smoker.  Body mass index of 33.
Booked at 24 weeks gestation.  Admitted with antepartum haemorrhage
and a background diagnosis of a low lying placenta at 25 weeks gestation.
Emergency caesarean section at 37 weeks gestation for a non-reassuring
CTG.  Placenta noted to be morbidly adherent at the time of delivery.  1.2 litre
blood loss.  Placenta protruding through the lower uterine segment.  Sub-
total hysterectomy undertaken.  Admitted to the High Dependency Unit
following delivery.  Ileus post-operatively.  Discharge home well on day 6
postnatally with arrangement for follow-up MRI in the Mater Hospital.
Follow-up also arranged for six weeks postnatally.
2. See Massive Obstetric Haemorrhage (8)
3. See Massive Obstetric Haemorrhage (23)
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Pulmonary  Oedema or  Acute  Respiratory  Dysfunct ion  (3 )
1. See Massive Obstetric Haemorrhage (7)
2. See Massive Obstetric Haemorrhage (8)
3. See Transfer Out (1)
Pulmonary  Embol ism (3 )
1. Age 34. Para 0.  Booked at 12 weeks gestation.  Medical history of asthma
and a prior laparotomy for bowel obstruction with a background history of
ulcer colitis.  Pulmonary embolism at 35 weeks gestation.  Commenced on
therapeutic low molecular weight heparin with transition to
unfractionated  heparin for induction of labour at 39 weeks gestation.
Spontaneous vaginal delivery of live born male infant weighing 2.79
kilograms.  Apgars 9 at 1 and 10 at 5.  Total estimated blood loss 350 mls.
Transitioned back onto low molecular weight heparin to complete a three
month course of anticoagulation.
2. Age 27. Para 2.  Two previous full term uncomplicated normal deliveries.
Booked at 14 weeks gestation.  Combined antenatal care.  Medical history of
asthma and recurrent urinary tract infections.  Provoked pulmonary
embolism at 37 weeks gestation.  Therapeutic anticoagulation and timed
induction of labour at 38 weeks gestation.  Spontaneous vaginal delivery of
a female infant weighing 3.42 kilograms.  Apgars 9 at 1 and 10 at 5.
Therapeutic anti coagulation recommenced postnatally.  Patient discharge
home well on day 3 postnatally with haematology follow-up.
3. See Massive Obstetric Haemorrhage (23).
Renal  or  L iver  Dysfunct ion  (2 )
1. Age 38. Para 0.  Booked at 17 weeks.  Hospital based care.  Past history of
resection of a uterine septum.  Primary infertility.  Normo-tensive at
booking.  Admitted at 30 weeks gestation with abdominal pain and
hypotension and acute renal failure.  Caesarean section.  Live born female
infant weighing 1.61 kilograms delivered.  Apgars 8 at 1 and 8 at 5.
Subsequent transfer of the patient to the High Dependency Unit postnatal
with renal team review.  Gradual resolution of acute renal failure.
Postnatal period complicated by maternal sepsis.  Positive maternal blood
cultures.  Subsequently discharged home well on day 8 postnatally.
2. Age 34. Para 0.  Transferred from another hospital in maternal interest at
24 weeks gestation with a suspected diagnosis of HELLP syndrome.
Emergency classical section at 26 weeks gestation for a non-reassuring
fetal CTG.  Live born male infant delivered weighing 545g.  Apgars 7 at 1 and
9 at 5.  Gradual resolution of hepatic dysfunction.  Discharged home well on
day 6 postnatally with arrangements for follow-up.
51639 Rotunda Clinical Report 2013 301014 v5_Clinical Rep  30/10/2014  11:57  Page 48
49
Uter ine  Rupture  ( 1 )
1. Age 30. Para 1.  Previous emergency LSCS at 39 weeks gestation.  Booked at
14 weeks.  Body mass index of 33.  Normotensive at booking.  Medical history
of spondylosis. Gestation diabetes in first pregnancy requiring insulin at 30
weeks.  Commenced on insulin at 15 weeks in this pregnancy.  Poor attender
to the combined multi-disciplinary diabetic clinic.  Mode of delivery
discussed.  Keen for VBAC.  Elective LSCS booked for 40 weeks and 3 days.
Spontaneous labour at 39 weeks and 2 days.  Emergency caesarean section
at 2 centimetres dilatation for suspected uterine rupture.  Uterine rupture
confirmed at section.  Live born male infant weighing 3.83 kilograms.
Apgars 8 at 1 and 7 at 5 and 10 at 10.  Discharged home well day 5 post
section.
Anaesthet ic  I ssue  ( 1 )
1. Age 45. Para 0+1.  IVF pregnancy.  Booked at 12 weeks gestation.  Combined
antenatal care.  No significant medical history.  Normal body mass index.
Presented at term with an non-reassuring CTG and a high fetal part on the
day of planned induction.  Emergency caesarean section.  Live born male
infant weighing 3.3 kilograms.  Apgars 9 at 1 and 10 at 5.  Maternal
anaphylactic shock.  Exact precipitant unidentified.  Admitted to the High
Dependency Unit.  Discharged home day 4 post section for review in
Beaumont Hospital for allergy testing.
Cardiac  Arrest  ( 1 )
See Master’s Report on Maternal Mortality
Coma ( 1 )
See Master’s Report on Maternal Mortality
Maternal  Death  (3 )
See Master’s Report on Maternal Mortality
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C O M P L I C A T E D  P O S T N A T A L  C L I N I C
D r  M a e v e  E o g a n
This clinic primarily offers postnatal review to women who sustain anal
sphincter injury at vaginal delivery. The Royal College of Obstetricians and
Gynaecologists recommend that such patients are seen in a dedicated Perineal
Clinic in order to: 
•  Discuss delivery and associated events in further detail
•  Assess for symptoms of continence compromise
•  Arrange appropriate treatment / referral
•  Advise on future deliveries
This clinic also reviews women who are pregnant again after a previous anal
sphincter injury in order to discuss options and risks in terms of mode of
delivery. It also provides care for women who have had other postnatal concerns,
including wound infection, perineal pain and dyspareunia. 
419 new patients were seen in the clinic in 2013, an increase of 22 patients
compared with 2012. The indications for their attendances are tabulated below:
Indication for Attendance Number of Patients Seen
Postnatal Third Degree Tear (includes patients 
referred from other institutions) 180
Postnatal Fourth Degree Tear (includes patients 
referred from other institutions) 7
Postnatal Perineal Infection or Pain 62
Faecal Incontinence 8
Antenatal Assessment (next pregnancy) 109
Other (incl perineal pain, dyspareunia) 53
Total 419
The largest group of patients seen were those who attended after obstetric anal
sphincter injury. 185 patients sustained anal sphincter injury in the year 2013, 179
of whom had third degree tear, while 6 patients sustained fourth degree tear
(extending to involve anal mucosa). The modes of delivery of those who
sustained anal sphincter injury are tabulated below:
Mode of Delivery Third Degree Tear Fourth Degree Tear
SVD 96 3
Ventouse 37 1
Ventouse & Forceps 22 0
Forceps 24 2
Born before arrival 0 0
Total 179 6
Clinic review after anal sphincter injury takes place after the 6th postnatal week.
However, all patients will have been offered physiotherapy follow-up prior to that
and the clinic works closely the Department of Physiotherapy. A history is taken,
including continence score if there are symptoms of faecal incontinence. 
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Information regarding perineal healing and other postnatal symptoms is also
obtained. Appropriate treatment or referral is initiated as required, and the clinic
visit also provides an opportunity to answer questions regarding the index
delivery and to discuss mode of future deliveries.
44 patients who attended the clinic required treatment or ongoing referral (in
addition to physiotherapy, which is offered to all). The specific treatments
required are enumerated below:
Procedure/Referral Number of Patients
Removal of persistent suture material (OPD) 10
Treatment of granulation tissue (OPD) 10
Fenton’s procedure / perineal revision  (day case) 11
Perineal injection (day case) 4
Referral to colorectal service 9
A number of patients who have undergone female genital mutilation (FGM) as
children have also attended the clinic. Some presented prior to pregnancy
requesting reversal to facilitate intercourse while some women were referred
after a pregnancy when FGM had first been noted during delivery. As providers
of care for these patients it is important that, as always, we provide a supportive
and responsive service. 
I am very grateful to Ms Ann Brannigan at the Department of Colorectal Surgery,
Mater Misericordiae University Hospital for both clinic and operative support
and also to Cinny Cusack and all staff of the Physiotherapy Department at the
Rotunda Hospital for their ongoing care. 
The clinic undertook a retrospective study of patients’ preference regarding
mode of delivery following previous anal sphincter injury (ASI) which also
evaluated perineal outcome following subsequent vaginal birth. This identified
an approximate 15% recurrence risk following previous third degree tear and we
find it helpful to have local results to inform practice. This work has been
published  in the European Journal of Obstetrics, Gynaecology and Reproductive
Biology (Ali A, Glennon K, Kirkham C, Yousif S, Eogan M.  Delivery outcomes and
events in subsequent pregnancies after previous anal sphincter injury. European
Journal of Obstetrics, Gynaecology and Reproductive Biology Dec 2013-Epub
ahead of print). 
. 
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YEARS 2012 2013
Total number of cases 249 199
Booked 245 198
Unbooked 4 1
Incidence against delivery 3.0% 2.3%
Eclampsia % 0.00% 0.50%
Stillbirths 2 1
Neonatal Deaths 0 3
Multiple pregnancy 23 21
Par ity  of  Pat ients  at  Del ivery
0 165 125
1 49 49
2 21 14
3 8 6
4 plus 6 5
Total 249 199
Gestat ion  of  Pat ients  at  Del ivery
< 28 weeks 3 3
28 - 29 weeks 5 3
30 - 31 weeks 7 8
32 - 33 weeks 11 10
34 - 35 weeks 23 25
36 weeks plus 200 150
Total 249 199
H Y P E R T E N S I O N  W I T H  P R O T E I N U R I A
T h e  M a s t e r  
52
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The rate of induction of labour for the year 2013 was 29%, one percent up on 2012,
but identical to 2011.  The indications for induction were broadly similar.  There
were slightly fewer inductions for post dates pregnancies.
INDUCTIONS OVER 5 YEARS
Year Nullip       % Multip      %   Total        % 
2009 1147 56% 885 44% 2032 23%
2010 1326 57% 1008 43% 2334 27%
2011 1482 57% 1134 43% 2616 29%
2012 1414 57% 1064 43% 2478 28%
2013 1372 54% 1151 46% 2523 29%
INDICATIONS FOR INDUCTIONS 2013
REASONS TOTAL %
Post Dates 822 32.6%
Prolonged SROM 427 16.9%
Reduced Fetal Movements 84 3.3%
Diabetes 70 2.8%
Hypertension 259 10.3%
Heart Disease 2 0.1%
IUD 27 1.1%
Anomaly 17 0.7%
Antibodies * 3 0.1%
Diminished Liquor 112 4.4%
IUGR 158 6.3%
Large Baby 33 1.3%
Medical/Social 216 8.6%
Multiple Births 23 0.9%
Other 183 7.2%
Poor Obstetric History 72 2.9%
Decreased Placental Function 11 0.4%
Poor Byphysical Score 4 0.2%
Total 2523 100%
* Anti D detected or Anti E
I N D U C T I O N O F L A B O U R
T h e  M a s t e r
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INDUCTION OF LABOUR
YEARS 2012 2013
Total No. of cases 2478 2523
Incidence against deliveries >500 28% 29%
No. of Caesarean sections for Inductions 549 537
Stillbirths 24 28
Neonatal Deaths 6 3
METHOD OF INDUCTION
YEARS 2012 2013
ARM 207 182
ARM + Synto 510 471
Prostin + ARM + Syntocinon 595 678
Prostin + ARM 387 410
Prostin 268 305
Cytotec 13 22
Prostin + Syntocinon 208 176
Syntocinon 290 279
54
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The overall caesarean section rate for 2013 was 31% which was 2% up on the
previous year, but in line with recent trends.  The principle reason for the rise
was in group nullip single cephalic term in spontaneous labour which rose from
10.3% to 12%.  All of the other categories were broadly similar.
YEARS 2012 2013
Total number of cases 2538 2650
Incidence against 
total deliveries > 500g 28.7% 30.6%
Maternal Mortality 2 2
Primary C.S. 58.5% 58.9%
Repeat C.S. 41.5% 41.1%
Classical C.S 2 2
Tubal Ligation at C.S. 64 91
C/S Hysterectomy 5 3
C A E S A R E A N  S E C T I O N
T h e  M a s t e r
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CAESAREAN SECTION ANALYSIS
All Deliveries for 2013 8549
All Caesarean Sections 2650
Section Rate 31.0%
Group 1 - Nullip Single Ceph Term Spont Lab 204/1707
Section Rate 12.0%
Group 2 - Nullip Single Ceph Term Induced 414/1315
Section Rate 31.5%
Group 2a - Nullip Single Ceph Term CS Before Labour 195
Group 3 - Multip Single Ceph Term Spont Labour 54/2095
Section Rate 2.6%
Group 4 - Multip Single Ceph Term Induced 64/1041
Section Rate 6.1%
Group 4a - Multip Single Ceph Term CS before Labour 158
Group 5 - Prev Section Single Ceph Term 920/1180
Section Rate 78.0%
Group 6 - All Nullip Breeches 147/154
Section Rate 95.4%
Group 7 - All Multip Breeches 145/156
Section Rate 92.9%
Group 8 - All Multiple Pregnancies 139/190
Section Rate 73.2%
Group 9 - All Abnormal Lies 20/20
Section Rate 100.0%
Group 10 - All Preterm Single Ceph 190/438
Section Rate 43.4%
Elective Caesarean Section Total 1343
Emergency Caesarean Section Total 1307
Total Multips 4982
Total Primips 3668
56
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INDICATION FOR PRIMARY SECTIONS 2013
DELIVERY METHOD INDICATION 2012 2013
Fetal Distress {Antepartum & Intrapartum} 498 511
Failure to progress 1st stage 121 132
Failure to progress 2nd stage 49 46
Breech 225 218
Abruption/APH 11 23
P.E.T. 26 24
Transverse Lie/Oblique 14 16
Pyrexia 16 13
Placenta Praevia 34 30
Poor Obstetric History 13 27
Cord Prolapse/Presentation 11 6
Disproportion & Deep Transverse arrest 0 0
Failed Forceps/Ventouse 24 21
Face/Brow Presentation 6 5
Multiple Birth 44 39
Failed Induction 80 74
Prematurity 7 7
Hypertension 9 20
Emergency CS Scheduled for Elective CS 10 16
I.U.G.R. 17 25
Maternal Request 20 22
Medical Disorders 37 41
Poor Biophysical Profile 1 1
Other 160 174
Recurring indications 4 2
Rhesus Antibodies 0 0
Previous 3/4th degree tear 38 52
Malpresentaion in labour 10 15
Total 1485 1560
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INDICATION FOR REPEAT SECTIONS 2013
DELIVERY METHOD INDICATION Elective Emergency 
Failure to progress 1st stage       0 28
Failure to progress 2nd stage       0 2
Fetal distress                      0 60
Disproportion(Malpresentation in Labour)                       0 2
Breech                              24 7
Hypertension                        3 4
Placenta praevia                    2 4
P.E.T.                              8 4
Poor obstetric history              3 2
Previous LSCS                       729 75
Previous classical CS               4 2
Multiple birth                      5 1
Abruption / APH 0 6
Failed induction                    2 12
Antepartum fetal distress           0 2
Emergency CS scheduled for elective CS 0 12
Failed forceps/ventouse             0 0
I.U.G.R.                            6 6
Medical disorders                   6 1
Transverse lie / Oblique lie 3 1
Other                               43 10
Maternal request 2 1
Prematurity 2 2
Previous 3/4th Degree tear 2 2
TOTAL 844 246
** These reasons are the  First reason for  Caesarean Section 
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CLINIC New Return Total
Attendances Attendances
 Antenatal & Postnatal 10,403 35,477 45,880
Gynaecology 3,783 7,119 10,902
Paediatrics 5,663 3,085 8,748
Endocrinology 2,833 2,736 5,569
Gastroenterology 28 25 53
Haematology 332 506 838
Anaesthetics 456 0 456
Nephrology 242 576 818
Psychiatry 393 391 784
Dove Medical 130 173 303
Allied Health Clinics 3,215 3,093 6,308
Diagnostic Clinics 11,720 19,472 31,192
Total 39,198 72,653 111,851
O U T PA T I E N T  A C T I V I T Y  D A T A  2 0 1 3
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Departmental
Reports
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OPERATION CATEGORIES
2009 2010 2011 2012 2013
Obstetrical Majors 2556 2469 2745 2604 2717
Obstetrical Minors 1189 1273 1287 1284 1259
Vaginal  Surgery 512 677 626 610 609
Abdominal:Uterus 130 113 110 125 93
Abdominal:Tubes & Ovaries 344 360 336 317 311
Other procedures 2170 2760 2615 2365 2245
D E PA R T M E N T  O F  G Y N A E C O L O G Y
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THEATRE GYNAECOLOGIC  WORKLOAD 
VAGINAL SURGERY 2012 2013
Vaginal hysterectomy 33 13
Manchester repair 1 0
Pelvic Floor Repair 27 48
Vaginal Hysterectomy & AP Repair 53 35
Sacro Spinous Colpopexy 13 8
Removal of IUCD 94 134
Insertion of IUCD 379 357
Other 10 14
Total 610 609
ABDOMINAL OPERATIONS 
OF THE UTERUS 2012 2013  
Total Abdominal Hysterectomy 49 33
Myomectomy 29 17
TAH & Bilateral Salpingo-oophorectomy 28 23
Sub Total Hysterectomy 19 20
Total  125 93
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OTHER PROCEDURES 2011 2012   
Laparoscopy 269 297
Laparoscopy and Dye 242 216
Hysteroscopy 276 199
D&C/H&C 733 853
UBT 76 46
EUA 47 46
Cystoscopy 20 18
Laparotomy 58 48
Excision Bartholins Cyst 47 36
Fentons 9 4
Diathermy Vulval Warts 2 1
Operative Hysteroscopy 6 4
Endometrial Ablation {Rollerball} 14 14
Laparoscopic division of Adhesions 44 47
Laparoscopic Ablation of Endometriosis/Argan 125 124
Polypectomy 61 71
TVT 16 10
Punch Biopsy of Cervix 11 12
LLETZ 78 21
Other Gynae Surgery 184 136
Other Surgery - fetal/anaesthetic 47 42
Total 2365 2245
GRAND TOTAL
Gynae Grand Total Minors & Majors 3441 3258
THEATRE GYNAECOLOGIC  WORKLOAD 
ABDOMINAL: TUBES AND OVARIES 2012 2013   
Tubal Surgery 28 2
Laparoscopic Sterilisation 25 33
Tubal Ligation at Caesarean Section 64 91
Salpingectomy 82 73
Ovarian Cystectomy 82 73
Oophorectomy 14 17
Ovarian Biopsy 5 7
Salpingo-oophorectomy 17 15
Total 317 311
64
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Consultant Colposcopists DR. PAUL BYRNE (Director Of Colposcopy)
DR. TOM WALSH
DR. YAHYA KAMAL (locum)
DR IRAM BASIT (locum)
Lead Nurse Coordinator MS. SELINA IGOE
Nurses MS. ROSE THORNE
MS. CAROLE O’ROURKE
MS. JENNIFER O’NEILL
MS. VIRGINIE BOLGER
Health Care Assistants MS. TRISH O’DONOVAN
MS. MARGARET CARROLL
MS. ANNA WILSON
Colposcopy Team Leader MS. CATHY HAYES (JANUARY 2012)
MS. SUSAN DALY (FROM FEBRUARY 2013)
Administrative Support MS. ÉILIS DALTON
MS. NIAMH O’CARROLL
MS. OLGA PEARSON
MS. MARITA PABERZA
C o l p o s c o p y  S e r v i c e
Our Service Level Agreement with the National Cancer Screening Service was to
see 1500 new patients in 2013.  During the year 1569 new patients were seen and
there were 3235 return visits, giving a total of 4776 patient visits (Table 1). This
represents a slight increase compared to the previous year. Compared to 2012,
the number return visits was higher.  We believe that this is in part due to the
new HPV “test of cure” which was introduced last year. Our DNA rate is 9% for
first visits and 13% for return visits.  These figures are close to the National
Cervical Screening Programme target of <10%. 
Table 1. Clinic Attendances
2010 2011 2012 2013
New attendances 1664 1908 1563 1569
Return visits 2568 2769 3159 3325
Total 4232 4677 4722 4776
Of the 1569 new referrals, 300 (19%) had smears showing HSIL (moderate or
severe dyskaryosis) as shown in Table 2.  However, 383 (24%) were referred with
ASCUS (borderline) smears. This shows that women with borderline smears
continue to represent a significant burden on the clinical workload despite the
fact that these women have a very low risk of developing cervical cancer.     
Table 2. Cytology on referral of new patients (n=1569)
ASCUS LSIL HSIL ASCUSG Clinical Other Total
Number 383 440 300 52 245 149 1569
% 24 27 19 3 16 10 100
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The downward trend in the number of LLETZ treatments continued in 2013
(Table 3). This reflects the fact that for the last two years we are reluctant to
consider LLETZ treatment in women with CIN1 unless there are strong clinical
indications for this. Our aim is to avoid treating women with low-grade lesions,
but this requires the reassurance of a biopsy-proven diagnosis.
Table 3. Biopsies and treatments
2010 2011 2012 2013
Biopsies 732 991 1014 1013
LLETZ 784 914 752 465
Total 1516 1905 1966 1478
There were 13 cases of invasive disease in 2013. The histological diagnosis in LLETZ
and biopsy specimens is shown in Table 4. This highlights that 9 women who had
a LLETZ treatment for what was presumed to be pre-invasive disease were found
to have invasive disease when assessed histologically.  Another four women had
colposcopic features of invasive disease that was confirmed on biopsy. 
Table 4. Histology of LLETZ and Colposcopic Biopsies
CIN 1 CIN 2 CIN 3 CGIN/AIS SCC Incl. Adenoca.
Microinvasion
LLETZ 127 126 162 3 7 2
Biopsies 493 191 125 2 2 2
The provision of the colposcopy service in the Rotunda Hospital is based on the
Quality Standards set out by the National Cervical Screening Programme (NCSS).
These standards cover every aspect of the screening pathway. Some of the key
administrative and clinical targets are shown in Tables 5 and 6. The fact that we
have exceeded most of the targets in 2013 is a reflection of the hard work and
dedication of all members of the Colposcopy Department. All of this is done in a
facility that is far too small for the clinical workload. Our colposcopy clinic is
currently located in what was once the neonatal unit. We have two small clinical
rooms, with very limited office space. We need to increase our clinical space, both
for patient comfort and so that we can increase our clinical workload.
Table 5.
Administrative Standards Rotunda Target
Proportion referred with HSIL seen within 4 weeks 88% >90%
Proportion referred with LSIL seen within 8 weeks 92% >90%
Proportion of appointments that were unattended 12% <10%
New appointments 9%
Follow-up appointments 13%
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Table 6.
Clinical Standards Rotunda Target
Proportion of LLETZ as outpatients 98% >80%
Proportion of women with CIN on histology
LLETZ 96% >85%
Biopsy 89% >85%
Proportion of women treated at first visit with CIN 
on histology 99% >90%
Proportion of women admitted as inpatients 
following LLETZ <1% <2%
All of our consultants are BSCCP accredited colposcopists. The clinics are
supported by specialist registrars. Dr Byrne is a BSCCP accredited trainer and
oversees the training of the registrars and nurses, all of whom are working
towards BSCCP accreditation
In 2013 we introduced a weekly nurses colposcopy clinic. At present, this is
confined to the investigation of women with low-grade smears. However, the
plan is to introduce a nurse led-colposcopy clinics which will include
management of women with high-grade abnormalities. We also plan to
introduce the treatment modality of “Cold Coagulation” in the near future. This
is a less invasive treatment than LLETZ and is ideal for the management of
women with persistent low-grade abnormalities. 
Monthly Multidisciplinary Team (MDT) meetings are held. We are most grateful
to Dr. Eibhlis O’Donovan and her team for their support.  We recognise that these
meetings represent a significant workload for the Histopathology Department.
These meetings are not made any easier by the fact that the smears are
processed and reported in the USA by Quest laboratories.  This inevitably leads
to difficulties when trying to correlate the cytology and histological diagnoses
for the meetings. In an ideal world, smears taken from women in Ireland would
be processed and reported in this country. 
We are also grateful to Dr Boyd and Dr Walsh who take over the management of
all cases of invasive cancer in the Gynaecology Oncology Department in the
Mater Hospital. Women diagnosed with vaginal intraepithelial neoplasia
(VAIN) are also referred to the Mater for LASER therapy.
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DR. D. CORCORAN , DR. A. FORAN (CLINICAL DIRECTOR), 
PROF.  N. MCCALLION, DR A. EL KHUFFASH, DR B. HAYES, 
PROF. M. D. KING, DR. S. KEANE
ADMISSIONS TABLES (1.1-1.10) 
2013 was an exceptionally busy year for the neonatal unit, overall our staff cared for
2,177 babies. The total number of admissions to the unit increased by 14% compared to
2012 (1,323 Vs 1,135) with an average occupancy rate of 93% which peaked in July and
August. There was a similar increase in the numbers treated from the wards (854 Vs
720) without any increase in resources. At times close to 20 babies were being treated
in the 13 bedded. It is a credit to all our staff especially frontline nursing staff that we
managed to achieve such good results overall, but this cannot be sustained. At a
national level the clinical lead for neonatology is seeking significant increases in whole
time equivalent nurses and consultants for baby units throughout the country, we
whole heartedly support this. In the interim we have submitted a business case to the
Clinical Director Dr Mc Kenna to seek one more neonatal consultant as a matter of
urgency to increase consultant delivered care in the key critical front line area of
intensive care. We are also pleased that executive management in the new hospital
strategy supports our bid to develop a transitional care unit. Close to 300 babies
admitted to NICU with birth weights > 2Kg could have been treated in such a unit. We
see this expansion of the neonatal unit foot print in the hospital as a high priority, to
facilitate maintaining a high intensity case mix, thus preventing intensive care cots
being filled by high dependency or special care babies.
This is the first year we are in a position to present more detailed data on babies
admitted with birth weights >1500g. We wish to thank the IT midwives and especially
Kathy Conway for their hard work in compiling this data. Going forward this will help
us develop a new model of care and identify those babies that can be nursed safely in
a transitional care unit.
Vermont OxfordNETWORK (SECTION 2 TABLES 2.1-2.5) 
This was our busiest year for admissions < 1500g with a total of 134 babies. Table 2.2
and 2.3 show our survival rates by gestation at delivery and birthweight.  The
survival rate for infants of 24 to 26 weeks gestation is over 70%, however birth
weight remains an important predictor of outcome, we have a 65% mortality rate
for infants who weigh less than 700g at birth.  
Table 2.4 shows morbidities and interventions in infants < 1500g compared to the
Network.
Our outcomes for key indicators are generally consistent with the network averages,
though our interventions show some variation.  We have a high rate of multiple
births compared to the network. There is a trend towards less invasive respiratory
support in preterm infants, and our rates of ventilation and early surfactant use,
though falling year on year, are higher than the network average. We have recently
purchased high flow units which will increase our use of non invasive
ventilation. We have a high availability of neonatal functional echocardiography
D E PA R T M E N T  O F  P A E D I A T R I C S
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in our unit and this increases our rate of diagnosis of patent ductus arteriosus and
also our use of nitric oxide  to treat  pulmonary hypertension in preterm infants.  Our
nosocomial infection rates are lower than the network averages.
Table 2.5 shows our most important outcomes for preterm babies which are
adjusted for birth weight and gestation, and are compared to average outcomes of
over 50000 infants  for the Vermont Oxford Network of neonatal units, and are also
compared to our outcomes over a 3 year period.  A standardized rate of < 1 indicates
a better than average outcome, if the upper confidence limit is also less than 1.   Our
adjusted outcomes for mortality, late onset sepsis and nosocomial infection, severe
intra ventricular haemorrages and chronic lung disease are all comparable to
network averages, and the trends for these indicators are improving.  Our
necrotizing enterocolitis rates are higher than average, which is a source of concern.
NEONATAL MORTALITY (< 28 DAYS)(TABLES 3.2 AND 3.3)
Congenital Malformations (3.2)
There were 18 neonatal deaths attributed to congenital anomalies or
malformations. Their gestation at birth spanned from 22 to 40 weeks. All of those
were identified antenatally with the exception of 1 infant with Pallister Killian
Syndrome and perisylvian polymicrogyria. The majority of infants were delivered
by elective caesarean section. Most deaths occurred within the first 3 days of life. 
Deaths of Normally formed infants receiving intensive care (3.3) 
Overall mortality was less than in 2012. There were 15 deaths of normally formed
infants. The majority were preterm (13) with 7 being 23 weeks gestation, 2 of whom
were born before arrival. Most deaths occurred within the first week of life. Of the 2
term babies who died one was external and both were due to severe asphyxia where
intensive care was withdrawn. The challenge in 2014 will be to review our policy and
decide whether we actively resuscitate all babies from 23 weeks gestation. 
Neonatal Encephalopathy (Table 3.1) 
There were a total of 38 babies with hypoxic ischaemic encephalopathy (HIE). Of
these, 24 had signs of mild (Grade 1) encephalopathy and did not meet criteria for
therapeutic hypothermia. Two of these were out born babies transferred in for
cooling assessment. Ten babies (2 out born) had evidence of moderate (Grade 2 )
HIE. All but one of these received therapeutic hypothermia. Follow up is available
on the 8 inborn babies. Of whom, 7 had an essentially normal MRI of the brain and
have normal development to date. The remaining baby had significant brain MRI
changes in the initial neonatal period and is showing signs of evolving cerebral
palsy. There were 4 babies (2 out born) classified with severe (Grade 3) HIE. All of
whom received cooling. Intensive care was withdrawn on 2 of these babies (1
inborn, 1 out born) .The remaining 2 babies had a normal MRI brain following
cooling. There were a further 8 term babies with encephalopathy and seizures not
attributed to HIE (6 inborn).Four had normal MRI brain imaging and have normal
neurodevelopmental progress to date. The remaining four babies had abnormal
neuroimaging. Neonatal presentation and neuroimaging abnormalities were due
to infection in two cases [bacterial meningitis (1); congenital CMV infection (1)]. A
diagnosis of KCN Q2 encephalopathy has been confirmed in another child. 
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The remaining child as yet has no confirmed diagnosis but has normal
neurodevelopmental progress to date and follow up is ongoing.
Follow-up of babies <1500g
All very low birth weight infants i.e. <1500g, born in or who were admitted to
Rotunda N.I.C.U. are eligible for neurodevelopmental follow up at 2 years corrected.
There were 109 children in the birth year 2011 to be assessed. All of these were sent
appointments at 2 years corrected and a total of 81 attended. Follow up rate of 74%.
Following assessment 14 were referred for speech and language therapy (10M:4F).
6 were diagnosed with cerebral palsy (4M:2F) and 2 were thought to have autistic
spectrum disorder. We thank Dr Keane for providing this service.
This information has facilitated us developing a more streamlined follow up for
very low birth weight infants. All these high risk babies are now offered formal
physiotherapy follow up at 4-6 months post discharge and targeted
neurodevelopmental follow up at 4 and 9 months corrected gestation in a bid to
improve earlier detection of problems. We are grateful to our colleagues in
physiotherapy for helping us develop a more systematic developmental follow up
programme. Accessing early intervention services for children particularly those
from the greater Dublin area has become very challenging with further cut backs.
COMMENTS
In 2013 the neonatal unit was asked by executive management to pilot managing
its own budget. Monthly meetings took place between the director Dr Foran, Orla
O Byrne and Kathy Conway. Key stake holders were then invited intermittently
e.g. HR, laboratory, pharmacy etc., to inform decisions. We could highlight issues
with NCHD and nursing overtime and identify trends such as significant
reductions in laboratory costs with the continued role out of more near patient
testing. It also facilitated succession planning for the retirement of Ann Frankish
Chief pharmacist and our no longer being in a position to make TPN on site. While
anticipated TPN costs were expected to reach 500,000 euro we managed to keep
them under 300,000 by the development of an approach used in Hammersmith
London.  Brian Cleary our new chief pharmacist undertook a huge amount of work
with the help of one of our senior registrars Alina Zidura and our ANP Christine Mc
Dermott. He has developed a user friendly software package which allows in the
main to give generic TPN rather than patient specific in the first 7-10 days, without
compromising nutrient content. We have been invited to share this with the
national neonatal TPN consortium and with adequate resources i.e. a dietician
and a neonatal pharmacist we could facilitate this and roll it out regionally then
nationally. A business case for a dietician was submitted to executive
management in March 2013.While there are many things we have little control
over, overall managing the NICU budget has been a very informative process. We
will continue to hold monthly business meetings in 2014.
Paediatric outpatients attendances remained high at 8,748 but saw a drop of
almost 17% from 2012 (10,547) and 25 % from 2011 (12,032). An audit was carried out
towards the end of 2013 to examine in more detail the babies being referred back
to the SHO clinic. The vast majority of referrals were for jaundice review. Despite
this only 31% of jaundice reviews needed bloods done and only 3.7% required
admission. There were high numbers of babies being reviewed for what are more
commonly seen as primary care issues e.g. 2 week baby check, sacral dimple, 70
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umbilical granulomas, constipation etc. Some presentations were referred by SHOs
unnecessarily. A more thorough education program at induction for new NCHDs
might cut down on numbers being brought back to clinic. Overall there are areas that
need to be improved. Our plan is to extend this audit to Temple Street Emergency
Department and to a local GP practice. We will review if mothers are presenting to the
appropriate services. Following the results of both audits we hope to introduce an
information leaflet for new mothers outlining the services available to them and a GP
education leaflet for the local GPs in the area outlining common neonatal problems
and their solutions could help save costs. Prof Mc Callion is hoping to run a targeted
GP study day in 2014 to address some of these common referrals.
The Dublin North East neonatal network (encompassing the Rotunda, Drogheda
and Cavan) continues to evolve. Forty five babies were transferred to the rotunda
either in or ex utero, contributing to 279 maternal and 599 NICU bed days in the
Rotunda respectively. Quarterly education meetings continued and audit of
transfers both to and back from the Rotunda continue. We have been able to
demonstrate that compared to 71% in 2012, in 2013 95% of high risk babies were born
within the network. In comparison to 2010 before the formalization of the network
when over 20% of babies < 27 weeks were born outside a tertiary unit only 9% in
2013.The plan to develop joint guidelines e.g. infectious diseases are being
progressed to improve uniformity. The network was set up and funded mainly to
improve care for babies < 27 weeks gestation. Funding may be needed to facilitate
the care of older babies especially those requiring therapeutic hypothermia.
The neonatal transport finally moved to 24/7 in December 2013. This will
significantly improve the quality and timely delivery of tertiary services to
babies form the country as a whole. A transport consultant Jan Franta was
appointed between the 3 Dublin maternity hospitals in late 2013, he will take up
his post in April 2014.  Given the significant increase in work load and call outs
between 5pm-8am careful audit, staff training and the development of a retro
transfer retrieval service are probably all needed. 
The neonatal unit continues its active role in research, and during 2013 there were a
total of four higher degree candidates in the Department of Paediatrics: Drs Michael
Boyle, Adam James, Elaine Neary and Raga Malika. While consultants were invited
speakers and projects were presented at many local and national meetings, we have
presented only publications and presentations at larger international meetings. 
The hospital continues to support staff wishing to undertake the Postgraduate
Diploma in Neonatal Nursing in partnership with the other Dublin Maternity
Hospitals and the RCSI. Three staff completed the program in 2013. A new
foundation program (level 1) in neonatal nursing was developed in 2012 in
partnership with the three Dublin Maternity hospitals. The program focuses on
nursing care of babies requiring special care and is for both new staff and updating
current staff who have not undertaken the Post Graduate Diploma.  To date 4 nurses
have completed the program. In 2014 a Level 2 foundation program will focus on
High Dependency and Intensive Care and we are facilitating 2 staff to do this 7
week course. The expansion of the ANP role within the unit is progressing. With
significant charitable donations from parents, the parents waiting room was
renovated. This is a key facility for parents during a very stressful time. Going
forward we hope to improve breast milk expressing facilities, develop a counselling
room and overnight accommodation for parents from outside Dublin. We thank 
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these parents for their very generous and thoughtful donations. We would also like
to thank all those who fundraise on our behalf including the ride out for prems and
premature babies Ireland organizations. We would especially like to thank Sheila
Thompson and the board of the Friends for their continued support.
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long years of service to the NICU. We wish her every success with her retirement.
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TABLE 1.1 
ADMISSION & DISCHARGE TO THE NEONATAL UNIT
 ADMISSIONS 1,323
DISCHARGES 1,315
INFANTS > 1.5Kg 1,174
INFANTS TREATED ON WARD 854
*Including readmissions
TABLE 1.2 
ADMISSION WEIGHT TO THE NEONATAL UNIT
500 - 1000grms 57
1001 - 1500grms 84
1501 - 2000grms 159
2001 - 2500grms 213
Over 2500grms 802
TOTAL INFANTS DISCHARGED 1,315
* Based on Infants Discharged from NICU
TABLE 1.3 
MAIN INDICATIONS FOR ADMISSION TO THE NEONATAL UNIT
RESPIRATORY SYMTOMATOLOGY 497
PREMATURITY < 37 WEEKS 426
JAUNDICE 410
LOW BIRTH WEIGHT < 2.5Kg 343
HYPOGLYCAEMIA 239
CONGENITAL ABNORMALITIES 222
SUSPECTED SEPSIS 46
NEONATAL ABSTINENCE SYNDROME 35
SEIZURES 26 
HIE 38
GASTRO-INTESTINAL SYMPTOMS 13
SOCIAL 11
DEHYDRATION 10
*Some Infants are assigned more than one reason for admission
SECTION 1
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TABLE 1.4
TERM BABY CAUSES OF RESPIRATORY MORBIDITY (>37 WEEKS)
MORBIDITY TABLES FOR PATIENTS ADMITTED TO THE NEONATAL UNIT
TRANSIENT TACHYPNOEA OF THE NEWBORN 195
MECONIUM ASPIRATION SYNDROME 26
PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN 23
RESPIRATORY DISTRESS SYNDROME 21
STRIDOR 13
CONGENITAL PNEUMONIA 9
AIR LEAK 2
CONGENITAL DIAPHRAGMATIC HERNIA 2
LARYNGOMALACIA 1
TRACHEO-OESPHAGEAL FISTULA 1
CONGENITAL CYSTIC ADENOMATOID MALFORMATION 1
PULMONARY HYPOPLASIA 1
TABLE 1.5 
CONGENITAL HEART DISEASE (ALL GESTATION)
PATENT DUCTUS ARTERIOSUS 91
DYSRHYTHMIA 53
PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN 41
VENTRICULAR SEPTAL DEFECT 27
ATRIAL SEPTAL DEFECT 9
ATRIOVENTRICULAR SEPTAL DEFECT 4
HYPOPLASTIC LEFT HEART SYNDROME 4
TRANSPOSITION OF THE GREAT ARTERIES 3
TETRALOGY OF FALLOT 1
TABLE 1.6 
GASTROINTESTINAL ANOMALIES
GASTRO-OESOPHAGEAL REFLUX 15
INGUINAL HERNIA 7
CLEFT PALATE ONLY 5
OMPHALOCOELE 3
CLEFT LIP AND PALATE 2
GASTROSCHISIS 2
SPONTANEOUS PERFORATION 2
IMPERFORATE ANUS 1
BOWEL ATERESIA 1
TRACHEO-OESPHAGEAL FISTULA 1
PYLORIC STENOSIS 1
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TABLE 1.7 
CENTRAL NERVOUS SYSTEM ABNORMALITIES
NEONATAL ABSTINENCE SYNDROME 35
SEIZURES NOT HIE 26
HIE 38
MEINGITIS 5
HYDROCEPHALUS 4
ERB'S PALSY 3
MICROCEPHALY 3 
SCHIZENCEPHALY 2 
SUBDURAL HAEMORRHAGE 1
TABLE 1.8
METABOLIC / ENDOCRINE /HAEMATOLOGICAL ABNORMALITIES
HYPOGLYCAEMIA 218
ANAEMIA OF PREMATURITY 104
THROMBOCYTOPENIA 35
DISSEMINATED INTRAVASCULAR COAGULOPATHY 33
HYPERGLYCAEMIA 23
POLYCYTHAEMIA 20
ANAEMIA(NOT INCL OF PREMATURITY) 7
HYPOTHYROIDISM 3
SIADH 3
HYPERINSULINISM 2
GALACTOSAEMIA 2
HAEMOLYTIC DISEASE OF NEWBORN 1
TABLE 1.9
DYSMORPHIC SYNDROMES
TRISOMY 21 *17
DYSMORPHIC FEATURES (NO FINAL DIAGNOSIS) 10
TRISOMY 18 (EDWARDS) 2
TRISOMY 13 (PATAU) 0
* 22 Infants born with T21, 17 aadmitted to NICU
TABLE 1.10
JAUNDICE IN TERM BABIES > 37 WEEKS
NON-HAEMOLYTIC 132
HAEMOLYTIC
ABO 26
RH 2
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Gestational  Inborn Survival % Survival % Outborn Survival % Survival % Total %
Age Infants to to Infants to to Survival
(completed) 28 days Discharge 28 days Discharge to 
weeks Discharge
21 0 0 (0%) 0 (0%) 0 0 (0%) 0 (0%) 0 (0%)
22 0 0 (0%) 0 (0%) 0 0 (0%) 0 (0%) 0 (0%)
23 5 0 (0%) 0 (0%) 0 0 (0%) 0 (0%) 1 (0%)
24 8 6 (75%) 6 (75%) 0 0 (0%) 0 (0%) 6 (75%)
25 6 4 (67%) 4 (67%) 1 1 (100%) 1 (100%) 5 (71%)
26 20 18 (90%) 16 (80%) 3 1 (33%) 1 (33%) 18 (74%)
27 18 17 (94%) 16 (89%) 0 0 (0%) 0 (0%) 16 (89%)
28 20 20 (100%) 20 (100%) 2 2 (100%) 2 (100%) 22 (100%)
29 10 10 (100%) 10 (100%) 3 3 (100%) 3 (100%) 13 (100%)
30 6 6 (100%) 6 (100%) 0 0 (0%) 0 (0%) 6 (100%)
31 10 10 (100%) 10 (100%) 1 1 (100%) 1 (100%) 11 (100%)
32 9 9 (100%) 9 (100%) 1 1 (100%) 1 (100%) 10 (100%)
> 32 9 7 (78%) 7 (78%) 1 1 (100%) 1 (100%) 10 (80%)
Total 121 109 (90%) 107 (88%) 12 11 (92%) 11 (92%) 118 (89%)
SECTION 2    -    VLBW INFANTS
TABLE 2.1
NUMBER OF CASES REPORTED TO VON 2013
All Cases Excluding Congenital 
Anomalies
Infants < 401g but >22 wks gestation 0 0
Infants 401-500g 1 1
Infants 501-1500g 131 122
Infants > 1500g but ≤29 wks gestation 2 1
Total 134 124
TABLE 2.2
GESTATIONAL AGE BREAKDOWN AND SURVIVAL TO DISCHARGE OF ALL
INFANTS REPORTED TO VON (INCLUDING THOSE WITH CONGENITAL
ANOMALIES) 2013 (N=134)
Birth  Inborn Survival % Survival % Outborn Survival % Survival % Total %
Weight Infants to to Infants to to Survival
(grams) 28 days Discharge 28 days Discharge to 
Discharge
<500 1 0 (0%) 0 (0%) 0 0 (0%) 0 (0%) 0 (0%)
501-600 7 2 (29%) 1 (14%) 1 0 (0%) 0 (0%) 4 (12%)
601-700 7 4 (57%) 4 (57%) 0 0 (0%) 0 (0%) 4 (57%)
701-800 12 11 (92%) 11 (92%) 0 0 (0%) 0 (0%) 11 (92%)
801-900 16 13 (81%) 13 (81%) 2 1 (50%) 1 (50%) 16 (78%)
901-1000 7 7 (100%) 6 (86%) 0 0 (0%) 0 (0%) 7 (86%)
1001-1100 12 12 (100%) 12 (100%) 1 1 (100%) 1 (100%) 13 (100%)
1101-1200 15 15 (100%) 15 (100%) 2 2 (100%) 2 (100%) 17 (100%)
1201-1300 14 14 (100%) 14 (100%) 1 1 (100%) 1 (100%) 15 (100%)
1301-1400 15 13 (87%) 13 (87%) 1 1 (100%) 1 (100%) 15 (88%)
>1400 15 15 (100%) 15 (100%) 4 4 (100%) 4 (100%) 16 (100%)
Total 122 109 (89%) 108 (89%) 12 8 -(67%) 8 (67%) 118 (87%)
TABLE 2.3
BIRTH WEIGHT AND SURVIVAL TO DISCHARGE OF ALL INFANTS REPORTED TO
VON (INCLUDING THOSE WITH CONGENITAL ANOMALIES) 2013 (N=134)
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TABLE 2.4
MORBIDITY FIGURES FOR INFANTS 501-1500G BORN (CONGENITAL
ANOMALIES INCLUDED) COMPARED TO THE VERMONT OXFORD NETWORK
N Rotunda VON
(n=131) n=60047
Inborn  134 122 (91%) 87%
Male 134 66 (49%) 51%
Antenatal Steroids (partial or complete) 126 104(83%) 81%
C/S 131 95 (73%) 73%
Antenatal Magnesium Sulphate 126 67 (53%) 48%
Multiple Gestation 131 48 (37%) 28%
Any major birth defect 131 8(7%) 5%
Small for gestational age 131 28 (22%) 24%
Surfactant in DR 131 87 (66%) 28%
Conventional Ventilation 130 86 (66%) 58%
High Frequency Ventilation 130 30 (23%) 21%
Any Ventilation 127 87 (69%) 60%
High Flow Nasal Cannula 130 2 (2%) 51%
Nasal IMV/SIMV 130 3 (2%) 28%
Nasal CPAP 129 106 (82%) 74%
Nasal CPAP before ETT Ventilation 104 28 (27%) 53%
Ventilation after Early CPAP 28 11 (39%) 37%
Surfactant at any time 131 97 (74%) 59%
Steroids for CLD  130 6 (5%) 9%
Inhaled Nitric Oxide 130 21(16%) 5%
RDS 113 97 (86%) 71% 
Pneumothorax 127 9(7%) 4% 
Chronic Lung Disease (at 36 wks) 113 17 (15%) 23% 
Chronic Lung Disease, Infants <33 wks 95 16 (17%) 26% 
Early Bacterial Infection 128 0 2% 
Late Bacterial Infection  125 6 (5%) 8% 
Coagulase Negative 125 7 (6%) 5%
Staphylococcus Infection
Nosocomial Bacterial Infection 125 13 (10%) 12% 
Fungal Infection 125 0 1% 
Any Late Infection (Bacterial or Fungal) 123 12(10%) 12% 
NEC Surgery 127 7 (6%) 3% 
PDA ligation 127 3 (2%) 5% 
Surgery for ROP 127 4 (3%) 3% 
Any Grade of IVH (Grade 1-4) 113 27(24%) 20% 
Severe IVH (Grade3-4)  122 8 (7%) 8%
Cystic PVL 124 4 (3%) 3%
Retinopathy of Prematurity 98 16 (16%) 31%
Severe ROP (Stage 3 or more) 97 6 (6%) 6%
Anti-VEGF Drug 130 0(0%) 1%
Focal GI perforation 130 2(2%) 2%
Indomethacin 130 1 (1%) 14%
NEC  127 18 (14%) 5%
PDA 130 49 (38%) 29%
Ibuprofen for PDA 130 25 (19%) 8%
Probiotics 128 116 (91%) 11%
Mortality 133 20 (15%) 15%
Mortality excluding Early Deaths 125 14 (11%) 9%
Survival 133 113 (85%) 85%
Survival without Specified Morbidities 133 79 (59%) 56%
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Measure N SMR SMR 95% SMR 95% N SMR SMR 95% SMR 95%
Lower Upper Lower Upper 
Mortality 130 1.1 0.7 1.6 379 1.3 1 1.6
Mortality Excl Early Deaths 125 1.2 0.7 1.8 368 1.3 1 1.7
Death or Morbidity 130 0.9 0.7 1.2 379 1 0.9 1.1
Chronic Lung Disease 102 0.8 0.5 1.2 315 1 0.8 1.2
CLD, Infants < 33 Weeks 95 0.8 0.5 1.1 295 1 0.8 1.2
NEC, Any Location 127 2.1 1.3 3 372 1.5 1.1 2
Late Bact Infection, Any Location 123 0.6 0.3 1.2 354 0.8 0.5 1.1
Coag Neg Staph, Any Location 123 0.9 0.4 1.7 354 0.9 0.5 1.3
Nosocomial Infection, Any Location 123 0.8 0.5 1.3 354 0.8 0.5 1.1
Fungal Infection, Any Location 123 0.2 0 1.2 354 0.1 0 0.6
Any Late Infection, Any Location 123 0.8 0.4 1.2 354 0.8 0.5 1
Any IVH, Any Location 122 1.2 0.9 1.5 358 1.3 1.1 1.6
Severe IVH 122 1 0.6 1.5 358 1.3 0.9 1.7
Pneumothorax, Any Location 127 1.3 0.7 2 373 1.3 0.9 1.8
Cystic PVL 124 1.1 0.4 2.2 360 1.1 0.6 1.8
Any ROP 97 0.6 0.4 0.9 318 0.5 0.4 0.7
Severe ROP 97 1.2 0.5 2 318 0.7 0.3 1.1
TABLE 2.5 
SHRUNKEN STANDARDISED 
MORTALITY AND MORBIDITY (SMR) 
RATES 2013
SHRUNKEN STANDARDISED 
MORTALITY AND MORBIDITY (SMR) 
RATES 2011- 2013 INCLUSIVE
Gestation Age at Birth Gender Delivery Apgars Inborn Congenital Anomaly
(weeks) Death weight Outborn / Malformation 
(Days) (g)
22 1 500 Male Vaginal Breech 1 & 1 Inborn Ventriculomegaly / Pyelectasis / 
Rocker Bottom Feet
31 1 1540 Female SVD 2 & 2 Inborn Encephalocele
32 1 1810 Female Vaginal Breech 2 & 2 Inborn Hydrocephalus / Alobar 
Holoprosencephaly 
33 > 7 days 2220 Female EL LSCS 9 & 9 Inborn Severe asymetrical Hydrocephalus 
/ large VSD & DORV
33 2 3190 Male EL LSCS 2 & 7 Inborn Hydrops Fetalis / Right  
bronchopulmonary sequestration 
33 70 3330 Male EM LSCS 3 & 7 Inborn Pallister Killian Syndrome / 
Perisylvian Polymicrogyria
36 1 1310 Male SVD 1 & 1 Inborn Trisomy 13
36 1 2970 Male SVD Outborn Megacystis / Hydroureter / 
anhydramnious 
36 2 2140 Male EL LSCS 3 & 7 Inborn Congenital Heart block / 
Biventricular hypertrophy 
36 1 1420 Female SVD 2 & 2 Inborn Monosomy 13q
37 1 1390 Female EL LSCS 6 & 6 Inborn Trisomy 18 / Cardiac Malfomations 
37 > 7 days 3520 Female EL LSCS 5 & 8 Inborn Grade 4 posterior fossa 
Medulloblastoma 
37 1 2890 Male EL LSCS 2 & 2 Inborn Severe Hydrocephalus
38 1 4620 Female EL LSCS 1 & 0 Inborn Hydrocephalus / large 
meningomylocele
38 2 1770 Female EL LSCS 5 & 7 Inborn Trisomy 18
38 3 1760 Male EL LSCS 9 & 10 Inborn Trisomy 18 / hypoplastic left heart 
38 1 3860 Male SVD 2 & 2 Inborn Large Encephalocele 
40 1 3000 (est) Female EM LSCS 1 & 0 Inborn Anencephaly
TABLE 3.2  - INBORN /OUTBORN INFANTS WITH CONGENITAL ANOMALIES (18)
SECTION 3  - HYPOXIC ISCHAEMIC ENCEPHALOPATHY AND MORTALITY TABLES
TABLE 3.1  -  HYPOXIC ISCHAEMIC ENCEPHALOPATHY (HIE)
Inborn Outborn
TOTAL 32 6
Mild HIE (Grade 1) 22 2
Moderate HIE (Grade 2) 8 2
Severe HIE (Grade 3) 2 2
Therapeutic Hypothermia 9 4
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Gest BW (g) Age (days) Gender Mode of delivery Apgars Principle Cause Death
(weeks)
23+3 570 1 M SVD N/A Extreme prematurity, born at home, 
unresponsive to resuscitation on arrival in hospital
23+3 620 2 M SVD N/A Extreme prematurity, born at home, resuscitated 
on arrival, sever RDS, anaemia, hypotension, 
pulmonary haemorrhage, bilateral grade 2 IVH.
23+5 750 19 M vaginal breech 1,4,6 Extreme prematurity, pulmonary haemorrhage, 
perforated necrotizing enterocolitis
23+5 640 23 M EMLSCS 7,7,8 Extreme prematurity, antepartum haemorrhage, 
chronic lung disease,HFOV,  pulmonary 
hypertension, renal failure.
23+6 510 1 M EMLSCS 0,1,0 Extreme prematurity
25+6 860 6 M SVD 0,4,6 Extreme prematurity, PPROM from 18 weeks, 
severe pulmonary hypoplasia, severe pulmonary 
hypertension, bilateral pneumothoraces, 
Pulmonary interstitial emphysema, Grade 3 and 
Grade 4 IVH, refractory hypotension.
26 990 33 M EMLSCS 4,4,9 Gram negative septicaemia (Klebsiella Oxytoca), 
extreme prematurity, respiratory distress syndrome.
26+4 890 2 F LSCS 2,4,9 Extreme prematurity, severe RDS, bilateral 
pneumothoraces, refractory hypotension.
26+4 850 18 F LSCS 3,4,6,9 Extreme prematurity, severe RDS, recurrent 
pneumothoraces, grade IV IVH.
27+2 540 31 F EMLSCS 9,10 Prematurity, Chronic lung disease, pulmonary 
hypertension, severe bilateral periventricular 
leucomalacia, intensive care withdrawn.
27+3 700 2 M EMLSCS 4,6 Prematurity, IUGR due to PET, Severe RDS, 
pneumonia.
36+3 2840 2 M EMLSCS 0,2,4 Placental abruption, severe hypoxic ischaemic 
encephalopathy, withdrawal of intensive care.
40+3 3600 2 M EMLSCS Cavan 2,4 Postnatal transfer from Cavan, Uterine rupture, 
Severe neonatal encephalopathy, seizures, 
intensive care withdrawn.
TABLE 3.3  -  INBORN /OUTBORN INFANTS NORMALLY FORMED  > 500G
ACADEMIC ACTIVITIES 
Peer reviewed Publications
1. Neary E, Okafor I, Al-Awaysheh F, Kirkham C, Sheehan K, Foran A, Corcoran JD, Ni
Ainle F, Cotter M, McCallion N. Laboratory coagulation parameters in extremely
premature infants born earlier than 27 weeks upon admission to a neonatal
intensive care unit. Neonatology. 2013;104(3):222-7.
2. Hayes BC, McGarvey C, Mulvany S, Geary MP, Matthews TG, King MD. A
Case/Control Study of Hypoxic Ischaemic Encephalopathy in Infants Greater than
36 Weeks Gestation. Am J Obstet Gynecol. 2013;209(1):29.e1-29.e19. 
3. Hayes BC, Cooley S, J Donnelly, Doherty E, Grehan A, Madigan C, McGarvey C,
Mulvany S, Ryan S, Gillian J, Geary MP, Matthews TG, King MD.The placenta in
infants >36 weeks gestation with neonatal encephalopathy: a case control study.
Arch Dis Child Fetal Neonatal Ed. Arch Dis Child Fetal Neonatal Ed. 2013
May;98(3):F233-9. 
4. Leslie A, EL-Khuffash A, Jain A, Keyzers M, Rogerson S, McNamara PJ. Evaluation of
Cerebral Electrical Activity and Cardiac Output after Patent Ductus Arteriosus
Ligation in Preterm Infants. J Perinatol, 2013;33(11):861-6.
5. EL-Khuffash A, Herbozo C, Jain A, Lapointes A, McNamara PJ. Targeted Neonatal
Echocardiography (TNECHO) Service in a Canadian Neonatal Intensive Care Unit- a
4 Year Experience. J Perinatol, 2013 2013;33(9):687-90.
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6. Saleemi S, Bruton K, EL-Khuffash A, Kirkham C, Franklin O, Corcoran JD.
Myocardial assessment using Tissue Doppler Imaging (TDI) in preterm very low
birth weight infants before and after red blood cell transfusion. J Perinatol.
2013;33(9):681-6.
7. EL-Khuffash A, McNamara PJ, Lapointe A, Jain A. Adrenal Function in Preterm
Infants Undergoing Patent Ductus Arteriosus Ligation . Neonatology. 2013 Apr
25;104(1):28-33.
8. EL-Khuffash A, Jain A, McNamara PJ. Ligation of the Patent Ductus Arteriosus in
Preterm Infants: Understanding the Physiology. J Pediatr. 2013;162(6):1100-6.
Book Chapters
1. Breda C Hayes, Kalpathy S Krishnamoorthy, Janet S Soul. Neonatal Neurology
Chapter 19  Handbook of Pediatric Neurology 1st Edition. Lippinott Williams
&Wilkins; November 2013. ISBN  9781451175486
International Presentations 
1. Afif F EL-Khuffash, Amish Jain, Dany Weisz, Luc Mertens, and Patrick J
McNamara. Cardiac Troponin, Myocardial Tissue Doppler Velocities and Strain
Values in Infants at Risk of Post Ligation Cardiac Syndrome (PLCS) Following
Patent Ductus Arteriosus (PDA) Ligation. Paediatric Academic Society Meeting.
Washington DC, May 2013. 
2. Amish Jain, Afif El-Khuffash, Adel Mohamed, Patrick J McNamara, Luc Mertens.
Myocardial Performance Index (MPI) and Tricuspid annular plane systolic
excursion (TAPSE) using Traditional vs. Tissue Doppler Imaging - A comparison
of technique reliability. Paediatric Academic Society Meeting. Washington DC,
May 2013.
3. Dany Weisz, Amish Jain, Patrick J McNamara, Afif F EL-Khuffash. Non-invasive
Cardiac Output Monitoring (NICOM) in Preterm Infants post Patent Ductus
Arteriosus (PDA) Ligation: A Comparison with Echocardiography. Paediatric
Academic Society Meeting. Washington DC, May 2013.
4. Amish Jain, Afif El-Khuffash, Prakesh S Shah, Christopher W Hooper, Naoko Brown,
Stanley D Poole, Jeff Reese, Patrick J McNamara. Efficacy of Acetaminophen on
Patent Ductus Arteriosus Closure May be Dose Dependent: Evidence From Murine
and Human Studies. Paediatric Academic Society Meeting. Washington DC, May
2013.
5. Amish Jain, MD, Adel Mohamed, Afif El-Khuffash, Patrick J McNamara, Luc
Mertens, Robert P Jankov. Quantitative Echocardiography Assessment of Right
Ventricular Dimensions in neonates: Normal Reference Ranges. Paediatric
Academic Society Meeting. Washington DC, May 2013.
6. Amish Jain, Adel Mohamed, Afif El-Khuffash, Robert p Jankov, Luc Mertens,
Patrick J McNamara.  Prospective Study to Establish Quantitative Indices of
Normal Right Ventricular Function in Newborn Infants Using Echocardiography.
Paediatric Academic Society Meeting. Washington DC, May 2013.
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7. Michael Boyle, David Watson, Ailbhe Tarrant, Stephanie Ryan, James Meaney,
Martin McGinnity, Adrinne Foran. Resting state fMRI connectivity analysis of
the intra-uterine growth restricted infant brain. Irish Paediatric Association
Meeting, Dublin, Nov 2013 *Best Investigator Award and Research Bursary
¤1000*
8. Michael Boyle, Aisling Lyons, Stephanie Ryan, Fergal Malone, Adrienne Foran.
Neonatal MRI brain following fetoscopic laser surgery for twin-twin transfusion
syndrome: Implications for clinical practice. Society for Maternal Fetal Medicine
Meeting. San Francisco, Feb 2013.
9. Prematurity Versus Growth Discordance: Impact on Cognition in a Cohort of
Twins. Cecilie Halling, Fionnula M. Breathnach, Fergal D. Malone, Elizabeth Tully,
Patrick Dicker, John D. Corcoran. Paediatric Academic Society Meeting.
Washington DC, May 2013.
10. Growth Discordance and Development: Is the Smaller Twin at Risk?
Cecilie Halling, Fionnula M. Breathnach, Fergal D. Malone, Elizabeth Tully,
Patrick Dicker, John D. Corcoran. Paediatric Academic Society Meeting.
Washington DC, May 2013.
Research Awards 
1. David Corcoran: Collaborator. Management of Hypotension In the Preterm
Extremely Low Gestational Age Newborn. ¤200,000
2. Adrienne Foran: Collaborator. Wellcome Trust Strategic Award for Multicentre
national study of a seizure detection EEG algorithm for newborns Principal
Investigator: Professor Geraldine Boylan UCC – ¤3,000,000 (Research Fellow
RagaMallika Pinnamaneni)  
3. Adrienne Foran: Principal Investigator/MD supervisor 3.0 T MRI imaging of
growth restricted newborns - ¤260,000 (Research Fellow Mike Boyle)
4. Adrienne Foran: Principal Investigator/MSC supervisor Long-term follow-up of
babies who are acidotic at birth - ¤ 75,000
5. Adrienne Foran. Principal Investigator/SpR supervisor NIRS monitoring of
babies in NICU -  ¤ 25,000
6. Afif EL-Khuffash. Co-principal Investigator: The HANDLE Study: Haemodynamic
Assessment iN pregnancy anD neonataL Echocardiography assessment -
MRCG/HRB/Friends of the Rotunda  ¤188,125
7. Afif EL-Khuffash. Principal Applicant. The Use of Targeted Neonatal
Echocardiography to Predict Short Term Clinical Sequelae Associated with a
Patent Ductus Arteriosus - Friends of the Rotunda ¤38,745 (Research Fellow
Adam James) 
8. Naomi McCallion: Principle investigator. To determine reference ranges for
coagulation parameters and to characterize thrombin generation in very
preterm infants ¤195,375 (Research Fellow Elaine Neary). 
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CONSULTANT SURGEON Mr. Paul Connolly FRCSI, FRCSOrth
ORTHOPAEDIC PHYSICIAN Dr. Hilary Lane MB, PhD
The Orthopaedic Service in the Rotunda hospital provides a neonatal screening
service for Developmental Dysplasia of the Hip (DDH) as follows:
1.) Clinical examination for hip instability in the neonatal period by 
experienced clinicians.
2.) Ultrasound examination of the hips in at-risk babies in the late neonatal 
period.  Risk factors which warrant hip ultrasound screening are: 
• unstable/ dislocated hip on clinical examination, 
• positive family history of DDH (first and second degree relatives),
• breech presentation 
• congenital malformations of the foot 
• oligohydramnios 
• ligamentous laxity 
The use of hip ultrasonography has replaced hip radiographs as the principal
screening method for the majority of our at-risk neonates. Hip xrays are used to
follow-up  a subset of infants who require further surveillance. Those
undergoing treatment for hip instability and dysplasia are rountinely followed-
up with serial hip xrays.
Inpatient and Outpatient Activity
Total No. Patients 2009 2010 2011 2012 2013
In-Patient activity 5847 5724 5577 5172 5348
Out-Patient 
Activity 539 761 916 786 978
Hip radiographs reviewed 1642 1392 1924 1453 1281
Since the introduction of hip ultrasound as the principal tool for DDH screening
for  babies at risk of dysplasia or hip instability by The Master, Dr. Sam Coulter
–Smith, the incidence of operative intervention for DDH has fallen.*
The number of hip radiographs has also decreased.
There has been an increased number of detections of DDH.
DEPARTMENT OF ORTHOPAEDIC SURGERY
51639 Rotunda Clinical Report 2013 301014 v5_Clinical Rep  30/10/2014  11:57  Page 81
DATA FROM THE DDH SCREENING SERVICE
2009 2010 2011 2012 2013
Total No. of babies with Hip 
Instability  Clinical Diagnosis 55 66 82 77 81
Total No. of babies with Hip Instability/ 
dysplasia; US/X-raydiagnosis 20 37 39 42 44
Total No. of babies treated for 
DDH in Pavlik harness 69 103 111 108 103
Total No. of babies treated for 
DDH in Abduction Brace 6 7 10 11 22
Total No. of babies treated for DDH 75 110 121 119 125
Total no of babies requiring surgery
for DDH in CUH, Temple Street 20 15* 12* 16* 7*
In 2013 a total of 125 babies born in the Rotunda were treated for DDH.
103 babies were treated in Pavlik harness.
22 were treated in abduction braces.
81 cases of DDH were picked up on clinical examination as hip instability. 
44 cases were picked up on US or x-ray screening.
There has been a steady improvement in the rate of pick-up of DDH since the
introduction of selective hip ultrasound screening. 
This has been associated with a decline in number of operations for DDH. (New
cases may yet come to light*).
*The figures given above need to be amended as new information comes to
light. If operative intervention is required, these babies are included in the
cohort with whom they were born(*) not the year in which the operation took
place. 
In 2011, one baby required operative intervention for persistently dislocated left
related to non-compliance. 
In 2012,  2 babies diagnosed with dislocated hips in the early neonatal period
eventually required surgery. 
They had intercurrent medical and surgical issues which needed to be
prioritised over the dislocated hip.
Currently in The Rotunda DDH screening takes the form of : clinical
examination in the early neonatal period by experienced clinicians coupled
with ultrasound screening of the hip for those babies at-risk for DDH.
However,we continue to advocate for  a Universal Ultrasound Hip Screening
Programme for every neonate. We propose a trial of Universal Hip Ultrasound of
ten thousand babies born in the Rotunda to ascertain the true incidence of DDH
in an Irish population and the potential cost benefit (or not) of preventative
screening.
82
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D E PA R T M E N T  O F  A N A E S T H E S I A
DR. MARY BOWEN, DR. NIAMH HAYES, DR. JOHN  LOUGHREY  
DR. CONAN MC CAUL, DR. ROISIN NI MHUIRCHEARTHAIGH, 
DR. PATRICK THORNTON.
Dr. Patrick Thornton was appointed as Consultant Anaesthetist this year. We are
delighted to welcome him to our Department on a permanent basis. Dr. Conan
Mc Caul remained as College of  Anaesthetists Tutor. Dr. John Loughrey resigned
from the Departmental Chair and Dr. Mary Bowen took up the post as Director of
Anaesthesia.  We would like to thank John for all his dedication in this capacity.
Dr. Niamh Hayes continued in her position as Director of Simulation Training in
the College of Anaesthetists of Ireland and continues to run the RHOET courses
on a regular basis.
Non-Consultant Hospital Doctors:
The Department continues to provide training in  Obstetrical Anaesthesia and to
avail of five trainees from the National training programme, two other NCHDs and
one Fellow in Obstetrical Anaesthesia. We would  like to congratulate  Dr. Emma
Mc Murray who joined the SPR scheme in Northern Ireland.  Also Dr. Kim Caulfield
and Dr. Laura Mac Darby who both passed their  Part 1 FCA examinations. 
The Department continues to participate in high risk cardiac obstetrical cases
and multidisciplinary six weekly meetings with Dr. Kevin Walsh, Consultant
Cardiologist, Mater Misericordiae University Hospital, Dr. Fionnuala NíAinle,
Consultant Haematologist (Adult) and Dr. Peter Mc  Kenna, Consultant
Obstetrician Gynaecologist/Clinical Director.
DELIVERY  SUITE  ACTIVITY
DELIVERIES UNDER EPIDURAL
The number of deliveries under epidural remains high, a similar rate to the
previous year. Patients receiving epidurals  continue to receive patient controlled
epidural infusions  PCEA  with a background infusion . 
Labour Analgesia is also provided by Entonox, TENS  and   and  Remifentanil  PCA.
A remifentanil  PCA is available to patients in whom epidurals are
contraindicated or who want an alternative to epidural analgesia. 33 patients
availed of a remifentanil PCA in 2013.
2012 % 2013 %
Nulliparous {%of Primups less C/S 2571 73% 2327 72%
before labour {2012-3533}   {2013-3247}
Multiparous {%of Multips less C/S before labour 1672 44% 1697 45%
{2012-3796} {2013-3740}
TOTAL {Multips & Primips excluding Emerg/Elec 4243 4024
Onsets of labour         {2012-7329} {2013-6987}
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Mode of Delivery for Parturients who Select Epidural Analgesia
NULLIPAROUS
Mode of Delivery 2012 % 2013 %
Normal 892 34.7% 778 33.4%
Forceps 286 11.1% 298 12.8%
Vacuum 843 32.8% 715 30.7%
L.S.C.S 546 21.2% 535 23.0%
Breech 4 0.2% 1 0.04%
Total 2571 2327
MULTIPAROUS
Mode of Delivery 2012 % 2013 %
Normal 1258 75.2% 1294 76.3%
Forceps 41 2.5% 58 3.4%
Vacuum 209 12.5% 193 11.4%
L.S.C.S 161 9.6% 146 8.6%
Breech 3 0.2% 6 0.4%
Total 1672 1697
Epidural % CSE %
2104 64.8% 263 8.1%
1495 40.0% 226 6.0%
3599 489
Some patients had CSE + Epidural so combined totals different
The obstetrical   outcomes for  parturients  receiving epidural analgesia remains
consistent with low dose techniques  with 33.4% of primiparous patients  and
76.3% of mutiparous patients  having normal  unassisted deliveries.
84
CAESAREAN SECTION RATE 2012- 2013
2012
Mode of Anaesthesia Elective % Emergency %
Spinal 1214 96.3% 499 35.2%
GA 12 1.0% 182 12.8%
Epidural 9 0.7% 641 45.2%
CSE 25 2.0% 95 6.7%
Total 1260 1417
Some patients had more than 1 analgesia during Caesarean Section
2013
Mode of Anaesthesia Elective % Emergency %
Spinal 1312 96.8% 573 39.6%
GA 10 0.7% 160 11.1%
Epidural 2 0.1% 612 42.3%
CSE 32 2.4% 102 7.0%
Total 1356 1447
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ANAESTHESIA OUTPATIENT CLINIC
The Pre-Anaesthesia Assessment Clinic continues on a weekly basis  with 456
attendees.
A separate clinic has been established for the Cardiac Obstertical  patients. This
is held on a monthly basis.
OPERATING THEATRE ACTIVITY
GYNAECOLOGICAL REPORT
Operation Categories 2009 2010 2011 2012 2013
Obstetrical Majors 2556 2469 2745 2604 2717
Obstetrical Minors 1189 1273 1287 1284 1259
Vaginal  Surgery 512 677 626 610 609
Abdominal:Uterus 130 113 110 125 93
Abdominal:Tubes & Ovaries 344 360 336 317 311
Other procedures 2170 2760 2615 2365 2245
POST DURAL-PUNCTURE HEADACHE (PDPH)
There were 4024 epidurals performed and 1885 obstetric  spinal anaesthetics and
650combined spinal epidurals CSEs .                                                                                                                                                  
32 patients had  documented post  dural  puncture headaches and 13 patients
required blood patches.  One of these patients required a repeat blood patch and
a CT scan for a persistent headache. The CT scan was negative and the headache
resolved.
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H I G H  D E P E N D E N C Y  U N I T
DR. MARY BOWEN  CONSULTANT ANAESTHETIST
Obstetrics  179 95.9% of total admissions
Obstetric Category Number % Overall % Obstetric Admissions
Haemorrhage (APH/PPH) 74 38% 41%
PET/Eclampsia/ HELLP 49 24% 27%
Sepsis 15 8% 8%
Cardiac Disease 11 6% 6%
Miscellaneous 30 15% 17%
Miscellaneous Obstetric HDU Admissions included cases of:- 
Persistent Tachycardia for Investigation
Deep Venous Thrombosis
Cardiac – Fast Atrial Fibrillation for Stabilisation
Anaphylaxis 
Pain Control
Urinary Retention/Renal Injury Post-Caesarean Section
Post-Chemotherapy Pyrexia (Known Breast CA)
Moya-Moya Syndrome Post Caesarean Section  Monitoring
Known Crohn’s disease with ileostomy. Developed bowel obstruction. 
Had emergency LSCS at MMUH and end to end bowel anastomosis *
Aplastic Anaemia Platelet Transfusion Pre Caesarean Section
Nephrotic Syndrome With Stage 3 Chronic Kidney Disease
Smoker, Desaturation Post Caesarean Section Requiring Oxygen Therapy
High BMI Ruptured Ectopic Pregnancy
Type 1 Diabetes.  Post Renal and Pancreatic Transplant Post Caesarean Section
Uterine Rupture, Emergency Caesarean Section Post-Operative Care
Maternal Cardiac Arrest During Second Stage Labour Requiring CPR (Troponin
Rise And ECG Changes), Cardiac Monitoring MMUH CCU and Rotunda HDU 
Goodpasture’s Syndrome With Renal Transplant And Autoimmune
Thrombocytopenia Post Caesarean Section
H1N1 Influenza (Antepartum Care)
86
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Gynaecology 18 patients (9% of total admissions)
Gynaecology Category Number % gynae 
admissions
Assisted reproduction: OHSS 1 6%
Bleed after 
egg retrieval 1 6%
Pain control 3 16%
Sepsis 2 11%
Bleeding 6 33%
Miscellaneous 5 28%
Miscellaneous Gynaecology HDU Admissions 
Post-operative Laryngospasm 1
Post-operative Bronchospasm 1
Post-operative status Epilepticus 1
Hyponatremia Post-TCRE 1
Observation for Excessive Sedation 1
Transfers to Mater Misericordiae University Hospital (7)
1 Known placenta accreta.  Required emergency Caesarean Hysterectomy. 
Massive transfusion. Transferred for continuing management
2 Patient complaining of neck stiffness and headache. Hypertensive. No PET 
in ante partum period. Sent for neurology opinion and investigations > CT 
Brain and Lumbar Puncture
3 Known case of HOCM. Had LSCS under CSE. Transferred for post-op 
telemetry in CCU
4 Elective LSCS under Spinal. Bleeding from broad ligament. Re-laparotomy 
for control of haemorrhage. Massive transfusion
5 Elective LSCS at MMUH for Cardiomyopathy. Transferred back to Rotunda. 
Developed tachyarrthymias. Transferred to MMUH for telemetry in CCU
6 Patient collapsed while pushing in second stage labour. Needed CPR. ECG 
changes and raised troponin levels post event. Transferred to CCU for 
monitoring
7 Emergency LSCS under GA for placenta accreta & concurrent sepsis. Patient
collapsed on ward D1 post-CS. CPR, defibrillated and transferred to MMUH. 
RIP
Transfers from Mater Misericordiae University Hospital (3)
1 Elective LSCS at MMUH for significant cardiac anomaly
2 Known Crohn’s disease with ileostomy. Developed bowel obstruction. Had 
emergency LSCS at MMUH and end to end bowel anastomosis *
3 Triple transplant recipient (patient booked at Coombe Women’s Hospital: 
Heart, Lungs and kidneys.  Elective LSCS at MMUH and return to Rotunda for
post-op care
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Caesarean Hysterectomies  (2)
Maternal Death: (1) patient
Emergency LSCS under GA for placenta accreta & concurrent sepsis. Patient
collapsed on ward D1 post-CS. CPR, defibrillated and transferred to MMUH. RIP
Additional/Invasive Monitoring.
Arterial Line 41
Central Line/Vasocath 5
Long Line 1
Cerebral Oximetry 1
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D O V E  C L I N I C
DR JACK LAMBERT, Consultant in Infectious Diseases
DR MAEVE EOGAN, Consultant Obstetrician and Gynaecologist
DR WENDY FERGUSON, Infectious Diseases Associate Paediatric Specialist 
(The Rainbow team)
DR BARRY KELLEHER, Consultant in GI/Hepatology
DR URSULA NUSGEN, Consultant Microbiologist 
MS MAIREAD LAWLESS, ID Liaison Midwife
MR JUSTIN GLEESON, Drug Liaison Midwife 
MS NICOLA ROGERS, Medical Social Worker
DR VALERIE JACKSON, Clinical Audit & Surveillance Scientist
INTRODUCTION
The DOVE clinic was set up to look after the specific needs of women who have
or are at risk of blood and sexually transmitted bacterial and viral infections.
This could be through drug use, unprotected sex, or any contact with infected
blood or body fluid.  
DOVE BOOKINGS IN 2013
During 2013, 206 women booked into the DOVE clinic for their antenatal care. Of
these, 
• 59 (28% of bookings) women were positive for Hepatitis B surface antigen, 
representing a decrease of 17% compared to 2012 (Fig 1). 
• 59 (28%) women were positive for Hepatitis C antibody, a decrease of 5% 
compared to 2012.
• 24 (12%) were positive for HIV infection, a decrease of 33% compared to 2012. 
• 20 (10%) women had positive Treponemal serology, an increase of 33% 
compared to 2012.
• 48 (23%) women were known to be on prescribed methadone programs
Fig 1: DOVE Bookings by Year
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DOVE DELIVERIES 2013
Deliveries to HIV Positive Mothers 2013
Total Mothers Delivered <500g (incl miscarriage) 0
Total Mothers Delivered >500g 30
Total Mothers Delivered 30
Live Infants 31 (1 set of twins; incl 1 NND)
Miscarriage 0
Stillbirths 0
Infants <37 weeks gestation 4
Infants ≥37 weeks gestation 27
Infants delivered by Caesarean Section 16
HIV Positive Infants 0
Maternal Data (n=30)
Median Age 34
Newly Diagnosed at ANS 6
NND = neonatal death
Deliveries to HCV Positive Mothers 2013
Total Mothers Delivered <500g (incl miscarriage) 7
Total Mothers Delivered >500g 51
Total Mothers Delivered 58
Live Infants 53 (incl 3 NND)
Miscarriage 5
Stillbirths 0
Infants <37 weeks gestation 12
Infants ≥37 weeks gestation 41
Infants delivered by Caesarean Section 15
HCV Positive Infants 3*
Maternal Data (n=58)
Median Age 32
Newly Diagnosed at ANS 6
NND = neonatal death; *Final serology not yet available for all infants, 
Results presented for 46/50 live infants
Deliveries to HBV Positive Mothers 2013
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 52
Total Mothers Delivered 53
Live Infants 52
Miscarriage 1 
Stillbirths 0
Infants <37 weeks gestation 4
Infants ≥37 weeks gestation 48
Infants delivered by Caesarean Section 17
HBV Positive Infants 0*
Maternal Data (n=53)
Median Age 28
Newly Diagnosed at ANS 11
*Final serology not yet available for all infants, Results presented for 25/48 live infants90
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Deliveries to Syphilis Positive Mothers 2013
Total Mothers Delivered <500g (incl miscarriage) 1
Total Mothers Delivered >500g 9
Total Mothers Delivered 10
Live Infants 9
Miscarriage 1
Stillbirths 0
Infants <37 weeks gestation 1
Infants ≥37 weeks gestation 8
Infants delivered by Caesarean Section 3
Syphilis Positive Infants 0
Maternal Data (n=10)
Median Age 34.5
Newly Diagnosed at ANS 2
Deliveries to Mothers under DLM* service 2013
Total Mothers Delivered <500g (incl miscarriage) 5
Total Mothers Delivered >500g 73
Total Mothers Delivered 78
Live Infants 74 (1 set of twins)
Miscarriage 5
Stillbirths 0
Infants <37 weeks gestation 16
Infants ≥37 weeks gestation 58
Infants delivered by Caesarean Section 20
NICU admissions for NAS 16
*DLM: Drug Liaison Midwife
In 2013, 270 infants attended the Rotunda Paediatric Infectious disease clinic
(The Rainbow clinic) for follow up. The clinic is delivered solely by a paediatric
specialist (Dr Ferguson).
EDUCATION AND TRAINING 
Members of the DOVE team are actively involved in undergraduate,
postgraduate and hospital education programmes. 
The British Association for Sexual Health and HIV (BASHH) accredited Sexually
Transmitted Infection Foundation (STIF) Course continues to be held Dublin,
with Dr Lambert acting as course director. The course ran in June and November
2013 and provided multidisciplinary training in the attitudes, skills, and
knowledge required for the prevention and management of STIs. Further
courses are planned for 2014. 
The Sexual Health Awareness Week (SHAW) took place on 12 - 14 November 2013
at the Royal College of Physicians of Ireland – Dr Maeve Eogan was on the
organising committee.  The theme was Communication and Sexual Health and
there was a broad range of events during SHAW including sexual health and
education needs of young people, practitioners’ obligations in reporting child
protection concerns, and preventing sexual violence.
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RESEARCH ACTIVITIES OF THE DOVE CLINIC
There are several research projects ongoing, many in collaboration with the ID
and Hepatology teams at the Mater Misericordiae University Hospital. Areas of
interest include the emergence of drug resistance and the pharmacokinetics of
HAART during pregnancy. 
A 2-year study of universal screening for genital Chlamydia trachomatis
infection in, all sexually active women presenting for care who are <26 years old,
was completed in December 2013. Data is currently being analysed and a paper
will be prepared for publication.
STAFF CHANGES
After many years of loyal service as the Medical Social Worker with the DOVE
clinic, Ms Nicola Rogers left the DOVE team in December 2013. Her longstanding
commitment to the team is gratefully acknowledged and we wish her every
success with her new life in Canada.
PUBLICATIONS AND PRESENTATIONS
1. Ali A, Glennon K, Kelleher B, Eogan M, Jackson V, Brennan M, Lawless M,
Ferguson W, Lambert J. Five year retrospective review of antenatal
Lamivudine (LAM) to reduce the perinatal transmission of Hepatitis B
(HBV). Presented at the British Maternal and Fetal Medicine Society 16TH
Annual Conference, 26th April 2013, Dublin. Printed in Arch Dis Child Fetal
Neonatal Ed 2013;98:Suppl 1 A42-A43 doi:10.1136/archdischild-2013-
303966.144
2. A Varughese, V. Jackson, M .Cafferkey, M. Brennan, M. Lawless, V .Ciprike,
M. Eogan, W. Ferguson, S. Coulter- Smith, J. Lambert. Syphilis Serology in
Pregnant Women Over a Period of 7 Years (2005–2011) in a Large Maternity
Hospital in Dublin, Ireland. Presented at the British Maternal and Fetal
Medicine Society 16TH Annual Conference, 26th April 2013, Dublin. Printed
in Arch Dis Child Fetal Neonatal Ed 2013;98:Suppl 1 A53
doi:10.1136/archdischild-2013-303966.180
3. JS Lambert, V Jackson, M Lawless, W Ferguson, M Eogan, M Brennan, L Else,
S Khoo. Transplacental Passage of Atazanavir and Neonatal
Hyperbilirubinaemia. 14th International Workshop on Clinical
Pharmacology of HIV Therapy 22 – 24 April 2013, Amsterdam, The
Netherlands
4. JS Lambert, V Jackson, M Lawless, W Ferguson, M Eogan, M Brennan, L Else,
S Khoo. Placental Transfer of Atazanavir and Neonatal
Hyperbilirubinaemia. CHIVA Annual Conference 2013, 10th May 2013 Leeds
5. JS Lambert, V Jackson, M Lawless, W Ferguson, M Eogan, M Brennan, L Else,
S Khoo. Atazanavir in pregnancy: transplacental transfer and neonatal
hyperbilirubinaemia. 7th IAS Conference on HIV Pathogenesis, Treatment
and Prevention 30 June– 3 July 2013, Kuala Lumpur, Malaysia
6. JS Lambert, V Jackson, L Else, M Lawless, W Ferguson, M Eogan, G
McDonald,  D Le Blanc, M Brennan, S Khoo . Transplacental transfer of
Atazanavir and the incidence of neonatal hyperbilirubinaemia. 14th
European AIDS Conference/EACS Brussels, Belgium from October 16-19,
2013.
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7. C. Finnegan, R. Moore, M. Lawless, V. Jackson, M. Eogan, J. Lambert. An audit
of compliance with glucose tolerance testing among HIV infected pregnant
women taking protease inhibitors. Lifespan Diabetes Research November
14th 2013 – World Diabetes Day The Pillar Room, Rotunda Hospital, Dublin
8. R. Moore. An audit of compliance with glucose tolerance testing among HIV
infected pregnant women taking protease inhibitors. Junior Obstetrics &
Gynaecology Society Annual Scientific Meeting, Friday, 29th November
2013. Royal College of Physicians of Ireland, No 6 Kildare Street, Dublin 2
9. C. Finnegan. Anti-retroviral use during labour – an audit of compliance with
Rainbow Clinic guidelines. Junior Obstetrics & Gynaecology Society Annual
Scientific Meeting, Friday, 29th November 2013. Royal College of Physicians
of Ireland, No 6 Kildare Street, Dublin 2
*   *   *
1. J Lambert, V Jackson, S Coulter-Smith, M Brennan, M Geary, TB Kelleher, 
M O'Reilly, K Grundy, N Sammon, M Cafferkey. Universal Antenatal
Screening for Hepatitis C. Irish Medical Journal  May 2013, Vol 106 (5).
2. C Monteith, F Ní Áinle, S Cooley, J Lambert, B Kelleher, V Jackson, M Eogan.
Hepatitis C virus-associated thrombocytopenia in pregnancy: impact upon
multidisciplinary care provision. Journal of Perinatal Medicine. 2013. Vol 42
(1) 135–138. 
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STEPHANIE RYAN  FFR RCSI 
NEIL HICKEY FFR RCSI
AILBHE TARRANT FFR RCSI
The radiology department in the Rotunda Hospital performed 7,335 exams in
2013 representing no significant change in activity over 2012 figures. Our
department images both adults and children. 7% of these were adult
examinations and 93% were paediatric examinations.
We continue to train radiographers in ultrasonography and in particular in hip
sonography and continue to provide a neonatal hip screening programme.  We
have set up a quality improvement and audit programme and have quarterly
meetings to review progress in this area.
ADULT RADIOLOGY 
The adult radiology service in the Rotunda Hospital is provided by Dr. Neil
Hickey. In 2013 a total of 385 adult radiological examinations were performed of
which 138 (36%) were hysterosalpingograms, performed as part of the fertility
clinic work up. Other examinations also include other fluoroscopic procedures
such as cystograms, non-obstetrical ultrasound (general abdominal, renal,
pelvic, head and neck, vascular and soft tissue) and plain films.
PAEDIATRIC RADIOLOGY 
Paediatric imaging accounts for 93% of the workload in the Department of
Radiology. In 2013, a total of 6,823 paediatric studies were performed. Of these,
3,034 were paediatric ultrasound examinations. Half of these examinations, 1,515
scans, were hip ultrasound examinations done on outpatient babies. As the hip
screening service is well established now, there is no significant change in the
number of hip ultrasound scans performed this year, when compared to 2012.
The number of hip x-rays performed was 1,295, an increase of 13% compared with
the same period in 2012. In addition 66 fluoroscopic studies were performed
predominantly for investigation of the upper GI tract (60), but also for evaluation
of the lower GI tract (6), often as an emergency out of hours study. There has
been an increase in the number of modified feeding studies done in Rotunda
hospital but many of these still need to be referred to TSH where facilities for
feeding the baby upright are available and where the advice of the Speech and
Language therapists can be sought.
The MRI unit at the Children’s University Hospital, Temple Street, which has
state of the art neonatal monitoring equipment, scanned a total of 114 Rotunda
babies from both NICU and POPD.  This is particularly valuable in the evaluation
of the newborn with neonatal encephalopathy and adds very useful additional
information to the bedside cranial ultrasound examination.  MRI scanning was
also used for the evaluation of babies with brain and spine malformations as
well as metabolic and other diseases.  
R A D I O L O G Y /
P A E D I A T R I C  U L T R A S O U N D
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14 paediatric patients were referred to Temple Street for CT scanning.  Fetal MR
imaging was also done in Temple Street for 27 obstetric patients at the Rotunda.
Many of these Rotunda babies are discussed at multidisciplinary meetings in
Temple Street Children’s University Hospital attended by Rotunda
neonatologists and radiologists and where the input of paediatric neurology and
paediatric neurosurgery teams is valuable.  
Both Dr Ryan and Dr Tarrant are actively involved in training at several levels
and in paediatric radiology research. Several audits have been performed. There
were several publications from our department as well as presentations and
lectures at national meetings. 
TABLE 1: STAFF COMPLIMENT
WTE
Diagnostic radiographers / ultrasonographers 2.5
Secretary 0.5
Consultant paediatric radiologist 0.76
Consultant adult radiologist 0.20
Senior medical physicist As needed
TABLE 2: ACTIVITY LEVELS
ADULT EXAMS 385
HSG 138
PAEDS   (X-ray & US) 6,823
TOT PAEDS US 3,034
CRANIAL 1,067
NICU US & CR 3,573
HIP US 1,515
NEONATAL FLUOROSCOPY 67
PUBLICATIONS AND PRESENTATIONS
PUBLICATIONS 2013
1. Hayes B, Cooley S; Donnelly J; Doherty E; Grehan A; Madigan C; McGarvey C;
Mulvany S; Ryan S; Gillian J; Geary MP; Matthews TJ; King MD. The Placenta in
Infants more than 36 weeks Gestation with Neonatal Encephalopathy: A Case
Control Study. Arch Dis Child Arch Dis Child Fetal Neonatal Ed. 2013 98(3):F233-
9  
2. Barrett MJ, Donoghue V, Mooney EE, Slevin M, Persaud T, Twomey E, Ryan S;
Laffan E; Twomey A. Isolated acute non-cystic white matter injury in term
infants presenting with neonatal encephalopathy. Arch Dis Child Fetal
Neonatal Ed 2013;98(2):F158-160.    
3. Butler G, Assaf N, Tarrant A, Ryan S, EL-Khuffash A. Using Lateral Radiographs
to Determine Umbilical Venous Catheter Tip Position in Neonates: A
Comparison with Anteroposterior Films. IMJ Article s-5596 Accepted Dec 2013
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PUBLICATIONS ON EURORAD: European Assoc Radiology On line Case studies file
1. Case 10675 Adrenoleukodystrophy.  Ryan J, Bolster F, Crosbie I, Ryan S. Feb 2013
2. Case 10891 Aicardi Goutieres Syndrome. Bolster F, Ryan S. July 2013
AUDITS
1. Quantification of cranial ultrasound anomalies identified in moderately 
premature infants. Aoife Cahalin, Ayesha Suliman, Stephanie Ryan, 
Ailbhe Tarrant, Elaine Neary, Naomi McCallion
2. Using Lateral Radiographs to Determine Umbilical Venous Catheter Tip 
Position in Neonates: A Comparison with Anteroposterior Films.  Butler G,
Assaf N, Tarrant A, Ryan S, EL-Khuffash A.
3. Audit of Gastrojejunal tubes placed in Temple Street Hospital over a two 
year period. Mc Mahon J, Macken S, Ryan S, Laffan E. Presented at Temple 
Street Hospital Audit day , 21 June 13
4. Assessment of the success of Radiological Reduction of Intussusception in
Children – A Clinical Audit.  Siobhan Hoare, Eoghan Laffan, S Ryan; VB 
Donoghue, E Twomey, E Kelliher, I Robinson. Presented at Temple Street 
Hospital Audit Day, 13 Dec 2013
5. Do recurrent respiratory infections predict an abnormal Videofluoroscopic
Swallowing Study?  Siobhan Hoare, Joy Tan, Imogen Carter, Noirin Carroll,
Sharon Keogh, Tanya Gilroy, Claire Salley, Stephanie Ryan. Presented at 
Temple Street Hospital Audit Day, 13 Dec 2013
INVITED LECTURES
1. CXR in Children – radiologists’s perspective on technique. Paediatric 
Imaging – considerations and concerns.  University College Dublin 
2 Mar 2013
2. The Radiology conference – at the Centre of Multidisciplinary Team Work.
Temple Street 140 symposium. Royal College of Physicians, Dublin  Nov 13
3. Cranial US: Technique and Pathology. Cranial Ultrasound Study Day, 
Rotunda Hospital, Dublin, June 2013.
96
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MS. MARGARET PHILBIN, DIRECTOR OF MIDWIFERY/NURSING
The hospital again experienced high levels of activity throughout 2013.  Midwives and
Nurses continued to meet the challenges posed by capacity and activity issues. The
team worked with skill and dedication to provide high quality care for women, babies
and families both within the hospital and in the community. The ongoing
commitment of staff to the hospital and to those who attend for care is truly
appreciated. 
STAFFING
Ms. M. Philbin Director of Midwifery/Nursing
Ms. P. Williamson Assistant Director of Midwifery/Nursing
Ms. F. Hanrahan Assistant Director of Midwifery/Nursing
Ms. M. Keane Assistant Director of Midwifery/Nursing
Ms. T. McCluskey Assistant Director of Midwifery/Nursing 
(resigned November 2013)
Ms. M. O’Reilly                         Practice Development Co-ordinator
Ms. A. O’Byrne                            Practice Development Co-ordinator
Ms. M. Brennan Assistant Director of Midwifery/Nursing-Infection 
Control
Ms. J. MacFarlane Acting Night Superintendent
Ms. M. Whelan Clinical Audit Facilitator
STAFF IN POST AT 31ST DECEMBER 2013
POST WTE in Post
Director of Midwifery/Nursing 1
Midwifery/Nursing Administration 5
Practice Development Co-ordinators 1.60
Advanced Nurse Practitioner (Neonatology) 2
CMM/CNM 3 5.77
Clinical Skills Co-ordinator 1.90
Clinical Placement Co-ordinator (BSc Midwifery) 2
Allocations Officer (BSc Midwifery) 0.5
PGDM Clinical Co-ordinator 1
Neonatal Discharge Co-ordinator 1
Colposcopy Nurse Co-ordinators 2
CMM/CNM 2 25.62
CMS/CNS 10.60
CMM/CNM 1 26.60
Staff Midwives 145.72
Staff Nurses 76.91
Student Midwives 19.40
Maternity Care Assistants 27.39
Total 329.67
D E PA R T M E N T  O F
M I D W I F E R Y / N U R S I N G
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APPOINTMENTS WTE
Midwives and Nurses        Midwifery Students
29.46   38
TOTAL:   67.46
RESIGNATIONS/ RETIREMENTS
Midwives and Nurses    Midwifery Students
24.59 43
TOTAL:    67.79
RETIREMENTS/RESIGNATIONS
There were no retirements from the Midwifery and Nursing staff in 2013. One
notable resignation was that of Ms. Teresa McCluskey, Assistant Director of
Midwifery and Nursing, who left the service in November 2013. Teresa worked
for a relatively short time in the hospital but was responsible for the
introduction of a number of initiatives which contributed greatly to the quality
and safety agenda. We offer thanks and best wishes to Teresa.
RECRUITMENT AND RETENTION
Recruitment and retention of appropriately trained and skilled Midwifery and
Nursing staff continued to be a major focus for the hospital in 2013 as in previous
years. The HSE moratorium on recruitment continued to impact on our ability to
recruit staff in the numbers required for service provision. Despite this, of the
twenty-five Higher Diploma and eighteen Undergraduate Midwifery Students
who graduated in September a substantial number were offered employment.
HOSPITAL BASED MIDWIFERY AND NURSING SERVICES
Staff in the Adult Outpatients Department facilitated a total of 42,038 attendances
of pregnant women with an additional 6,321 attending the various specialist
clinics in the department. There were a total of 19,338 attendances at Ultrasound,
Fetal Assessment and Prenatal Diagnosis clinics and a further 5,124 attendances at
the Early Pregnancy Unit. Midwives and Nurses attended 8,647 women during
labour and delivery and cared for 8,649 babies in the postnatal wards. 
The Nurses and Midwives in the Neonatal Unit faced another year of high activity
with 1,331 babies admitted to the unit with varying requirements for care while
continuing to provide intensive and specialist care for ill newborn infants referred
from hospitals throughout the country. Staff in the Paediatric Outpatient
Department facilitated 8,748 neonatal reviews.
Staff in Theatre continued to work to full capacity with an increasingly complex
workload. Cell Salvage was successfully used on a number of patients during the
year. Two Theatre Nurses have been trained in the use of this device to date.
The Midwifery and Nursing staff in the Gynaecological Department faced a
challenging environment with 2,068 admissions with a diverse mixture of
antenatal and postnatal women, high dependency and bereaved patients and
elective and day work being undertaken in that department. 
. 98
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Clinical Audit
Clinical audit offers a structured approach to evaluating care against local, national
and international standards of best practice. Ms Mary Whelan, Audit Facilitator,
continued to assist and support Midwifery and Nursing staff to plan and conduct
audits across all clinical areas. In 2013 there were sixteen formal audits undertaken
by Midwifery and Nursing staff. Outcomes from all audits were presented at the
monthly Quality and Safety Committee meetings and at the quarterly and bi-annual
Audit Results meetings. Recommendations for actions resulting from audits
requiring immediate attention are circulated to the Executive Management Team
and reported quarterly to the Board of Governors.
Maternity Care Assistants       
Maternity Care Assistants continued to play a pivotal role in assisting Midwifery
and Nursing staff in the provision of care for women and babies during 2013.  They
are important members of the team who contribute to the work of the hospital
with energy and commitment and are deserving of our sincere thanks. 
COMMUNITY MIDWIFERY SERVICES
The Community Midwifery Services at the Rotunda Hospital have been in place
since 2005 with the service developing over the years to meet the requirements
of those who attend for care. 2013 was no exception with the team successfully
establishing a service in the Coolock catchment area. This clinic initially had an
attendance rate of 2-4 women per clinic which had risen to 20 per clinic by the
end of 2013. There are now 17 Midwives working in the Community Service. The
team provide all aspects of antenatal care including home booking and currently
provide antenatal clinics in the following areas/sites (Table 1):
Table 1 Community Midwifery Antenatal Care Clinics
Blanchardstown Monday 17.00hrs-20.00hrs
Coolock Tuesday 17.00hrs-20.00hrs (2013)
Finglas Wednesday 14.00hrs-17.00hrs
Swords Wednesday 17.00hrs-20.00hrs 
Ballymun Thursday 14.00hrs-16.00hrs
Cabra Friday 09.00hrs-11.00hrs
Rotunda Hospital Friday 16.00hrs-18.00hrs
The service offers access to midwife-led or managed care during the antenatal,
intrapartum and postnatal periods. Women availing of the Community
Midwifery Services are considered to be ‘low risk’ in that they have no major
health or obstetric problems. The Midwifery Team offer community based
booking and antenatal review clinics. In the event that a woman encounters
complications in pregnancy care is carried out by the Community Midwifery
Team in conjunction with the Obstetric Team where it is considered safe to do so.
A mobile phone service is also available to all women attending the community
service. This service is operational from 08.00hrs-20.00hrs with direct access to
a Community Midwife.
In 2013, a total of 235 women were booked directly for care with the Community
Team of Midwives with a further 396 women referred from the Adult Outpatient
Department to the Community Services following their initial booking visit.
Women are encouraged to book into the service before 8 weeks gestation. Of
those who originally booked, 15 women were deemed unsuitable for community
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care and a further 40 women were referred back to the obstetric led service due
to developing a variety of pregnancy related medical complications during their
pregnancy. Five women transferred their care to a Self Employed Community
Midwife to facilitate a home delivery which is not available via the Rotunda
service and a further 7 women moved out of the catchment area during the
course of their pregnancy. 
A total of 631 women remained with the service up to the point of delivery. This
figure represented an increase of 120 women from the 2012 numbers. Of that
number 63% (n=406) of women achieved a spontaneous vertex delivery. The
percentage of women who required an emergency caesarean section was 12%
(n=76) an increase of 2.6% or 28 women on the previous year, while 3% (n=19) of
women underwent an elective caesarean section. Other statistics pertaining to
this group of women are reflected in Table 2:
Table 2 Community Midwifery Service outcomes
Total number of deliveries 2013 631 100%
SVD 406 63.0%
Emergency C/S 76 12.0%
Elective C/S 19 3.0%
Ventouse 92 15.0%
Forceps 30 5.0%
Ventouse/Forceps 8 2.0%
BBA 0 0%
Stillborn 0 0%
Inductions 177 28.1%
Spontaneous Onset of Labour 423 67.3%
Pain Relief
Entonox 358 56.7%
Epidural 346 54.8%
Entonox + Epidural 418 66.3%
General Anaesthetic 7 1.0%
Spinal +CSE 94 14.9%
Tens 25 3.9%
Pethidine 34 5.4%
No analgesia 73 11.6%
Women continued to be offered early discharge between 6-48 hours post delivery,
a total of 2,941 women availed of the service, an increase on the previous year. The
Community Team carried out a total of 8,785 post natal visits in 2013 with each
woman receiving an average of 3 visits in the home.  Midwifery and Nursing staff
continuously enhance their skills to provide the highest standard of care for
women and babies. The Community Midwifery Team is no exception with staff
successfully undertaking education programmes in newborn examination,
midwife prescribing, scanning and at Master of Science level.
Midwifery Education/Practice Development Unit
The Practice Development Department provides practice and educational support to
Midwifery and Nursing Students and ongoing learning and development
opportunities for qualified staff. In addition, the Practice Development Team work
in collaboration with the Centre for Midwifery Education in the development, 100
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implementation and evaluation of professional advancement for staff. The
Rotunda Hospital and the University of Dublin, Trinity College, its academic
partner for midwifery education have also continued to work closely together as
in previous years. 
In the first nine months of 2013 the Practice Development Team provided
support for 98 midwifery students (73 undergraduate and 25 higher diploma)
and a further 39 students who commenced in September. In addition, the team
supported 115 general/paediatric/public health students during their obstetric
clinical module placement and provided education sessions to the midwifery
students in Trinity College.
The Practice Development Team supported staff at ward level on a number of
quality initiatives throughout the year. Work continued on the Productive Ward
series. This initiative resulted in an 11% increase in direct patient care and
significant financial savings. The Productive Ward Team submitted a poster
presentation entitled ‘the well organised ward’ at the All Ireland Productive
Ward Conference in the autumn and were awarded first prize. Congratulations
are extended to all involved in this venture. Moving forward this initiative will
be rolled out to other departments in 2014.
The recording of Nursing and Midwifery Metrics was introduced in the Delivery
Suite and Theatre Department in 2013. The purpose of this project was to
introduce standards of measurement for midwifery and nursing care, which can
be monitored against agreed standards. Due to the success of the pilot phase, the
team continued to work on the Regional Steering Group to develop further
metrics for the antenatal and postnatal departments which will be
implemented in the early months of 2014.
During the month of April staff throughout the hospital participated in the pilot
phase of the roll out of the national I-MEWS observation chart and the Practice
Development Team were also champions in organising a patient safety
awareness day in May which was extremely well received by the hospital staff.
The Practice Development Team continued to co-ordinate the
Midwifery/Nursing Prescribing initiative and facilitated a number of workshops
including IV cannulation, IV medication administration, bladder care and
Preceptorship programmes.
The hospital supported Midwives to undertake education at Master’s, Diploma
and Degree level in 2013. Funding and study leave was also provided to staff to
attend Basic Life Support, Neonatal Resuscitation, Newborn Examination,
RHOET, Lactation and Management programmes. Staff were facilitated to attend
National Conferences and continuous professional development programmes in
conjunction with the Centre for Midwifery Education with a total of 907 days
allocated to further education and training in 2013 thus enhancing skills and
supporting the clinical environment.
The Clinical Skills Facilitator continued to offer support and guidance to new
and established staff in relation to clinical practice. In particular, she focussed on
the uptake of the K2 CTG training package and by using a number of strategies
increased the uptake of this training package for staff from 13.5% in 2012 to 91%
by mid May 2013 which is a hugely significant increase in compliance.
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I would like to acknowledge the work and dedication of all of the staff in the
department and thank them for their commitment to improving the quality of
care provided by Midwives and Nurses throughout the organisation.
LACTATION SERVICES
The Rotunda Hospital remains the only Dublin Maternity Hospital to have achieved
the Baby Friendly Hospital Accreditation Award. We continue to protect, promote
and support breastfeeding as the optimum way for mothers to feed their babies. 
During 2013 the breast feeding initiation rate remained at 70% which is the highest
rate in the country. The Lactation Specialists promote and support breastfeeding
throughout the hospital and saw 550 new patients during the year.  In addition, the
service received 800 calls from postnatal mothers with queries in relation to
breastfeeding. A total of 507 antenatal women attended the breastfeeding
workshops in the Outpatients Department and 615 mothers attended the
breastfeeding support sessions on the postnatal wards. 
Mothers and babies are supported in a variety of ways throughout their clinical
journey.
Antenatal Support
• Breastfeeding information is given on an individual basis as required in
the antenatal clinics.
• Pregnant women and their partners who attend antenatal education 
programmes provided by the hospital are informed of the benefits and 
management of breastfeeding.
• A breastfeeding workshop is provided by the Lactation Specialists and 
other Midwives every Tuesday and Thursday evening.
Delivery Suite Support
• Hospital policies include mother friendly labour and birthing practices.
• Skin to skin contact is policy for all mothers including those following 
Caesarean Section.
• Initiation of breastfeeding is also encouraged within the first hour of 
birth.
Postnatal Support
• Individual assistance and support with early breastfeeding problems is 
available from ward staff and Lactation Specialists when required.
• Rooming-in to promote the mother and baby bonding process.
Support Following Discharge
• An Outpatient service is available for mothers with breastfeeding issues
from Monday to Friday.
• A phone service is available Monday to Friday for counselling and advice.
• A Breastfeeding Support Group is held every Thursday 
from 11.30 to 12.30 hrs.
• Community links with Public Health Nurses, General Practitioners and 
voluntary support groups are maintained with mothers referred to these
services when appropriate.
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Breastfeeding Committee 
The Breastfeeding Committee, a multi disciplinary committee which includes
members from the voluntary breastfeeding support groups held a total of four
meetings during the year. Breastfeeding education workshops and lectures were
included in all orientation sessions for new staff. Lectures were also provided for
Medical Students and those attending the Higher Diploma in Neonatal Nursing
programme. National Breastfeeding Week was celebrated with a breastfeeding
information stand situated in the main reception area for all staff, expectant and
delivered mothers and their families. This stand was extremely well attended. Other
activities scheduled for that week included a coffee morning for mothers and babies
and a hospital wide breastfeeding quiz. The Rotunda Hospital continues to participate
in the HPH/BFHI Breastfeeding Supportive Workplace Initiative and maintains a
Breastfeeding Supportive Workplace Silver Award. 
OCCUPATIONAL HEALTH SERVICE
The Occupational Health Department looks after the health, safety and welfare
of the workforce. The service is readily accessible to all employees and plays an
extremely important role in employee welfare. Many of the services provided by
the Occupational Health Department are underpinned by the Safety, Health and
Welfare at Work Act 2005. The management of occupational blood and body
fluid exposures is an important occupational health role. Induction education for
all employees and in-service education is an ongoing measure to heighten
awareness and reduce exposures in the workplace.
A Consultant led routine clinic is held one morning per week. Consultations are
by appointment but very urgent consultations are facilitated as required. The
department has walk in phlebotomy and vaccination clinics.  Any staff member
with a work related health matter can contact the Occupational Health
Department for assistance and advice.
The “Sharps” EU Directive was introduced in 2010 is still waiting to be transposed
into Irish Legislation.  The aim of the EU directive is to eliminate or minimise the
risk of a sharps injury to an employee. Staff in the Occupational Health
Department chaired a sub-committee for the EU Directive that risk assessed all
known sharp devices in every department in the hospital with a view to
eliminate or minimise the risk of a sharps injury.  New safety sharp devices were
evaluated by the end users, user training for the safety devices was provided and
work continues on this matter.
Occupational blood/body fluid exposure management and prevention is one of
the major occupational health roles within the organisation. Induction training
is provided to all new staff and in-service education is facilitated to raise
employee awareness and reduce exposures on an ongoing basis.
The influenza vaccine is offered to all employees each year. These vaccination
clinics commenced in October 2013.  From October to December a total of 32% of
staff from all disciplines availed of the vaccine, this campaign will be ongoing
until April 2014.
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There was a national increase in the number of people presenting with whooping
cough in 2012.  As a consequence a campaign for all health care workers to receive the
Pertussis vaccine commenced in January 2013.  Pertussis vaccination clinics were
held throughout the year and the vaccine continues to be offered to all employees.
MENTAL HEALTH SUPPORT
The Midwives working in the Perinatal Mental Health Service in the Rotunda
continued to see a growing demand for their services in 2013.  A total of 1,659
women gave a history of mental health illness at their booking visit, an increase of
226 on the previous year.  This represented 19% of the total number of women
delivered in 2013. The following table (Table 3) provides a breakdown of the mental
health illnesses reported at booking.
Table 3 Mental Illness History at booking visit
Depression no treatment 151
Depression 14
Anxiety 396
BPAD 13
Depression requiring treatment 478
No diagnosis 0
Manic Depression 1
Other 294
PND 249
Puerperal depression needing treatment 58
Schizophrenia 5
Total 1659
A total of 478 women gave a history of depression requiring treatment. A further
396 gave a history of anxiety with some women declaring co-morbidities. A small
number of women (n=5) gave a diagnosis of schizophrenia and 14 gave a history of
Bi-polar disorder/Manic depression. Asking about personal and family history of
mental illness is recognised as best practise as a history of mental illness is a
predictor of perinatal mental illness.
The Mental Health Support Midwives saw 513 women in the health promotion
clinic.  These women are seen individually for up to an hour each.  Many of these
women attend for assessment, for talk therapy and support in the antenatal and
postnatal periods.  Women are welcome to return to the support midwifery service
up to six months following their delivery.   A further 1,629 women with a mental
health history were reviewed at ward level for brief intervention, including health
promotion, mental health management and follow up advice.
All women are offered the opportunity to complete the Edinburgh Postnatal
Depression Score (EPDS) document prior to discharge. The EPDS is a self reporting
assessment tool to monitor mood. An audit of completion of EPDS on discharge was
commenced in the latter part of 2012.    The results showed that 71% of women
discharged home from the Rotunda completed the EPDS. As it would be preferable
to have a higher completion rate the mental health midwives collaborated with
colleagues on postnatal wards and in the community to educate midwives about
the value of the EPDS and the value of offering women the opportunity to complete
the tool.  A further audit is planned for early 2014.
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World Mental Health Week (October 2013) was marked by the Mental Health
Midwife developing a colourful poster and leaflet stand at the main reception area of
the hospital to raise awareness of mental health. The stand created much interest as
evidenced by the numbers of leaflets taken and enquiries raised with the team.
As a quality initiative the team have developed a mental health referral form. These
forms, used in the outpatient and community clinics, provide a uniform referral
pathway for patients where a mental health concern is raised and increase the
communication between disciplines in relation to the treatment and support of this
cohort of women attending for care.
There was a steady demand for the Mental Health Support Team to present to
Midwifery Students in TCD, midwifery interns and Public Health Nurses. The team
also worked closely with the Perinatal Mental Health providers in the National
Maternity and the Coombe hospitals. This collaboration led to the development of a
very successful study day for midwives hosted in the National Maternity Hospital on
May 29th 2013. The aim of the study day was threefold;
• To increase clinicians knowledge and awareness of Perinatal Mental Health 
• Reduce the stigma of Mental Heath Disease
• Ensure that women with a mental health history receive the best possible care
It is envisaged that this study day will continue as an annual event. 
PARENT EDUCATION
The Parent Education Midwife working closely with the Physiotherapy Department
continued to provide an extensive range of education sessions to both in-patients
and outpatients during 2013 with 7,159 women availing of this service.  Parent
education sessions aim to convey positive messages to parents regarding their role in
the development of healthy children and their lifestyles.  This is achieved by woman
focused sessions with the role of the father emphasised throughout.  Education is
provided to expectant women and their birth partners on issues relating to
pregnancy, labour and the immediate postnatal period with feeding choices, baby
care and the future demands of parenthood also discussed.  Information is also
provided to inform parents where to source support and resources when they go
home with their new baby. Special education sessions were organised for groups
with specific identified needs including:
• Those with hearing disabilities
• Parents with sight disabilities
• Those with language difficulties
BEREAVEMENT SUPPORT AND CHAPLAINCY SERVICES
The Rotunda Hospital acknowledges that the loss of a baby before or shortly after
birth is one of the most painful experiences imaginable in any parent’s life.  We offer
a range of services through the Bereavement Team, Recurrent Pregnancy Loss and
Fetal Anomaly Clinics to afford bereaved parents the necessary support to meet their
individual needs. The entire Bereavement Team comprising of the Bereavement
Support Midwife, dedicated Medical Social Worker, Chaplain, Administrative
Assistant and Anatomical Pathology Technicians offered support to the families of
the 222 babies who died at all gestations during 2013 endeavouring to provide
sensitive, compassionate and individualised care to those families.
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The work of the hospital is greatly assisted by the Chaplains and Ministers who are
available to offer support to patients and staff alike. Their dedication and attention
to women, their babies and families and staff is very much appreciated. The
presence of a lay Chaplain on staff has added enormously to the service provided
within the organisation.
Service of Remembrance
The annual Service of Remembrance was again held in the Pro Cathedral in
November 2013 with an attendance of over 1,100 families, parents and hospital
staff. We are extremely grateful for the continued assistance of Cannon Damien
O’Reilly in facilitating this important event. The service was led by the Chaplains
from the main churches with bereaved parents, staff members and members of
the Board of Governors present. The occasion was enhanced by the presence of
soloist Mary Flynn and harpist Denise Kelly to whom we send a sincere thanks
for their involvement. Many staff volunteered to assist on the day and our
gratitude is extended to them also. 
Health Promoting Hospitals
The Rotunda Hospital is a committed member of the Health Promoting Hospitals
Network. Work in particular continued on the important role of support for those
seeking to reduce or cease smoking.  Extensive work was undertaken during the year
which culminated in the Rotunda becoming a ‘Smoke Free Campus’ in November
2013.  I wish to acknowledge the work and commitment of all staff in supporting this
initiative which will result in a healthier environment for patients and staff alike. 
CONCLUSION
I would like to take this opportunity to thank the Chairman, Ms. Hilary Prentice,
and the members of the Board of Governors for the support they have continued
to provide to Midwifery and Nursing in 2013.  I would like to extend my sincere
thanks to the Master, Dr. Sam Coulter Smith and Secretary/Group General
Manager, Ms. Pauline Treanor, for their support. I would like to extend my
appreciation to Medical, Allied Health and Support staff colleagues for their
continued assistance. I wish to acknowledge and thank all of the external
agencies that have continued to support Midwifery and Nursing education and
practice and the Hospital throughout the year especially Ms. Eithne Cusack,
Director, Nursing and Midwifery Planning and Development, Dublin North East
and Ms. Kathryn Muldoon, Assistant Professor of Midwifery, Head of Discipline
of Midwifery, Director of Midwifery Programme, School of Nursing & Midwifery,
Trinity College, Dublin.
The hospital could not run as effectively or efficiently without the dedicated
Midwifery and Nursing Team who have continued to provide such high quality
care despite the many challenges they face. I am indebted to them for their
endless enthusiasm to work in the Rotunda Hospital for and with women, babies
and families. I would like to add a special word of thanks to the Assistant
Directors of Midwifery/Nursing and to Carol and Ger in my office for their loyal
and endless assistance. They continue to meet the ever increasing demands on
their time and talents with patience and enthusiasm.
Ms Margaret Philbin
Director of Midwifery/Nursing 
2013 
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1. DEPARTMENT STAFF
PROFESSOR AND HEAD OF DEPARTMENT
Fergal D. Malone MD, FACOG, FRCOG, FRCPI
CONSULTANT SENIOR LECTURERS
Paul Byrne MD, FRCOG, FRCPI
Fionnuala Breathnach MD, MRCOG FRCPI DCH DipGUMed
Ronan Gleeson MA MD, FRCOG FRCPI 
HONORARY CLINICAL PROFESSOR
Sam Coulter Smith, MB, BCH, LCRPI & SI, FRCOG
HONORARY CONSULTANT SENIOR LECTURERS
Carole Barry MD, FRCOG
Mary Holohan FRCOG
Edgar Mocanu, MD, MRCOG
MATERNAL FETAL MEDICINE SUBSPECIALTY FELLOW
Etaoin Kent MD, MRCPI, MRCOG (from 1st January 2013)
Julia Unterscheider MD, MRCPI MRCOG (from July 2013)
SPECIALIST REGISTRAR LECTURERS
Naomi Burke MRCPI, MRCOG (to June 2013)
Siglinde Muellers MRCPI (from July 2012)
Siobhan Corcoran MRCPI (from July 2013)
Morgan Kearney MRCPI (from Jan to June 2013)
Hugh O’Connor MRCPI (from June to Dec 2013)
CLINICAL RESEARCH STAFF
Claire O’Rourke (Midwife Sonographer)
Ann Fleming (Midwife Sonographer) 
Elizabeth Tully (Research Manager) 
Grainne Mc Sorley (Research Nurse)
Patrick Dicker (Epidemiologist / Statistician)
ADMINISTRATIVE STAFF 
Suzanne Kehoe (Administrative Assistant)
Michelle Creaven  (Administrative Assistant)
Paula Carty (Administrative Assistant)
Lorraine Harte (Administrative Assistant) (covering maternity leave until Feb 2013) 
ROYAL COLLEGE OF SURGEONS IN IRELAND
DEPT. OF  OBSTETRICS & GYNAECOLOGY
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2.  PATIENT SERVICES
The RCSI Fetal Medicine Centre continues to provide advanced fetal medicine
services for patients of the Rotunda Hospital, as well as those referred from
throughout Ireland. During 2013 a total of 3666 fetal ultrasound examinations were
performed at the Centre. This included a total of 928 first trimester assessments for
fetal aneuploidy, based on combined nuchal translucency and serum screening. The
RCSI Fetal Medicine Centre operates a one-stop clinic for assessment of risk of fetal
aneuploidy, using the Brahms Kryptor biochemistry platform. Management of
multiple gestations contributed a significant workload to the Centre, with 50 twin
pregnancies, 2 triplet pregnancies and 1 higher order multiple gestation managed
through our unit. A new development this year was the implementation of non-
invasive prenatal testing for fetal aneuploidy, by examining fetal DNA from the
maternal circulation: a total of 44 such tests were performed in 2013. 
3.  TEACHING SERVICES
Two hundred and ninety four students participated in the RCSI Obstetrics &
Gynaecology and Neonatology clinical rotations. The RCSI Department of Obstetrics
and Gynaecology at the Rotunda has a leadership role in providing teaching and
assessment for undergraduates at the Rotunda, National Maternity Hospital, Our
Lady of Lourdes Hospital Drogheda, Midland Regional Hospital Mullingar, St. Luke’s
Hospital Kilkenny, and Waterford Regional Hospital. One hundred and ninety one of
these students attended the Rotunda Hospital for clinical attachments. 
These students participated as sub-interns on the hospital wards and in clinics,
contributing significantly to the mission and function of the hospital, while
providing increasingly positive feedback on their learning experiences. 
4. RESEARCH OUTPUT
a) Research Grants and Awards:
• Health Research Board, Ireland
- Medical Research Charities Group
- Hemodynamic Assessment in Pregnancy and Neonatal 
Echocardiography Assessment; The HANDLE Study
- A. El-Khufash, E. Kent and F. Malone, Co-Principal Investigators
- Total support €188,126
- 2014 – 2016
• Health Research Board, Ireland
- Novel Approaches to Determining Procoagulant State in Early Onset   
Preeclampsia
-    F. Ni Ainle, Principal Investigator 
-    F. Malone, MD, Co-Investigator 
-   Total support €326,940
-   2013 – 2016
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PERINATAL IRELAND UPDATE 2013
Perinatal Ireland is a multi-centre, all-Ireland research consortium focusing on
carrying out research into women's and children's health. The consortium, the first
HRB-funded network in the country, links the 7 major academic obstetric hospitals
across the island of Ireland (Rotunda Hospital Dublin, Coombe Women and Infants
University Hospital Dublin, National Maternity Hospital Dublin, Cork University
Maternity Hospital, University College Hospital Galway, Mid-Western Regional
Maternity Hospital Limerick, and Royal Jubilee Maternity Hospital Belfast), as well
as representatives of all 7 medical schools on the island of Ireland (UCD, TCD, RCSI,
UCC, NUIG, University of Limerick, and Queens University Belfast). The network is
headquartered at the RCSI Dept of Obstetrics & Gynaecology at the Rotunda
Hospital and is active in obstetric and paediatric research.
In addition to its clinical research activities, the Perinatal Ireland network is also
active in other educational activities and methods of advancing clinical care
including: annual teaching conferences for practitioners in critical areas of
obstetric and paediatric health; development of national clinical guidelines to
optimise the management of important obstetric conditions, and contribution
to international guidelines; development of new information technology
systems that underpin obstetric ultrasound equipment based on data developed
from Perinatal Ireland research data.
The existing Perinatal Ireland Research Consortium provides a unique, world-
class research infrastructure, comprising universal participation by the Irish
MFM community, together with central research, management support and
robust governance. The consortium has a full suite of ultrasound equipment
ring-fenced for conducting research, together with collaboration with other
services including neonatology, other pediatric specialties, midwifery, radiology,
pathology, epidemiology, and biostatistics. Each of the consortium partners is
represented by clinician scientists - each having a wealth of practical experience
and distinguished publication records.
A hallmark of Perinatal Ireland is selecting obstetric challenges of significant
importance to public health - delivering results that positively impact maternal
and child health at a population level – as evidenced by the publication of 2
national HSE guidelines. 
In 2013, Perinatal Ireland underwent its second external review by international
experts - the most recent concluding that the research outputs:
“…have had a tangible impact on clinical care, and that the level of outputs for the
stage of development of Perinatal Ireland is high.” 
Since its inception, Perinatal Ireland has published 21 articles in leading obstetric
journals and has made 53 research presentations at major international
scientific meetings in the US and Europe, and authored 2 HSE-approved national
guidelines.
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b) Scientific Publications – Peer-Reviewed Journals
• Bodnar LM, Rouse DJ, Momirova V, Peaceman AM, Sciscione A, Spong CY,
Varner MW, Malone FD, Iams JD, Mercer BM, Thorp JM, Sorokin Y, Carpenter
MW, Lo J, Ramin SM, Harper M. “Maternal 25-Hydroxyvitamin D and Preterm
Birth in Twin Gestations.” Obstetrics & Gynecology 122:91-98, 2013.
• Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, O’Donoghue K,
Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC, Malone FD. “Optimizing the
Definition of Intrauterine Growth Restriction: the Multicenter Prospective
PORTO Study.” American Journal of Obstetrics and Gynecology 208:290.e1-6, 2013.
• Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J,
Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. “The Customised Fetal
Growth Potential: A Standard for Ireland.” European Journal of Obstetrics
Gynecology and Reproductive Biology, 166:14-17, 2013.
• King T, Bergin D, Kent E, Manning F, Reeves E, Dicker P, McElvaney G, Sreenan
S, Malone F, McDermott J. “Endothelial Progenitor Cells in Mothers of Low
Birthweight Infants: A Link Between Defective Placental Vascularisation and
Increased Cardiovascular Risk?” Journal of Clinical Endocrinology and
Metabolism, 98:E33-39, 2013.
• Haddow JE, Craig WY, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick
JA, Malone FD, D’Alton ME. “Impact of Adjusting for the Reciprocal
Relationship Between Maternal Weight and Free Thyroxine During Early
Pregnancy.” Thyroid, 23:225-230, 2013.
• Barker ED, McAuliffe FM, Alderdice F, Unterscheider J, Daly S, Geary MP,
Kennelly MM, O’Donoghue K, Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC,
Malone FD. “The Role of Growth Trajectories in Classifying Fetal Growth
Restriction.” Obstetrics & Gynecology 122:248-254, 2013.
• Costantine MM, Lai Y, Bloom SL, Spong CY, Varner MW, Rouse DJ, Ramin SM,
Caritis SN, Peaceman AM, Sorokin Y, Sciscione A, Mercer BM, Thorp JM, Malone
FD, Harper M, Iams JD. “Population Versus Customized Fetal Growth Norms
and Adverse Outcomes in an Intrapartum Cohort.” American Journal of
Perinatology, 30:335-342, 2013.
• Gilbert SA, Grobman WA, Landon MB, Spong CY, Rouse DJ, Leveno KJ, et al.
“Cost-effectiveness of Trial of Labor After Previous Cesarean in a Minimally
Biased Cohort.” American Journal of Perinatology, 30:11-20, 2013.
• Figueroa D, Landon MB, Mele L, Spong CY, Ramin SM, Casey B, et al.
“Relationship Between 1-Hour Glucose Challenge Test Results and Perinatal
Outcomes.” Obstetrics & Gynecology 121:1241-1247, 2013.
• Breathnach FM, Donnelly J, Cooley SM, Geary M, Malone FD. “Subclinical
Hypothyroidism as a Risk Factor for Placental Abruption: Evidence from a Low
Risk Primigravid Population.” Australian and New Zealand Journal of
Obstetrics and Gynaecology 53:553-560, 2013.
• Gilbert SA, Grobman WA, Landon MB, Varner MW, Wapner RJ, Sorokin Y, et al.
“Lifetime Cost-effectiveness of Trial of Labor After Cesarean in the United
States.” Value Health 16:953-964, 2013.110
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• Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, O’Donoghue K,
Hunter A, Morrison JJ, Burke G, Dicker P, Tully EC, Malone FD.”Predictable
Progressive Doppler Deterioration in IUGR: Does it  Really Exist?” American
Journal of Obstetrics and Gynecology 209:539,e1-7, 2013.
• Burke N, Flood K, Murray A, Cotter B, Dempsey M, Fay L, Dicker P, Geary M, Kenny
D, Malone F. “Platelet Reactivity Changes Significantly Throughout All Trimesters
of Pregnancy Compared with the Nonpregnant State: A Prospective Study.” BJOG:
British Journal of Obstetrics and Gynaecology, 120:1599-1604, 2013.
• Grobman WA, Lai Y, Rouse DJ, Spong CY, Varner MW, Mercer BM, Leveno KJ, Iams
JD, Wapner RJ, Sorokin Y, Thorp JM, Ramin SM, Malone FD, O’Sullivan MJ, Hankins
GD, Caritis SN. “The Association of Cerebral Palsy and Death with Small for
Gestational Age Birthweight in Preterm Neonates by Individualized and
Population Based Percentiles. American Journal of Obstetrics and Gynecology
209:340.e1-5, 2013.
• O’Connor C, McAuliffe FM, Breathnach FM, Geary M, Daly S, Higgins JR, Dornan J,
Morrison JJ, Burke G, Higgins S, Mooney E, Dicker P, Manning F, McParland P,
Malone FD. “Prediction of Outcome in Twin Pregnancy with First and Early
Second Trimester Ultrasound.” Journal of Maternal Fetal and Neonatal Medicine
26:1030-1035, 2013.
• Hehir MP, O’Connor HD, Higgins S, Robson MS, McAuliffe FM, Boylan PC, Malone
FD, Mahony R. “Obstetric Anal Sphincter Injury, Risk Factors and Method of
Delivery – An 8-Year Analysis Across 2 Tertiary Referral Centers.” Journal of
Maternal Fetal and Neonatal Medicine 26:1514-1516, 2013.
• O’Connor HD, Hehir MP, Kent EM, Foley ME, Fitzpatrick C, Geary MP, Malone FD.
“Eclampsia: Trends in Incidence and Outcomes over 30 Years.” American Journal
of Perinatology 30:661-664, 2013.
• Ma KK, Mele L, Landon MB, Spong CY, Ramin SM, Casey B, et al. “The Obstetric and
Neonatal Implications of a Low Value on the 50g Glucose Screening Test.”
American Journal of Perinatology 30:715-722, 2013.
• Costantine MM, Mele L, Landon MB, Spong CY, Ramin SM, Casey B, et al.
“Customized Versus Population Approach for Evaluation of Fetal Overgrowth.”
American Journal of Perinatology 30:566-572, 2013.
• Unterscheider J, Ryan H, Morrison JJ, Malone FD. “Intrauterine Red Cell
Transfusion for Anti-Kell Isoimmunization in a Fetus with Glanzmann’s
Thrombasthenia.” Prenatal Diagnosis, In Press, 2013.
• Graves SW, Esplin MS, McGee P, Rouse DJ, Leveno KJ, Mercer BM, Iams JD, Wapner
RJ, Sorokin Y, Thorp JM, Ramin SM, Malone FD, O’Sullivan MJ, Peaceman AM,
Hankins GD, Dudley DJ, Caritis SN. “Association of Cord Blood Digitalis-Like Factor
and Necrotizing Enterocolitis.” American Journal of Obstetrics and Gynecology,
Nov 8, 2013.
• Ryan HM, Morrison JJ, Breathnach FM, McAuliff FM, Geary MP, Daly S, Higgins JR,
Hunter A, Burke G, Higgins S, Mahony R, Dicker P, Manning F, Tully E, Malone FD.
“The Influence of Maternal Body Mass Index on Fetal Weight Estimate in Twin
Pregnancy.” American Journal of Obstetrics and Gynecology, Nov 8, 2013.
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• Alderdice F, Savage-McGlynn E, Martin CR, McAuliffe FM, Hunter A,
Unterscheider J, Daly S, Geary MP, Kennelly MM, O’Donoghue K, Morrison JJ,
Burke G, Dicker P, Tully EC, Malone FD. The Prenatal Distress Questionnaire: An
Investigation of Factor Structure in a High Risk Population. Journal of
Reproductive and Infant Psychology 2013;31(5):456-64.
• M Ma’ayeh, N Purandare, M Flanagan, S Ash, M Geary, FM Breathnach. Ruptured
broad ligament ectopic gestation in a Jehovah’s Witness with a negative
pregnancy test. Med Legal J Irl 2013(19):37-39.
• Corcoran S, Donnelly J, Breathnach FM. Managing the emerging clinical risk of
cutaneous bullae and decubitus ulcers in obstetric patients. Int J Obstet
Gynaecol 2013 Mar; 120(3):285-6.
c) Invited Lectures and Oral Scientific Presentations: 
• Malone FD, “Ultrasound Diagnosis of Neural Tube Defects” – Institute of
Obstetricians and  Gynaecologists of Ireland, Neural Tube Defect National
Meeting, Dublin Castle, Dublin, Ireland, September 2013.
• J Unterscheider on Behalf of Perinatal Ireland. Stillbirth: The importance of fetal
growth restriction. The Impact of Stillbirth Conference, Cork, 2 November 2013 
• J Unterscheider on Behalf of Perinatal Ireland. IUGR - New Directions from the
PORTO Study Data. 2nd International Conference on Fetal Growth, Baltimore, 21
September 2013
• J Unterscheider on Behalf of Perinatal Ireland. Perinatal Mortality & IUGR – The
PORTO Study. 2nd International Conference on Fetal Growth, Baltimore, 19
September 2013
• J Unterscheider. IUGR: New Directions from the PORTO Study Data. Summer
Meeting, Ulster Obstetrical & Gynaecological Society, Belfast, 14 June 2013
• J Unterscheider, S Daly, MP Geary, FM McAuliffe, MM Kennelly, JJ Morrison, K
O’Donoghue, A Hunter, G Burke, P Dicker, E Tully, FD Malone. Perinatal outcome
of IUGR pregnancies with normal and abnormal Doppler studies – The
Prospective Multicentre PORTO Trial. Oral Platform Poster, 16th Annual
Conference, BMFMS, Dublin, 25 April 2013
• J Unterscheider, S Daly, MP Geary, FM McAuliffe, MM Kennelly, JJ Morrison, K
O’Donoghue, A Hunter, G Burke, P Dicker, E Tully, FD Malone. The Optimal
Definition of Intrauterine Growth Restriction Based on Perinatal Morbidity and
Mortality – The Results of the National Multicenter Prospective PORTO Trial. 33rd
Annual SMFM Meeting, San Francisco, 14 February 2013
• J Unterscheider, S Daly, MP Geary, FM McAuliffe, MM Kennelly, JJ Morrison, K
O’Donoghue, A Hunter, G Burke, P Dicker, E Tully, FD Malone. Sequential Doppler
changes in IUGR: is there a benefit of advanced multivessel Doppler assessment?
– Results of the National Multicenter Prospective PORTO Trial. 33rd Annual
SMFM Meeting, San Francisco, 14 February 2013
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• J Unterscheider, S Daly, MP Geary, MM Kennelly, FM McAuliffe, JJ Morrison, K
O’Donoghue, A Hunter, G Burke, P Dicker, E Tully, FD Malone. Does having an
EFW less than the 10th centile really matter? – Results of the multicenter
prospective observational PORTO Trial. 33rd Annual SMFM Meeting, San
Francisco, 14 February 2013
• F Breathnach. ‘Right Ventricle Abnormalitie’s. Irish Congenital Heart Foundation
Scientific Meeting, Carton House, Maynooth, November 2013
• F Breathnach. ‘Congenital Heart Disease and Structural Abnormality’. Irish
Congenital Heart Foundation Scientific Meeting, Carton House, Maynooth,
November 2013
• F Breathnach. ‘Investigating the Role of Early Low-dose Aspirin in Diabetes; The
Ireland Study’. North Dublin Voluntary Hospitals Diabetes Study Day, Nov 2013
• F Breathnach. ‘Discordant twin growth’. 22nd International Malaysian Congress
of Obstetrics and Gynecology, Kuala Lumpur, May 2013
• F Breathnach. ‘Optimising Timing of Delivery of Uncomplicated Twins’. 22nd
International Malaysian Congress of Obstetrics and Gynecology, Kuala Lumpur,
May 2013
• F Breathnach. ‘First Trimester Screening for Fetal Aneuploidy’.  RCSI Malaysia,
Visiting Lecture for Undergraduates and Faculty
• Alternative models of prenatal care for pregnancies complicated by gestational
diabetes. Kearney M(1), Corcoran S(1), Byrne M(2), Breathnach F(1) 
1. Rotunda Hospital, Royal College of Surgeons Ireland 2. Dept of Endocrinology,
Rotunda Hospital. NDVF Lifespan Diabetes Research Program on Nov 14 3013
• Accuracy of Third Trimester Ultrasound in Predicting Macrosomia in Patients
with Diabetes in Pregnancy S Corcoran, M Kearney, D Vaughan, E Tully, P Dicker,
K Flood, F. Breathnach. RCSI, Rotunda Hospital. NDVF Lifespan Diabetes Research
Program on Nov 14 3013
• Horgan R, Byrne P. How Accurate are Colposcopically Directed Biopsies? Junior
Obstetrical and Gynaecological Society. November 2013. (oral presentation)
d) Abstracts:
• Unterscheider J, Daly S, Geary M, Kennelly M, McAuliffe F, O’Donoghue K, Hunter
A, Morrison J, Burke G, Dicker P, Tully E, Malone F. “The Optimal Definition of
intrauterine growth restriction based on perinatal morbidity and mortality –
results of the National Multicenter Prospective PORTO trial.” American Journal of
Obstetrics and Gynecology, 208, S13, 2013.
• Unterscheider J, Daly S, Geary M, Kennelly M, McAuliffe F, O’Donoghue K, Hunter
A, Morrison J, Burke G, Dicker P, Tully E, Malone F. “Sequential Doppler changes in
IUGR: Is there a benefit of advanced multivessel Doppler assessment? Results of
the National Multicenter Prospective PORTO trial.” American Journal of
Obstetrics and Gynecology, 208, S15, 2013.
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• Unterscheider J, Daly S, Geary M, Kennelly M, McAuliffe F, O’Donoghue K, Hunter
A, Morrison J, Burke G, Dicker P, Tully E, Malone F. “Does having an EFW less than
the 10th centile really matter? Results of the National Multicenter Prospective
PORTO trial.” American Journal of Obstetrics and Gynecology, 208, S17, 2013.
• Murphy N, Diviney M, Donnelly J, Cooley S, Kirkham C, Foran A, Breathnach F,
Malone F, Geary M. “The effect of subclinical hypothyroidism on IQ in seven to
eight year old children.” American Journal of Obstetrics and Gynecology, 208, S85,
2013.
• Boyle M, Lyons A, Ryan S, Malone F, Foran A. “Neonatal MRI brain following
fetoscopic laser surgery for twin-twin transfusion syndrome: Implications for
clinical practice.” American Journal of Obstetrics and Gynecology, 208, S88, 2013.
• Dempsey M, Flood K, Burke N, Cotter B, Fay L, Fletcher P, Murray A, Geary M,
Kenny D, Malone F. “Platelet reactivity in recurrent miscarriage patients during
pregnancy.” American Journal of Obstetrics and Gynecology, 208, S102, 2013.
• Khalifeh A, Malone F, Lavelanet A, Chamchad D, Gerson A. “Comparative analysis
of two- versus three-dimensional sonography for nuchal translucency (NT)
measurement.” American Journal of Obstetrics and Gynecology, 208, S156, 2013.
• Flood K, Ali A, Breathnach F, McAuliffe F, Geary M, Daly S, Higgins J, Fogarty A,
Morrison J, Burke G, Higgins S, Dicker P, Tully E, Carroll S, Malone F. “Expectant
management of monochorionic diamniotic twins with selective intrauterine
growth restriction.” American Journal of Obstetrics and Gynecology, 208, S164,
2013.
• Unterscheider J, Daly S, Geary M, Kennelly M, McAuliffe F, O’Donoghue K, Hunter
A, Morrison J, Burke G, Dicker P, Tully E, Malone F. “Advanced multi-vessel Doppler
assessment in fetal growth restriction: learning curve and factors influencing
successful acquisition – Results of the National Multicenter Prospective PORTO
trial.” American Journal of Obstetrics and Gynecology, 208, S172, 2013.
• Mullers S, Flood K, Burke N, Malone F, Breathnach F. “Can ductus venosus
waveforms help modify counseling in the setting of first trimester septated
cystic hygroma?” American Journal of Obstetrics and Gynecology, 208, S196, 2013.
• Kent E, Breathnach F, Gillan J, McAuliffe F, Geary M, Daly S, Higgins J, Hunter A,
Morrison J, Burke G, Higgins S, Carroll S, Dicker P, Tully E, Malone F. “Relationship
between placental characteristics and antenatal ultrasound Doppler indices in
twin pregnancies – results of the ESPRIT study.” American Journal of Obstetrics
and Gynecology, 208, S237, 2103.
• Accuracy of third trimester ultrasound in predicting macrosomia in patients
with diabetes in pregnancy Siobhan Corcoran, Morgan Kearney, Denis Vaughan,
Elizabeth Tully, Pat Dicker, Karen Flood, Fionnuala Breathnach American Journal
of Obstetrics & Gynecology - January 2014 (Vol. 210, Issue 1, Supplement, Page S174,
DOI: 10.1016/j.ajog.2013.10.368
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1.  SERVICE
During 2013, the HARI Unit provided Assisted Reproductive Technology services
which included IVF, ICSI, frozen embryo transfers, natural cycles (IVF and ICSI), follicle
tracking with or without ovarian stimulation (anti-oestrogens, FSH), donor egg
monitoring, testicular biopsy, embryo freezing, oncology stimulation and
subsequent gamete and embryo cryopreservation to couples referred from
throughout Ireland.  In 2013, the Unit had on average 50 staff delivering medical care.
NURSING SERVICES
The Nursing department prides itself on recognizing each individual’s needs and
delivering tailored treatment.  HARI nursing staff provides a high standard of care
to couples attending the Unit whilst maintaining a safe, efficient and friendly
service.  The treatments and services provided range from ultrasound scanning and
hormonal monitoring, patient education and training to scheduling procedures and
intrauterine inseminations.  Nursing staff participates in continuous professional
development through regular meetings at national and international level as well
as training of new staff.  The role of the fertility nurse is unique, delivering continual
care and support for a complex reproductive treatment journey involving two
patients.
COUNSELLING SERVICES
Our team offers a comprehensive counselling and support service at HARI to our
ART and oncology patients.  The services range from psychological and emotional
support before, during and after treatment to mind/ body medicine, CBT and stress
management services.  Our counselling team comprise of highly skilled individuals
specifically trained in the area of infertility.  They work as an integral part of our
multi disciplinary group. 
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2. ART DEMOGRAPHICS AND OUTCOMES 
ART Activity
The female age among our IVF/ ICSI patients is a key determinant of the likelihood
of conception.  In 2013 the mean ages were 35.7 years for females and 37.5 years for
males. The mean duration of infertility of those undergoing fresh cycles was 3.6
years. The main indications for IVF or ICSI therapy were male factor (40%), tubal and
endometriosis (18%), unexplained (17%), ovarian (10%) and others (15%).
In these 12 months, 1,291 cycles were undertaken - 415 IVF, 487 ICSI and 421 frozen.  Of
the 902 fresh cycles commenced, 798 had oocytes collected (IVF 365, ICSI 433).
Embryos were transferred in 1048 cases (IVF 305, ICSI 354 and frozen 389).  A total of
393 clinical pregnancies were achieved, 246 after IVF/ ICSI cycles and 147 in frozen
embryo transfer cycles.
TABLE 1. Overall IVF/ ICSI activity (2013)
IVF ICSI FZT
Cycles started 415 487 421
Cycles abandoned 44 48 -
Oocyte collections 365   433  -
Zygote transfers 305 354 389
Clinical pregnancies 105 141 147
TABLE 2. Clinical pregnancy rates (2013)
Overall Overall IVF ICSI FZT
(n = 393) (n=246) (n = 105) (n = 141) (n=147)
Per cycle started 31% 27% 25% 29% 35%
Per oocyte recovery N/A 31% 29% 33% N/A
Per embryo transfer 38% 37% 34% 40% 38%
n= total number of patients ()= number of pregnancies
These figures are interpreted as follows: the overall likelihood to have a clinical
pregnancy after IVF/ICSI was 27% per cycle started, 31% per oocyte recovery and
37% per zygote transfer.  The clinical pregnancy rates for patients undergoing
frozen cycle transfers were 35% per thaw and 38% per embryo transfer.
PREGNANCY RATES
Pregnancy rates shown below are clinical pregnancy rates.  All types of fresh
treatments are included, namely: long protocol, antagonist, flare, and natural.
The terms used are defined below:
Clinical Pregnancy = all cases where an intrauterine visible pregnancy sac has
been identified to include ectopic pregnancies (ESHRE definition).
Clinical Pregnancy Rate per Cycle Started = number of clinical pregnancies per
number of patients that commenced therapy.
Clinical Pregnancy Rate per Oocyte Recovery = number of clinical pregnancies
per number of patients that had an oocyte recovery.
Clinical Pregnant Rate per Zygote Transfer = number of clinical pregnancies per
number of patients that had zygotes transferred.
Delivery Rate = number of delivery episodes of babies weighing more than 500
grams (per cycle started, per oocyte recovery, per zygote transfer).
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TABLE 3.   CLINICAL (IVF AND ICSI) PREGNANCY RATES ACCORDING TO  
FEMALE AGE (2013)
Age Overall IVF ICSI
(n = 902) (n = 415) (n = 487)
Per Cycle Started
≤ 35 31% (n=429) 29%    (n=174) 31%   (n=255)   
36-39 27% (n=303) 24%    (n=144)    30%   (n=159)
≥ 40 12% (n=170) 10%     (n=97) 15%   (n=73) 
Per Oocyte Recovery
≤ 35 34%  (n=388) 32%   (n=159)  35%  (n=229)    
36-39 32%  (n=256) 28%   (n=125)    36%  (n=131)
≥ 40 14% (n=154) 12%    (n=81)      15%  (n=73)
Per ZygoteTransfer
≤ 35 45%  (n=293) 40%   (n=127)  48%  (n=166)    
36-39 35%  (n=233) 33%    (n=107)     37%  (n=126)
≥ 40 16%  (n=133) 14%    (n=71)      18%  (n=62)
A female of age 35 years old or younger, undergoing fresh ART treatment had a
31% chance of a clinical pregnancy per cycle started, 34% per oocyte recovery and
45% per embryo transfer.
Single blastocyst transfer programme
The HARI elective Single Blastocyst Transfer (eSBT) programme continued in
2013.  Details of pregnancy rates after ICSI, IVF and FZT since 2008 are presented
in Table 4.  Pregnancy rates are expressed as positive test per eSBT and clinical
pregnancy rate per eSBT.
TABLE 4. Pregnancy rates after eSBT (2013)
ICSI eSBT All ages ≤ 35 36-39 ≥ 40
hCG+ve/eSBT 343/600(57%) 228/389(59%) 100/162(62%) 15/49(30%)
CPR/eSBT 274/600(44.2%) 184/389(47%) 84/162(52%) 6/49(12%)
IVF eSBT All ages ≤ 35 36-39 ≥ 40
hCG+ve/eSBT 356/691(51%) 204/365(56%) 129/254(51%) 23/72(32%)
CPR/eSBT 294/691(42%) 168/365(46%) 111/254(44%) 15/72(21%)
FZT eSBT All ages ≤ 35 36-39 ≥ 40
hCG+ve/eSBT 252/563(48%) 148/303(49%) 83/195(43%) 21/65(32%)
CPR/eSBT 200/563(35%) 115/303(38%) 70/195(36%) 15/65(23%)
The introduction of the eSBT was driven by the desire to reduce multiple
pregnancies while maintaining respectable pregnancy rates from one oocyte
recovery. As shown below, this approach offers an excellent chance of pregnancy
as cumulative clinical pregnancy rates, since the commencement of this
programme, were as high as 64% (Table 5) with an average multiple pregnancy
rate of only 1.9% after fresh transfers (Table 6).  The value in pursuing eSBT lies in
the enormous savings to the public purse in terms of prevention of prematurity-
related intensive neonatal care expenses.  Such savings should be made available
for the provision of free IVF to couples attending ART services that support
elective single embryo transfers.  
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TABLE 5. Female age related cumulative pregnancy rates 
after eSBT (2008-2013)
Day 5 transfers ≤ 35 35-39 years ≥ 40 years 
CPR 47% 47% 17%
Cumulative CPR
(One fresh and 
first frozen transfer) 57% 64% 38%
TABLE 6. Multiple pregnancy rates for eSBT (2013)
IVF ICSI FZT
Singleton 98.3% 96.9% 98.7%
Twins 1.7% 3.1% 1.3%
Triplets 0% 0% 0%
3. NATIONAL ONCOLOGY CRYOPRESERVATION SERVICES
The activity of the National Oncology Cryopreservation Centre includes
emergency onco-fertility consultations, counselling and gamete/zygote
preservation prior to gonadotoxic intervention, offered to all females and males
diagnosed with cancer referred by a Consultant.  In 2013, 155 male oncology
patients attended HARI and 140 patients had sperm cryopreserved.  The demand
for female cryopreservation services saw a further surge compared to 2012, with
82 patients attending, 52 started therapy and 46 reaching either egg or embryo
freezing.  New clinical protocols ensure, in suitable cases, commencement of
therapy at presentation, irrespective if the patient presents in the proliferative or
the luteal phase of the cycle.  This eliminates the need to delay lifesaving
oncology treatments in order to pursue fertility cryopreservation. 
TABLE 7. Oncology cryopreservation data
Year 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Males 
attended 114 142 142 158 186 174 163 173 127 155
Males with 
samples 
frozen 63 131 98 102 127 132 141 170 155 149 157 111 140
Not suitable
/No sample 11 21 15 12 15 10 17 16 19 14 16 16 15
Female 
attendances 5 5 5 6 14 12 23 25 32 62 82
Pursued 
cryopres -
ervation 3 4 0 1 10 4 7 19 22 32 52
Oocyte/ 
embryo 
cryopres -
ervation 3 4 0 0 5 3 5 16 22 25 46
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4. RECOGNITION
Training in Reproductive Medicine (RM)
HARI continues as the main RM teaching centre in Ireland.  In 2013, Dr Srwa Khalid
commenced training as a Fellow in Reproductive Medicine and Surgery (RMS) part
of the SpR in Obstetrics and Gynaecology HARI Scheme recognised by the Institute
of Obstetricians and Gynaecologists and RCPI.  This facilitates SpR’s with an interest
in RM to receive 12 months of training in HARI.  
The British Fertility Society continued HARI recognition for medical training in the
following certified special skills modules: Pelvic Ultrasound, Embryo Transfer/IUI,
Management of the Infertile Couple and Assisted Conception.  HARI is also certified
as the only RCOG subspecialty training centre in Reproductive Medicine and Surgery
in Ireland. In November, Dr Nikhil Purandare was appointed as a Subspecialty
Trainee in Reproductive Medicine and Surgery for a duration of 2 years, training
recognized by the RCOG. 
The unit is similarly recognised for training purposes by the Association of Clinical
Embryologists, UK.  Ms Ciara Hughes and Ms. Gerri Emerson are certified embryology
trainers, three embryologists have completed their training and a further two
embryologists were undergoing the ESHRE training programmes in 2013-2014.
Staff recognition nationally and internationally
Ciara Hughes continued her roles as Chair of the Irish Clinical Embryology Society (ICE)
and executive member on the ACE committee, and has been appointed to update the
joint BFS and ACE single embryo transfer guidelines.  Gerri Emerson continued as the
Irish Clinical Scientist National Representative to ESHRE (European Society of Human
Reproduction and Embryology). Dr Karen Deignan has qualified as Senior Embryologist
on the ESHRE certification scheme. 
Mrs. Joan Hamilton continued as the Chairperson of the Irish Fertility Counsellor
Association (IFCA).
Dr. Edgar Mocanu continued as member of Board of Directors of the International
Federation of Fertility Societies (IFFS), Treasurer of the Federation, chair the EUTCD
ESHRE Task Force and member of the Clinical Advisory Group of the Institute of
Obstetricians and Gynaecologists.  He was also nominated National Advisor
Oncofertility to the National Cancer Control Programme (NCCP).
5. QUALITY AND SERVICE IMPROVEMENTS
Quality and patient safety are the cornerstones of the culture within HARI with
a very successful audit taking in place in February 2013 by the Irish Medicines
Board. . Our dedicated Quality Department works closely with all staff within the
unit to ensure that the best possible care is provided in an environment of
optimal patient safety. Key to this has been the implementation of an extensive
Quality Management System (QMS). The effectiveness of the QMS is maintained
through teamwork and the commitment of staff. As part of our dedication to
continuous quality improvement all our staff members receive ongoing
education on the importance of their contributions to quality and patient safety
and their role as part of the healthcare team. 
IT system 
Appointments are managed more easily and clients now received SMS alerts as
reminders. As part of the clinical review meeting, the team are now able to view a
summary of the entire patients history on screen. This improves decision making
skills for further treatment plans. An activity system has been derived on the system
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which allows staff to inform colleagues if they need to contact patients or follow up
on any urgent actions with the aim of improving timely response and better patient
care.  A chart tagging system was introduced which allows the tracking of charts to
all areas. This was combined with an over haul of the chart filing system which is
now a much more efficient system for filing and retrieval.  Portable phones and
direct dial numbers have been issued to key staff and departments to ensure easy
access to the appropriate people with increased efficiency.
Embryology
The embryology laboratory continues to be at the forefront of developments in
Reproductive technology with the introduction of laser technology and also a
computer aided semen assessment system. The laser technology is used to assist
the hatching of embryos with the aim of improving implantation. It is also used
to collapse blastocyst embryos prior to freezing as this has shown to improve
survival rates. The computer aided semen assessment has offered HARI are more
accurate and consistent method of assessing concentration and motility.
In 2013, the HARI laboratory was the first in Ireland to introduce continuous
culture media for embryo development. Being able to support the embryos by
ensuring that they get the correct nutrients when they require them with the
additional benefit of not having to disturb them in culture has significant
potential to increase success rates for couples. The addition of an embryology
consult at time of treatment ensures that the couples understand the details of
the procedures as they go through treatment.  After a robust research and
validation program the unit introduced single step culture media to support
development of zygotes. The research and validation process identified that this
change might offer patients increased success rates going forward.
Clinical
Natural cycle IVF where the ovaries are not stimulated has been successfully
introduced initially as an end of the line therapy prior to donor oocytes.  Success
rates below 40 years of age reached 13%.  At present we are exploring this therapy
for couples where the female is young (<30 years of age) and a male factor is present. 
6.        ACADEMIC ACTIVITY
The teaching in Reproductive Medicine of students from Trinity College and the Royal
College of Surgeons in Ireland continued in the Rotunda and the HARI Unit.
Attendance at infertility clinics, theatre and ward rounds were routine during the
academic year.  The RCSI Consultant Senior Lecturer attended regular student
tutorials in HARI and participated as a final year examiner for RCSI and TCD students.
From a scientific point of view, during a very busy and successful year HARI staff
engaged in numerous activities at national, European and international level, as
presented below.  Dr Mocanu was invited as Editorial Board member of Human
Fertility, the official journal of the British Fertility Society and continues the ad-hoc
referee activity for 5 other journals in the Reproductive Medicine arena.
Scientific publications (peer reviewed Journals)
Straub, A Aslani, K Enohumah, R Rahore, I Conrick-Martin, D Kumar, M Campbell, P
Dicker, E Mocanu, JP Loughrey, NE Hayes, CL McCaul.  Evaluation of the effect of intra-
operative intravenous fluid on post-operative pain and pulmonary function: a
randomized trial comparing 10 and 30 ml kg− 1 of crystalloid.  BD Ir J Med Sci. 2013
Dec 10. [Epub ahead of print] PMID: 24323549.
51639 Rotunda Clinical Report 2013 301014 v5_Clinical Rep  30/10/2014  11:57  Page 121
122
Emerson G, Deignan K, O’Toole R, Afridi S, Hughes C, Roopnarinesingh R, Mocanu E.
Clinical pregnancy from a vitrified/ warmed human blastocyst. Ir Med J. 2013
Oct;106(9):280-1.
AP Ferraretti, V Goossens, M Kupka, S Bhattacharya, J de Mouzon, et al., 
Assisted reproductive technology in Europe, 2009: results generated from European
registers by ESHRE. Human Reproduction 2013, 28 (9), 2318-2331.
Book chapters
1. Mocanu E, Kelly J. Towards and Ovarian hyperstimulation syndrome (OHSS) free
clinic.  In Proceedings of the IFFS 21st World Congress on Fertility and Sterility. (2013).
Peer reviewed published abstracts 
1. B Hughes Lynch, G Emerson, C Hughes, E Mocanu. Cumulative clinical pregnancy
rates (CCPR) and implantation rates in patients undergoing intra cytoplasmic
sperm injection (ICSI) with cryopreserved testicular aspirated sperm (Cryo-TESE).
Fertility and Sterility 100 (3), S29-S29.
2. C Harrity, D Vaughan, G Emerson, E Mocanu. Effect of blastocyst stage and grade
on successful embryo transfer. Fertility and Sterility 100 (3), S288-S288.
3. C Harrity, V Denis, V Ciprike, G Emerson, E Mocanu. Does past exposure to
hepatitis B virus effect ART outcomes? Fertility and Sterility 100 (3), S474-S475.
4. V Ciprike, C Harrity, PVW Ooi, G Emerson, EV Mocanu. Should oestradiol levels be
routinely performed in hormone replacement therapy (HRT) controlled frozen
embryo transfer (FET) cycles? Fertility and Sterility 100 (3), S96-S96.
5. DA Vaughan, H Conor, E Mocanu. The oestradiol/oocyte ratio predicts the
outcome of assisted reproductive technology (ART) treatments. Fertility and
Sterility 100 (3), S466-S466.
6. PVW Ooi, SP Detho, V Ciprike, C Harrity, EV Mocanu. The application of natural
IVF/ICSI treatments in an Irish setting. Fertility and Sterility 100 (3), S458-S459.
7. F Sutton, G Emerson, J Kelly, E Mocanu. Cumulative clinical pregnancy rates
(CCPR) and laboratory outcomes in females with elevated anti-mullerian
hormone (AMH) level compared to females with normal AMH levels. Fertility
and Sterility 100 (3), S352-S353.
8. K Deignan, G Emerson, E Mocanu. Blastocyst gender bias. Fertility and Sterility.
Fertility and Sterility 100 (3), S480-S480.
9. RAM Rice, C Harrity, E Mocanu, G Emerson, J Kelly. Have advancements in ovarian
reserve testing resulted in a decline in the number of stopped cycles in ART?
Fertility and Sterility 100 (3), S62-S62.
Scientific presentations (oral and posters)
1. B Hughes, G Emerson, C Hughes, E Mocanu. Reproductive outcomes in young
females with different aetiologies undergoing ART.  Oral presentation.  16th May
2013, IFS Meeting. Athlone.
2. V Ciprike, C Harrity, PVW Ooi, G Emerson, EV Mocanu. Should oestradiol levels be
routinely performed in hormone replacement therapy (HRT) controlled frozen
embryo transfer (FET) cycles? O-313. IFFS ASRM Conjoint Meeting, October, 2013,
Boston, USA.
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3. B Hughes Lynch, G Emerson, C Hughes, E Mocanu. Cumulative clinical pregnancy
rates (CCPR) and implantation rates in patients undergoing intra cytoplasmic
sperm  injection (ICSI) with cryopreserved testicular aspirated sperm (Cryo-TESE).
O-92. IFFS ASRM Conjoint Meeting, October, 2013, Boston, USA.
4. RAM Rice, C Harrity, E Mocanu, G Emerson, J Kelly. Have advancements in ovarian
reserve testing resulted in a decline in the number of stopped cycles in art? O-205.
IFFS ASRM Conjoint Meeting, October, 2013, Boston, USA.
5. PVW Ooi, SP Detho, V Ciprike, C Harrity, EV Mocanu. The application of natural
IVF/ICSI treatments in an Irish setting. P-1075. IFFS ASRM Conjoint Meeting,
October, 2013, Boston, USA.
6. F Sutton, G Emerson, J Kelly, E Mocanu. Cumulative clinical pregnancy rates
(CCPR) and laboratory outcomes in females with elevated anti-mullerian
hormone (AMH) level compared to females with normal AMH levels. P-708. IFFS
ASRM Conjoint Meeting, October, 2013, Boston, USA.
7. C Harrity, V Denis, V Ciprike, G Emerson, E Mocanu. Does past exposure to
hepatitis B virus effect ART outcomes? P-1134. IFFS ASRM Conjoint Meeting,
October, 2013, Boston, USA.
8. DA Vaughan, H Conor, E Mocanu. The oestradiol/oocyte ratio predicts the
outcome of assisted reproductive technology (ART) treatments. P-1102. IFFS ASRM
Conjoint Meeting, October, 2013, Boston, USA.
9. K Deignan, G Emerson, E Mocanu. Blastocyst gender bias. Fertility and Sterility. P-
1154. IFFS ASRM Conjoint Meeting, October, 2013, Boston, USA.
10. C Harrity, D Vaughan, G Emerson, E Mocanu. Effect of blastocyst stage and grade
on successful embryo transfer. P-484. IFFS ASRM Conjoint Meeting, October, 2013,
Boston, USA.
Invited lectures, chairs, media appearances
Chairs
Mocanu EV:
Chair and Organiser Winter Forum Conference, Cluj Napoca, Romania. 
Session VI, Patient centered ART- synergizing our efforts.
Chair               The impact of reproductive surgery in increasing
pregnancy rates in ART. ESHRE Campus: Session 9.
Laparoscopy in ART.  April, Iasi, Romania.
Chair               Viral disease in reproduction. Session 36. 
29th ESHRE Annual Meeting, 9th July. 2013. London
Chair                             Scientific Program Prize Paper Abstract Session 1, 14th
October. IFFS ASRM Conjoint Meeting, 2013, Boston, USA
Moderator              RTW33 OHSS Free Clinic- Possible and How? 16th
October. IFFS ASRM Conjoint Meeting, 2013, Boston, USA
Invited lectures:
Hughes C
Hughes C. Preserving Fertility with Cancer- Post Graduate Course, School of
Nursing , UCD, Dublin January 20131
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Hughes C. Preserving Fertility for Breast Cancer Patients, Post Graduate
school of Nursing , Advanced Breast Care Nursing UCD. May 2013
Hughes C. Preserving Fertility for Breast Cancer Patients, Educational
Meeting, Mater Private Hospital , Dublin. September 20131
Hughes C. How technology can improve outcomes – a guide to
developments in embryology. Lomond Park, Limerick September
2014. 
Hughes C. Fertility Preservation: Fertility and the Haematology Patient,
Post Graduate Nursing in Oncology and Haematology,
Beaumont HospitalHaematology Education Programme, St
James Hospital September 2013
Hughes C. Sharing Best Practice in Fertility Nursing – Preserving Fertility
for Oncology Patients, Croke Park Hotel, Dublin, Ireland
November 2011
Hughes C. Post-Graduate Diploma in Haematology Nursing Lecture, St
James’s Hospital November December 2013
Hughes C Sessional tutor for RCSI 4th yr Medical students – Introduction to
Embryology 1
Mocanu EV: 
The role of natural killer cells in ART. St James’s Hospital
Immunology Grand rounds. Dublin, January 2013
Mocanu EV: Prognostic and complications of reproductive surgery. ESHRE
Campus Symposium: The impact of Reproductive Surgery in
increasing pregnancy rates in ART, Iasi, Romania, 12th April 2013.
Mocanu EV: Fertility following breast cancer treatment. IANO 31st Annual
Conference, Dublin, 19th April 2013.
Mocanu EV: Fertility Issues for cancer patients: what are they and how can
we help? Hot topics in Oncology Meeting, Dublin, 27th April 2013.
Mocanu EV: The role of the European Tissue Directive on TQM. ESHRE  2013
Pre Congress Course 12, 7th July, London. 
Mocanu EV: Towards an ovarian hyperstimulation syndrome-free clinic. IFFS
ASRM Conjoint Meeting, Trilogy 12- Safety in ART. 16th October,
2013, Boston, USA.
Mocanu EV: Polish Session. Facilitating the couple, protecting the
practitioners, Regulation of ART. IFFS Regional Meeting. Fertility
and Sterility Special Interest Group Polish Gynaecological
Society. IFFS ASRM Conjoint Meeting Boston, 15th October, 2013.
Mocanu EV: Infections from conception to birth-role of ART. Implications   of
the EU Tissue Directive. 8th November, ESHRE Campus, 2013,
Berlin.
Courses organised
Hughes C. ICE Scientific Day – Basic Microscopy Training (Research
Instrument UK Micron Optical, Rob Watkins Grafton Suite,
Dublin May 2013.
Hughes C. ACE Microscope Practical Training Course October 2013,
Cambridge IVF
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Conference Course Attendance
Deignan, K Practical training in Embryo and Blastocyst Biopsy, UCL October
2013
Emerson G Irish Fertility Society Annual Meeting, Athlone, May 2013
Emerson G ICE Scientific Day – Basic Microscopy Training (Research
Instrument UK Micron Optical, Rob Watkins Grafton Suite, Dublin
May 2013.
Furlong J Irish Clinical Embryologist Meeting- PGD Workshop, November
2013 Dublin 
Furling J  ICE Scientific Day – Basic Microscopy Training (Research
Instrument UK Micron Optical, Rob Watkins Grafton Suite, Dublin,
May 2013.
Hughes B
Lawson C. ESHRE, 28th Annual Meeting London July 2013
Hughes B ASRM 69th Annual General Meeting, Boston, October 2013
Hughes B Irish Clinical Embryologist Meeting- PGD Workshop, November
2013 Dublin 
Hughes B ICE Scientific Day – Basic Microscopy Training (Research
Instrument UK Micron Optical,)  Rob Watkins Grafton Suite, Dublin
May 2013.
Berney C.A.    BFS, June 2011,
Finnamore L.  BFS, June 2011
Furlong J. IVI Hands on Workshop for Vitrification, Valencia, Spain, April 2011
Hughes C. ACE Annual Conference – January 2013, Liverpool
Hughes C. Best Practice Meeting (Association of Clinical Embryologists)
Sheffield 22nd May 2013
Hughes C 
Emerson G. ESHRE, 287th Annual Meeting London July 2013
Hughes C ASRM 69th Annual General Meeting, Boston, October 2013
Johnson J ICE Scientific Day – Basic Microscopy Training (Research
Instrument UK Micron Optical, Rob Watkins Grafton Suite, Dublin,
May 2013.
Johnson J Irish Clinical Embryologist Meeting- PGD Workshop, November
2013 Dublin
Larkin L. ESHRE, 28th Annual Meeting London July 2013
Larkin L Practical training in Embryo and Blastocyst Biopsy, UCL October
2013
O’Reilly F NEQAS Training Day  Semen Assessment, Manchester, March 2013
Piersa K NEQAS Training Day  Semen Assessment, Manchester, March 2013
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DR FIONNUALA NÍ ÁINLE (DIRECTOR)
MR JOHN O’LOUGHLIN (LABORATORY MANAGER)
INTRODUCTION
The Department of Laboratory Medicine is staffed by dedicated and highly
educated professionals who are committed to providing a service of the highest
quality that is pro-active and responsive to the needs of the users of the service.
Quality is of paramount importance. These high standards are reflected in the
shortlisting of the Rotunda Hospital Laboratory as finalist in the 2013 Irish Medical
Laboratory of the Year awards and in continuing accreditation to International
Organisation for Standardisation ISO15189 requirements across all departments.
The Laboratory Annual Management Review, User Surveys and Users Committee
meetings inform the laboratory management of any concerns regarding the
services provided and also any changes in the requirements of service users.
Quality objectives are in place to ensure that the needs and requirements of users
are met; these quality objectives are reviewed annually. 
The overall laboratory workload is reflected in Tables 1 and 2.
*Histology work is numbered by case. Each case can include multiple specimens
and blocks, requiring ≥1 stains of various complexity
D E PA R T M E N T  O F  L A B O R A T O R Y
M E D I C I N E
TABLE 1: TESTS PERFORMED IN-HOUSE IN 2013 
Department Specimens/ Cases*
% Change
over 2012
Tests
/ Blocks*
% Change
over 2012
Haematology 47,201 -1 665,287 -1
Blood Group Serology 30,661 7.9 30,661 7.9
Transfusion 4,887 13 4,887 13
Clinical Microbiology 45,748 -6.3 88,805 -4.3
Virology / Serology 13,236 -3.2 30,427 -8.1
Biochemistry 22,543 -11 198,600 -8
Histopathology 4,333 -2.0 9,567 -23.2
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TABLE 2: TESTS REFERRED TO OUTSIDE LABORATORIES IN 2013
Specimens % Changeover 2012 Tests
% Change
over 2012
Haematology 1,646 -25.7 3,950 -17.1
Biochemistry* 4,173 11.7 7,692 -1.8
Microbiology 4,524 -0.2 19,480 7.07
Rubella/VZ/Syphilis 30,228 -1.5 30,515 -1.2
* Serology Confirmation and other specialized tests 
VZ: Varicella Zoster
STAFFING
Consultant posts
Dr Fionnuala Ni Ainle was appointed as Consultant Haematologist in March 2012. 
Dr John Gillan, Consultant Histopathologist retired. 
Laboratory manager
Following continued effort in 2013 by Laboratory Management and the Hospital
Executive Team, the necessary HSE approval and funding for a shared post of
Consultant Microbiologist was achieved. Dr Richard Drew was subsequently
appointed as Consultant Microbiologist in early 2014.  Dr Andrea Malone joined as
part-time temporary Consultant Paediatric Haematologist in February 2013. Dr
Ursula Nusgen joined as part-time temporary Consultant Microbiologist in
January 2013. 
Medical Scientist posts
Ms Gemma Tyrell and Ms Michelle Burns joined the departments of microbiology
and haematology respectively in May 2013.
QUALITY DEPARTMENT: 
Quality Manager: Ms Susan Luke
Deputy Quality Officer Ms Emily Forde*
Training Officer Mr. Ciaran Mooney* 
Health and Safety Officer Ms Aiveen O’Malley*
LIMS Officer/ POCT Co-ordinator Ms Jane Halligan 
(*duties carried out in addition to departmental position)
The Department of Laboratory Medicine is assessed by the Irish National
Accreditation Board (INAB) against ISO standards 15189 and 22870. In addition,
the departments of Blood transfusion and Haemovigilance are inspected against
the EU directive ‘minimum requirements for Blood Bank Compliance’, article 14
(traceability) and article 15 (notification of serious adverse reaction and events).
128
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In 2013, following an inspection by INAB, the accreditation of the department of
laboratory medicine was renewed in all disciplines including point of care testing
(POCT). The accreditation process was extended to POCT in 2013 as assessed to the
standard ISO 22870 for the first time with respect to blood gas and Hemocue
analysis. The INAB assessment process examined POCT across the clinical and
laboratory environment. INAB assessed the ability of the laboratory to provide
governance and a service to facilitate evaluation of new or alternative POCT
instruments /systems. The standard mandates that procedures and policies exist
governing purchase, installation, validation and running of equipment,
maintenance of consumables and reagents and provision of training to POCT
operators. A documented procedure for quality control and quality assurance is in
place. Ms Jane Halligan should be acknowledged for her work in enabling us
achieve accreditation in this joint area of providing a near patient test service. 
An up-to–date record of the status of the accreditation of the Department of
Laboratory Medicine can be found on the following websites: www.inab.ie. The
assessment team commended the laboratory on the quality management system
in place. An inspection is always challenging but is a great learning opportunity for
all involved. The inclusion of all staff in the laboratory in the accreditation process
has been recognised in the reports of the inspection bodies over the recent years,
which is gratifying.
The maintenance of the laboratory quality management system requires a
continuous active program to ensure achievement and compliance with the
required standards and quality of service. This is achieved through documented
procedures in testing, management and day to day running of the laboratory being
systematically reviewed. An audit calendar is drawn up at the beginning of each
year. In 2013 the laboratory was involved in the planning and execution in a
number of clinical audits to address trends identified by monitoring non-
conformances and complaints.
The laboratory consults users through surveys and user group meetings. In 2013 an
in-house user survey was completed during the first quarter. External users of the
Andrology services were surveyed in the final quarter on their satisfaction of the
service provided and the patient experience.
The laboratory information management system APEX was upgraded to APEX
version 5.8 in July 2013 and the Q-Pulse system was upgraded to Q-Pulse version 5.9
in 2013.
The laboratory submits an Annual Report for Blood Transfusion to the Irish
Medicines Board (IMB). This report documents the activity for the previous year
and reports blood usage and wastage, status of accreditation and informs of any
planned future changes. The report has been submitted for 2013. The annual report
for Blood Transfusion for 2011 submitted to the Irish Medicines Board (IMB). This
was satisfactory and no visit was deemed necessary.
The quality management system is embedded across the laboratory services and is
dependent on all those working in the laboratory. We are committed to providing
a service of the highest quality and shall be aware and take consideration of the
needs and requirements of the users which is reflected in our quality policy.
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HISTOPATHOLOGY DEPARTMENT
STAFF
Consultants: Dr. Deirdre Devaney, 
Dr Eibhlis O’Donovan, 
Dr Emma Doyle
Locum Consultant: Dr Sean O’Briain
Registrars: Dr Alan Beausang, Dr Ruth Law
Chief Medical Scientist: Colma Barnes
Senior Medical Scientist: Ms Phil Bateson, 
Medical scientists: Ms Sarah Morris, 
Ms Aderanti Morenigbade, 
Mr Michael Smith, 
Ms Tokiko Kumasaka, 
Ms Miriam Hurley
Senior Anatomical Technician: Mr Bill O’Neill
Laboratory Aide: Mr. Martin Fitzpatrick
The following Tables indicate the number of autopsies (full, limited, and Coroner’s)
performed in 2013.
*Includes  1 outside case.
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TABLE 3: AUTOPSY WORKLOAD >500GRAMS
Full
Postmortem 
Limited
Postmortem
Coroners
case Total
Stillbirths 21 6 1 28
Early Neonatal deaths 7 2 5 14
Late Neonatal deaths 0 0 0 0
Total 28 8 6 42
Outside cases* 0 0 1*
% of Total PMs 27.2% 7.8% 5.8% 40.8%
TABLE 4: AUTOPSY WORKLOAD <500GRAMS
Full
Postmortem
Limited Post
mortem
Coroners
case Total
No. of PMs 53 6 2 61
% of Total PMs 51.5% 5.8% 1.9 59.2%
TABLE 5: ROTUNDA PERINATAL MORTALITY FIGURES: 2013 (0-7DAYS)
No
examination
Limited
examination
Full Post
Mortem
Coroners
Cases Total
Stillbirths 14 6 21 1 42
Early Neonatal deaths 14 2 7 4 27
Total 28 8 28 5 69
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PERINATAL PATHOLOGY
The perinatal autopsy service in 2013 was as busy as the previous year (103 cases in
2013 with 101 cases in 2012). Turnaround times (TATs) for these cases remained in line
with previous years in that the majority of cases were reported within the
recommended 8 weeks allowing the clinicians to interface with grieving parents in
a timely fashion. In conjunction with this, there were no organs retained in 2013.
A full autopsy includes external examination, radiology, cytogenetics and internal
examination of all three body cavities (Chest, abdomen and cranium) in conjunction
with placental examination.  Limited autopsy examinations are in keeping with the
wishes of the parents, as expressed on the consent form  eg, external examination
and cytogenetics only or a single body cavity – as in a case of a known congenital
heart disease, the family may only wish to have the chest cavity opened. We endeavor
to examine all placentas associated with fetal demise, as in a large number of cases
the placenta will reveal a significant pathology which may be the cause of death.
103 autopsies were performed in 2013 (42 >500g and 61 <500g) leading to an overall
autopsy rate (AR) of 47.2% (42+61=103/218 cases through mortuary) in comparison to
45.3% in 2012 and  42.3% in 2011. The AR (Full, limited and coroners cases) for >500 g
was 54.5% (42/77) and 43.3% (full and limited – 61/141) for <500g. These figures take
into account some external transfers and late neonatal deaths.  The AR for the
Rotunda cases (perinatal mortality figures) is 59.4% (41/69 cases) up from 50% last
year        We performed 8 post mortem examinations at the request of the coroner (in
comparison to 15 last year) 1 of these was an external case and 2 were below 500g. 
As mentioned above, it is our policy to examine the placenta on all cases of perinatal
deaths.  There were 69 > 500g, 67 of these cases had placental examination. In the
other two cases, one baby had a known Trisomy 18, the other however had no post
mortem and no placental examination. 
Tulip Classification of Perinatal Mortality:
This is a Dutch Classification system that separates cause and mechanism of
perinatal mortality for the purposes of counselling and prevention.  The goal of the
system was to identify an unambiguous single cause system aiming to identify the
initial demonstrable pathophysiological entity initiating the chain of events that
irreversibly led to death based on a combination of clinical findings and diagnostic
tests including pathological findings. The causes of death are stratified into 6 major
categories:
1. Congenital Anomaly
2. Placenta
3. Prematurity / Immaturity
4. Infection
5. Other
6. Unknown
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Cause of Death: (perinatal figures Rotunda only  > 500g)
We have used a modified version of the Tulip classification to classify our causes
of death.
69 cases:
Congenital Malformation 29 (42%)
Placental causes: 21 (30.4%)
Cord 7
Parenchyma 14 
Prematurity / Immaturity 1 (1.5%)
Infection 8 (11.6%)
Other 2 (2.9%)
Unknown 8 (11.6%)
The 29 congenital malformations included 8 babies with chromosomal
abnormalities (2 babies had trisomy 21 and 3 had trisomy 18, 1 had trisomy 13 ,1 had
monosomy 13q and 1 had an abnormal karyotype), 6 babies were born with neural
tube defects (3 with anencephaly and 3 with encephalocoeles), 3 babies  had
cardiac malformations /congenital arrhythmias, 1 with a diaphragmatic hernia,  2
babies had bladder outlet obstruction. There was 1 case of sirenomelia and 4 cases
of multiple congenital anomalies. There was 1 case of holoprosencephaly, 1 case of
hydrops consequent upon bronchopulmonary dysplasia and 1 case of polysplenia
/ asplenia/ heterotaxy complex, and one further case of hydnops.
In the placental category, there were 7 cord accidents identified. There was evidence
of chronic uteroplacental insufficiency in 10 (including  4 cases of placental
abruption) cases.  There were 2 cases of villitis, 1 case of delayed villous maturation
and 1 cases of a neonatal death due to twin to twin transfusion syndrome.
8 deaths were attributed to infection. All of these were ascending infection. In the
ascending infection group, E. Coli was isolated from 3 babies and Group B
streptococcus was isolated from 1 baby.  Four babies had negative cultures but
there was histological evidence of ascending infection with a fetal response (i.e.
umbilical vessel vasculitis +/- a congenital pneumonia). In our use of the Tulip
classification we have modified this category – if we were to adhere to the strict
classification guidelines, these four cases would be relegated to the unexplained
category despite the fact there is histological evidence of infection.
There was one neonate who was assigned to the prematurity category.
The miscellaneous category included two cases of fetomaternal haemorrhage.
There were 8 cases that had no identifiable cause of death giving an unexplained
rate of  11.6%  ( in comparison to  8.8 % last year).  Significantly 5 of these 8 cases
did not have any form of post mortem examination.
Cause of Death (<500g)
141 cases:
Congenital Malformation: 15 (10.6%)
Placental: 29 (20.6%)
Infection: 35 (24.8%)
Other: 1 (0.7%)
Unexplained: 61 (43.3%)
132
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This cohort shows a much lower rate of congenital malformation with ascending
infection and placental categories as the most prominent cause of death. The high
unexplained rate reflects the fact that a significant number of these cases only
had a placental examination (i.e. did not consent to a full post mortem
examination) and also reflects the small size of the foetuses (1.22grams –
499grams) with 39 (27.6%) of these cases being 10 grams or less.
Placental Examination:
The placental work load was modified in 2012. During that year we introduced a
triage system for placental examination following Royal College of Pathologists
Guidelines. A protocol detailing which placentas should be examined is available on
the Labour ward and includes the examination of placentas from babies admitted
to the NICU, from all mothers with pyrexia, PPROM, PET, gestational diabetes
mellitus, multiple gestations and as alluded to earlier,  all cases of stillbirths and
neonatal deaths. These placentas are sent to the laboratory and are then stratified
into two groups. Group One placentas are those that require both gross and
histological examination. Whereas Group Two placentas are those cases that gross
examination only is deemed as sufficient. Should the clinician specifically require a
microscopic examination of these cases, it is available on request. 1629 placentas
were referred to the laboratory for examination in 2013. 590 (36.2%) fulfilled the
criteria for gross examination only. The remaining 1039 had both macroscopic and
microscopic examination.  The introduction of this triage system has been very
beneficial in that it has succeeded in reducing the histology workload of placental
examination by approximately one third, affording us extra time to devote to the
cases that require a more detailed examination.  Placental examination continues to
reflect a significant workload for the department.
Surgical pathology: 
The Histopathology department continued to provide a diagnostic service to the
colposcopy clinic, supporting the activity generated by the NCSS programme.
Multidisciplinary meetings for the colposcopy service were held on a regular
basis. The department continues to participate in the National Quality Assurance
programme in Histopathology with data submitted centrally to NQAIS.
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TABLE 6:  ANALYSIS OF THE SURGICAL PATHOLOGY WORKLOAD 
FROM 2010-2013
Surgical
data (no. & 
% increase
from prev
year
2010
no.
2010
%
Incre
-ase
from
2009
2011
no.
2011
%
Incre-
ase
from
2010
2012
no.
2012
%
Incre-
ase
from
2010
2012
%
Incre-
ase
from
2011
2013
no.
2013
%
Incre-
ase
from
2010
2013
%
Incre-
ase
from
2011
2013
%
Incre-
ase
from
2012
Surgicals (inc
llletz & colcb)
Total no. of
Cases: 4030 28.3 4476 11.07 4420 9.68 -1.25 4333 7.52 -3.19 -1.97
Total no. of
Specimens 5454 35.5 5571 2.15 5467 0.24 -1.87 5364 -1.65 -3.72 -1.88
Total no. of
Tissue Blocks 11661 33 13114 12.46 12464 6.89 -4.96 9567 -17.96 -27.05 -23.24
LLETZ
Total no. of
Cases: 783 46.3 914 16.58 752 -4.08 -17.72 465 -40.69 -49.12 -38.16
Total no. of
Specimens 1160 40.4 1175 1.29 910 -21.55 -22.55 520 -55.17 -55.74 -42.86
Total no. of
Tissue Blocks 4906 66.1
6045 23.22 4906 0 -18.84 2296 -53.2 -62.02 -53.2
Colcb
Total no. of
Cases 732 177.3
991 35.38 1014 38.52 2.32 1013 38.39 2.22 -0.1
Total no. of
Specimens 915 221.5
1214 32.68 1242 35.74 2.31 1366 49.29 12.52 9.98
Total no. of
Tissue Blocks 916 165.5
1216 32.75 1246 36.03 2.47 1374 50 12.99 10.27
TABLE 7:  LLETZ & COLPOSCOPIC BIOPSY GRADING 2013
CASES CIN 1 CIN 2 CIN 3 CGIN/AIS SCC inclmicroinvasion Adenoca
LLETZ 127 126 162 3 7 2
COLCB 493 191 125 2 2 2
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A review of the changes in the number of individual tests requested showed quite a
variance with some increasing significantly by more than 50% while others,
requested in relatively small numbers, decreased by more than 40% (Table 9).  There
was a significant increase in the number of samples analysed for glucose due to an
increase in the number of glucose tolerance tests (GTT) performed.  However,
following the adoption of the HSE national guidelines for the management of pre-
gestational and gestational diabetes, it is anticipated that although the number of
GTTs might continue to increase, the total number of samples analysed for glucose
should fall due to the implementation of the revised GTT protocol.  
As there had been a sustained increase in the number of requests for B12 and folate
analyses, it was agreed to repatriate these investigations as part of cost
containment.  In contrast, there was a significant decrease in the numbers of
requests for CK, LDH and GGT, such that it was no longer appropriate that these non-
urgent tests should be performed on-site.  These samples are now referred out and
the tests removed from the Biochemistry in-house testing repertoire and scope. A
decrease in the number of requests for fasting lipids was also noted. 
BIOCHEMISTRY:
Consultant: Prof Philip D Mayne
Chief Medical Scientist: Ms Ann Downey
Senior Medical Scientist: Ms Sharon Campbell
Medical Scientists: Ms Lorna Pentony
Mr Damian Lally
Clinical Scientist: Ms Aiveen O’Malley
Laboratory Assistants: Mr Paul Reilly
Following a year of significant staff changes, 2013 was relatively quiet. Ms Ann
Downey, Chief Medical Scientist resigned her position toward the end of the
year. Approval was granted to advertise the post and an appointment will be
made in early 2014.
The total number of Biochemistry tests requested during 2013 dropped slightly
by 5.7% (Table 8), corresponding to a slight decrease in the number of individual
patient samples received. However, there was a modest increase in number of
endocrine investigations performed and samples referred to external
laboratories, both in Ireland and abroad.  
TABLE 8: Biochemistry Departmental Workload 
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Test – marked increase Change%
Glucose 20%
B12 52%
Folate 61%
Ferritin 68%
CA125 15%
Test - Marked decrease Change
Lipid profile 72%
CK 66%
GGT 43%
LDH 49%
The Point of Care Testing (POCT) Committee met on a number of occasions during
the year.   The poor analytical precision when measuring low blood glucose levels
was addressed and the policy for referring samples to the laboratory in such
situations amended. In-house POCT training was undertaken through-out the
year. The Biochemistry laboratory experienced its second INAB inspection in May
2013 for compliance with ISO 15189. No non-conformances were reported by the
INAB assessors. Point of Care Testing was also successfully assessed for compliance
with ISO 22870. All staff are to be congratulated on a successful outcome and
thanked for their hard work throughout the year.
HAEMATOLOGY and BLOOD TRANSFUSION:
Consultant: Dr Fionnuala Ní Áinle (Adult Haematology)
Dr Melanie Cotter (Paediatric Haematology)
Dr Andrea Malone (Locum Paediatric 
Haematologist) 
Chief Medical Scientist: Ms. Deirdre Murphy 
Senior Medical Scientists: Mr Ciaran Mooney, 
Ms Deirdre O’Neill (returned from leave Sept 2013)
Ms Emily Forde
Medical Scientists: Ms Liliana Rasidovic, 
Ms Edel Cussen (commenced career break 
December 2013), 
Ms Noreen Brady (on leave from April 2013), 
Ms Deirdre Corcoran (commenced maternity 
leave November 2013), 
Ms Aileen Carr, 
Ms Michelle Burns (commenced May 2013), 
Ms Áine Meenaghan (locum post; commenced 
May 2013)
Laboratory Aide: Ms. Karen Fennelly
1. General Overview, and developments during 2013
During 2013, the Haematology and Blood Transfusion Laboratories continued to
provide an extensive repertoire of investigations required for care of women and
infants, with participation in the relevant External Quality Assessment programmes
TABLE 9: Significant changes in requesting patterns of some biochemical tests.
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in the United Kingdom and Ireland. In addition to routine tests (including full
blood counts and coagulation screens), specialized testing including
haemoglobinopathy screening by high performance liquid chromatography,
thrombophilia screening and flow cytometry for quantification of feto-
maternal haemorrhage are all provided in-house.
In July 2013, following extensive development of guidelines and care pathways,
Hospital Management approved the launch of a programme to provide routine
antenatal anti-D prophylaxis (RAADP) to all Rhesus D (RhD) negative pregnant
patients, in line with national and international recommendations on
prevention of RhD sensitization. The Rotunda Hospital is the largest maternity
unit to implement such a programme in the Republic of Ireland to date, and the
first of the Dublin Maternity Hospitals to do so.
2. Training and development initiatives
The department was approached by Dublin Institute of Technology, Kevin Street
in Sept. 2012 to provide in service training for 2012/2013 Degree students.
Provision of Blood Transfusion training commenced in January 2013. 
Another staff member successfully completed a masters degree in 2012; since
then, this excellent work has been has been accepted for peer-reviewed
publication in 2014.
3. In-house workload (Table 10)
A recent review of Rotunda Hospital guidelines for investigation of acquired and
inherited Thrombophilia has resulted in testing being performed in line with
international guidelines and best practice. Consequently, a large reduction in
thrombophilia testing was observed in 2013. 
Table 10: Haematology in-house workload
Test Name 2013 Change 2012
Full blood count 41,302 4.8% 39,408
Manual differential 1,421 -40.4% 2.385
Manual Platelet count 8 -33.3% 12
Reticulocyte count 413 -9.6% 457
Sickledex screen 92 -17.9% 112
Prothrombin Time 2,734 -13.0% 3,144
APTT 2,970 -13.5% 3,433
Fibrinogen 2,738 -12.9% 3,144
Lupus anticoagulant 207 -22.5% 267
Kleihauer 363 2.3% 355
Haemoglobinopathy 2,558 -2.8% 2,632
Malaria 2 -80% 10
Thrombophilia 74 -74.7% 293 
Total tests 72,689 -14.1% 84,621
APTT: activated partial thromboplastin time
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TABLE 11: HAEMATOLOGY REFERRED WORKLOAD
% CHANGE
TEST TESTS OVER 2012
Immunology 248 -16.5
Thrombophilia (referred component) 67 -75
Haemoglobinopathy confirmation 147 10
Lymphocyte subsets 105 -37
Factor Assays 146 -15
Cytogenetics 563 -17
Molecular Genetics 61 -21
YDNA 52 -28
CG by PCR 68 -30
ESR 16 -27
D-Dimer 11 -15
Anti-Xa assay 19 -85
Homocysteine 3 -83
Haptoglobin 2 -50
Factor V Leiden 5 -100
Anti-D  quantitation 83 -18
Anti-C quantitation 6 -60
Total 3950 -17.1
TABLE 12: BLOOD GROUP SEROLOGY WORKLOAD 
Test 2013 Change 2012
ABO Group 22606 10.1% 20527
Rhesus (Rh) Group 21934 6.9% 20527
Antibody Screen 18437 7.7% 17120
Direct Coomb’s Test 3231 3.4% 3125
Antibody Identification panel 610 -28.8% 843
Genotype 600 40.8% 426
Antibody Titre 85 14.9% 74
Antibody Elution 85 66.6% 51
Weak/Partial RhD Typing 49 63.3% 30
Flow Cytometry 817 -7.7% 885
Total Specimens 21934 6.9% 20527
4. Referred workload (Table 11)
Large reductions in the referred components of the thrombophilia screen and in
requests for the plasma Anti-FXa assay were observed, following the
implementation of updated evidence-based practice guidelines. 
CG: cytogenetics; PCR: polymerase chain reaction; ESR: Erythrocyte
sedimentation rate
5. Blood Group Serology (Tables 12 and 13)
A 10% increase in Blood Grouping was observed as a consequence of a change in
neonatal blood grouping introduced during 2013.
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TABLE 13: DETAILS OF RED BLOOD CELL ALLOANTIBODIES DETECTED 
Antibody Number Antibody Number
D 23 C 3
E 11 Fya 5
C + D 6 M 28
Cw 12 Lea 18
c +/- E 9 Leb 4
D + E 1 Jka 4
K 12 Jkb 1
E 5 Jka + Fya 1
Le a+b 4 Lea + M 1
Lea +D 1 K+E+Fya 1
Jka+Cw 1 D+C+Fyb 1
TOTAL 152
TABLE 14: BLOOD TRANSFUSION WORKLOAD 
Test 2013 Change 2012
Group and save 6974 18.3% 5894
Crossmatch 1492 -19.1% 1844
Patients crossmatched 705 15.8% 609
Red Cell Units transfused 689 -7.6% 746
Patients Transfused 377 7.4% 351
Crossmatch: transfusion ratio 2.1:1 -19.2% 2.6:1
IUT (red cell units) 12 50% 8 
Pedipack units transfused 104 babies -26.7% 142 babies
Transfused Components 2013 Change 2012
Plasma (adult) 66 -65% 189
Plasma (paediatric) 43 72% 25
Platelets (adult) 11 120% 5
Platelets (paediatric) 42 8.7% 46
Fibrinogen (adult) 68 25.9% 54
Fibrinogen (paediatric) 35 29.6% 27
Novoseven 0 N/A 0
Anti-D 2207 41.5% 1560
Wastage: 2013 Change 2012
Red cell (concentrated) 1.8% -48.6% 3.5 %
Platelets 15.9% 43.2% 11.1%
Plasma 19.9% 165% 7.5
6. Blood transfusion
There has been a modest increase in the number of patients transfused overall.
Interestingly, an increase in fibrinogen usage and a decrease in red cell units
transfused per patient were noted. A significant improvement in the cross-match to
transfusion ratio was observed (Table 14), reflecting introduction of new clinical
guidelines. Ongoing targeted audit aims to further improve this figure. Blood
wastage remains low, particularly in the most commonly prescribed product, red
cells. An increase in Anti-D use reflects the launch of the RAADP programme in 2013.
IUT: intrauterine transfusion
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7. Haemovigilance 
The haemovigilance officer (HVO) continues to provide extensive education on the
process of blood transfusion to clinical staff. During 2013, 154 Nurses, Midwives and
Student Midwives and 54 non-consultant hospital doctors attended
Haemovigilance  Education.
Once again, a very high standard was maintained in haemovigilance, with 100%
traceability of all blood components issued. The most common indication for blood
transfusion in the obstetric setting remains post-partum haemorrhage. The
Rotunda Hospital haemovigilance department maintains close links with the
National Haemovigilance Office (NHO) with the continuing aim of maintaining
quality of care through regular audit and education. The HVO reports serious
adverse events (SAE) or reactions to the NHO. Two SAE and one near-miss event
were reported to the NHO during 2013, both of which pertained to delayed
administration of Anti-D immunoglobulin. The recently revised clinical pathway
managing patients who require Anti-D for prevention of RhD sensitization
continues to be under review, and specific SAE numbers related to this process
remain low as a consequence, compared with previous years.
As detailed above, implementation of a programme of RAADP administration to
RhD negative women was launched in July 2013. Audit and evaluation of the system
is ongoing through the Rotunda Hospital multidisciplinary RAADP committee.
CLINICAL MICROBIOLOGY
1. Overview of Department of Microbiology
The role of the department of Microbiology is to assist clinicians in the
investigation and management of infections. The department also contributes to
the infection control programme of the hospital by generating antimicrobial
resistance data, and monitoring for emerging trends in terms of healthcare
associated infections. 
2. Staff of the Microbiology Department
Consultant: Dr. Ursula Nusgen (locum)
Chief Medical Scientist: Mr David LeBlanc
Senior Medical Scientists: Ms. Niamh Cahill 
Ms Deirdre Cafferty  
Medical Scientists: Ms Ita Cahill (0.5 WTE), 
Ms Patricia Baynes, 
Ms Ann Lamont (0.5 WTE), 
Ms Bernadette Lennon (0.5 WTE), 
Ms Ellen Lennon (0.5 WTE), 
Ms Gemma Tyrrell (started June) 
Ms Komal Lakho (started in June).
Laboratory Aide: Ms Grainne McDonald 
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The department has a close working relationship and is supported by the assistance
of other staff from across the hospital, namely;
• Ms. Marian Brennan, Assistant Director of Midwifery/Nursing in
Infection Prevention and Control
• Ms Alva Fitzgibbon, Infection Prevention and Control Midwife
• Ms Mairead Lawless, Infectious Diseases Liaison Midwife
• Dr. Wendy Ferguson, Associate Paediatric Specialist in Infectious Diseases
• Dr. Jack Lambert, Consultant in Infectious Disease
3.  Key Functions of the Microbiology Laboratory
3.1  General Microbiology Workload
The general microbiology workload incorporates the processing of clinical
samples for predominantly bacterial culture. The main samples that are received
are urine samples, blood cultures and swabs from non-sterile sites for culture.
Overall there was a slight decrease in the number of specimens (-4.27%) and the
number of tests (-6.26%) performed in the laboratory, which is in line with
overall hospital activity (Table 15).
TABLE 15: Overall general microbiology activity in the department. 
Sample types Specimens % Difference Tests 2013 % Difference
2013 over 2012 over 2012
Urine 21036 -3.47 33930 -5.66
Swabs 9881 -3.18 19762 -3.18
CSF 232 -21.62 751 -19.42
Blood Cultures 2868 14.31 2868 14.31
Placenta 217 -42.13 217 -42.13
Semen 1710 -10.56 4229 -8.07
Pregnancy Tests 152 20.63 152 20.63
Screening 5896 -9.83
PCR 2913 -6.30 2854 -7.76
(C.trachomatis and 
N.gonorrheae)
IQA 843 -8.96 843 -8.96
Total specimens 45748 -4.27 88805 -6.26
CSF: cerebrospinal fluid; IQA: Internal Quality Assurance; PCR: Polymerase Chain Reaction
The largest rise in absolute specimen numbers was seen in blood cultures, with an
associated rise in pregnancy tests. Typically pregnancy tests are performed as a
point of care test, however the number sent to the laboratory increased in 2013. 
There was a general decrease seen across other specimens sent for culture such as
urines and swabs for culture. Although cerebrospinal fluid sample numbers had
decreased by 21% this year, the number was still above the figure for 2011. A new
category of testing was introduced in 2012 called IQA (Internal Quality Assurance),
which is a required standard for ISO: 15189 Accreditation. There was an almost 9%
positive reduction in this category of testing which was achieved through
improved stock management and a rationalisation of the variety of test kits used.
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3.1  Screening for resistant organisms
A key role of the Microbiology Department is to perform surveillance screening for
resistant organisms across the hospital. This allows for outbreaks to be detected
early, and also ensures that patients with resistant organisms are identified, and
can then be isolated appropriately. The neonatal intensive care unit is an area
where screening is particularly important to ensure the welfare of patients. The
key organisms that the laboratory performs screening for are (Table 16):
• Meticillin resistant Staphylococcus aureus (MRSA)
• Rectal screens for
o Vancomycin resistant Enterococcus (VRE)
o Extended spectrum β-lactamases (ESBLs)
o Carbapenem resistant Enterobacteriaceae (CRE)
o Pseudomonas aeruginosa
TABLE 16: SURVEILLANCE SWABS 2013.
SPECIMENS % DIFFERENCE 
TEST IN 2013 FROM 2012
MRSA Screen 5326 -6.89
Rectal Screen 12932 -12.12
The rectal screen incorporates screening for Vancomycin resistant Enterococci,
extended spectrum β-lactamases, carbapenem resistant Enterobacteriaceae
(CREs) and Pseudomonas aeruginosa.
3.1  Virology/Serology workload
The number of antenatal booking bloods tested is similar with the number for 2012;
however the overall in-house virology testing is down on 2012 (Table 17). The
laboratory continues to provide testing for the HARI unit, in line with European
Union Tissue Directive. The 26% reduction in cytomegalovirus IgG testing is due to
a change in practice in the HARI unit regarding testing. 
During 2013 there have been some significant changes in practice:
• As part of a cost saving initiative, urgent varicella zoster IgG tests and
confirmation of hepatitis B core antibody levels are now sent to the National
Virus Reference Laboratory (NVRL). 
• The Abbott Architect analyser now performs testing 4 days a week instead of 5
days a week in order to help rationalise the amount of internal quality assurance
that is required. This has allowed for the deployment of staff to other duties
within the department.
• An income-generating service level agreement with MedLab pathology was
signed to perform a selection of urgent virology tests. 
• The situation of sending booking bloods for Rubella, Varicella Zoster IgG and
Treponema pallidum (syphilis) to two outside laboratories continued in 2013.
This arose out of historical reasons but requires a re-examination. Of note, there
is no direct electronic link with these outside laboratories, and all data has to be
entered on the computer when the results are received. This situation is being
reviewed as both staff time and resources may be better utilised if these tests
were to be performed on-site.
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TABLE 17: SUMMARY OF VIROLOGY AND SEROLOGY WORKLOAD
Sample types Specimens % Difference Tests 2013 % Difference 
2013 over 2012 over 2012
Tests performed in Rotunda hospital
HIV 11265 -4.03
HbsAg 11269 -3.98
Hepatitis B Core 1922 -23.94
HepC Antibody 4435 -8.54
CMV IgG 1517 -26.61
Hep B core - vidas 12 -85.19
VZ IgG - vidas 7 -92.47
Total in-house 
Virology/Serology 13236 -3.22 30427 -8.05
Tests referred to other laboratories
Rubella 10724 -1.35
Varicella IgG 9568 0
Treponemal tests 9936 +0.15 10223 -0.49
Parvovirus B19 510 58.88
Confirmation and other 
specialist tests referred 
externally (MA) 1052 -2.32
Confirmation and other 
specialist tests referred 
externally 4524 -0.20 10480 +7.07
Total number of 
referred tests 42557 1.57
3.4 Andrology workload
Semen analysis for infertility testing and post vasectomy testing continued into
2013 and was fully accredited to ISO: 15189 in early 2013. Semen analysis for
infertility is by appointment from Monday through Wednesday in the morning,
and for the first time a medical scientist has specifically been assigned to carry out
these tests. In view of accreditation, new forms were designed to facilitate
reporting of results, which has had an adverse impact on turnaround time for
reporting of results. Sample numbers for infertility were up slightly in 2013 (3.71%),
however overall numbers for semen analysis were down by 10.56%, reflecting a
drop in samples for post vasectomy testing.
3.5 Accreditation workload
Work involved in continuation of the ISO: 15189 standards continue to be both
challenging and time consuming. Batch acceptance (Internal Quality Assurance) of
all reagents, media, antibiotics and kits, began in 2012 and continued into 2013. This
is an important part of providing a quality service and although IQA was down
slightly in 2013 from 2012, this does not capture all the work involved. 
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Accreditation also involves updating standard operating procedures (SOPs) on a
continual basis, to ensure that they remain in line with international best practice.
Methods and procedures are forever evolving, requiring validation or verification of
new test methods. New media and/or reagents/kits come on-stream from time to
time and again require validation or verification before they can be employed.
Continual training for non-microbiology on-call staff and other new staff members
or returning staff members from long-term leave is always a challenge. Proficiency
testing and competency testing is an important part of a scientist training log. The
Microbiology department continues to strive towards international excellence and
to this end has ISO: 15189 for nearly 100% of its repertoire of tests and is looking
forward to implementing the new ISO standards for 2012. 
The laboratory was again inspected by INAB in 2013, and continues to enjoy ISO:
15189 Accreditation. 
4. Surveillance
Surveillance of resistant organisms continues to be a major part of the work of the
Microbiology department, on one hand the laboratory processing of the samples
but on the other hand the collection and analysis of surveillance data. Data is
presented to the infection control committee and this data contains information
regarding infection clusters, blood stream infections and antimicrobial resistance
patters. Surveillance data is also presented to the Neonatal Infection Prevention
and Control group to allow for monitoring of the situation in the neonatal
intensive care unit (NICU). The infection control report that has been completed for
the Board will contain the detailed analysis of the surveillance data for the year;
however some key points have been included below:
• Surveillance of the adult blood cultures saw a continuation of contamination
among the positive blood cultures (4.85%), which is slightly up on the 2012
figure (4.15%). Data sharing between the other two Dublin maternity hospitals
began in late 2013 and blood culture numbers and rates of contamination can be
compared.
• During 2013 the rectal screening of patients in the NICU yielded results that
were similar to that of 2012. In 2013 the incidence of each of the resistant
organisms is shown below:
o 24 Gentamicin resistant Coliforms, 
o 14 AmpC producing Coliforms, 
o 6 ESBL producing Coliforms, 
o 10 Pseudomonas spp 
o 75 Candida sp. (Candida screening ceased in December 2013)
• Screening for MRSA continued, yielding a total of 36 positives patients in 2013, 8
of which were in the NICU. These results are similar to previous years and the
Rotunda continues to enjoy low rates of MRSA.
• All cases of bacteraemia due to the organisms of interest as specified in the
Enhanced Antimicrobial Resistance Surveillance System (EARSS) were reported.
In total 14 cases were reported
o 11 E. coli
o 2 Staphylococcus aureus
o 1 Enterococcus. feacalis, 
144
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• A surveillance folder was set up in 2013 on a shared drive and is only accessible by
the Microbiology staff, Surveillance Scientist, Consultant Microbiologist and
Infection control team. This is a database where numbers and rates of positive
blood cultures, MRSA, resistant Gram-negative bacilli and other pertinent data are
kept. It is reviewed on a daily basis and kept up to date by the Microbiology team. 
• A new selective screening agar has been introduced for the neonatal unit to
detect Pseudomonas aeruginosa, a Gram-negative organism which can lead to
septicaemia.
• There were two cases of Clostridium difficile associated diarrhoea in 2013 and
both were community acquired.
• There were 4 positive test results for Norovirus as tested by PCR
5.  Changes in Laboratory Equipment and testing procedures
5.1  Validation of EUCAST
Komal Lakho (Final Year Medical Scientist Student) was given a placement in the
Microbiology department during the spring of 2013. Her final year project was to
validate the EUCAST susceptibility standards against the currently in-use CLSI
standards. This was an extensive piece of work involving the validation of different
agar and susceptibility testing on the Vitek 2 for a number of different
antimicrobials. Komal wrote her thesis entitled: “Validation of EUCAST and
comparison with CLSI in a Clinical Laboratory setting” on this project for which she
was awarded her degree. EUCAST was implemented for clinical testing in late 2013.
5.2  Changes in agar media
MacConkey agar media was replaced with urine chromogenic UTI media and
the number of samples requiring neomycin agar media was reduced. Some agar
media (UTI & MRSA) is now been sourced at an alternative supplier and a much-
reduced cost. All of these changes in agar media has resulted in cost-savings to
the department. New Pseudomonas aeruginosa selective agar was introduced to
improve the turnaround time for screening in the NICU.
5.3  Changes in Urine testing 
A number a small changes occurred on urine testing to improve turnaround
times, reduce waste and be more cost effective. 
o New selective agar was introduced which had a cheaper cost price
o Blood agar was dropped from Catheter specimen urines as it was 
regarded as non-beneficial to the results 
o Urine chemistry dipsticks were dropped from baby samples as it was not
clinically relevant or viable as a testing option
5.4  Chlamydia trachomatis & Neisseria gonorrhoeae Polymerase Chain 
reaction analysis  
The cobas TaqMan 48 analyser for performing molecular testing of both First
Visit Urines and Endocervical swabs for Chlamydia and gonorrhoea was
replaced with the much-improved Cobas 4800 (x and z) analyser. This was a free
upgrade, which allows the scientist to walk away from the analyser once the
samples are on, enabling the scientist to perform other important duties. 
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The cost of performing the tests was halved and the chances of repeating a test on
the specimen is dramatically reduced due to the low numbers of inhibitors present
compared with the older analyser. Also, the analyser is validated for any urine
type, high vaginal swabs, cervical swabs and endocervical swabs. Of note,
turnaround times, have been greatly improved since upgrading to the platform
and the system is now fully accredited to ISO: 15189.
5.5  Blood Culture Reporting times
Blood cultures are now loaded onto the BacT Alert 3D analyser as soon as they reach
the laboratory 24/7. Also, blood culture results are reported negative at 36 hours
instead of 48 hours, allowing the patient to be removed from antibiotics sooner and
freeing up the bed space quicker, having the overall effect of cutting costs.
5.6  Group B Streptococcus screening
All High vaginal swabs are now been screened for GBS using a chromogenic ID
agar. In general if GBS is present it is simply reported and an antimicrobial screen
is not performed, as all GBS are sensitive to penicillin. However, if a susceptibility
result is required, then this can be performed quickly. By not performing
antimicrobial tests on these isolates, this has reduced the use of Vitek 2 cards and
overall spends on these expensive tests.
5.7  New Automated Gram Stain analyser
Gram staining is an important part of a microbiological test and can influence
clinicians on which antibiotic is most appropriate to treat with, particularly
regarding positive blood cultures or cerebrospinal fluids. To help speed up Gram
staining times and improve Gram-staining results, an analyser was sourced by
tender. The Gram stain analyser that was chosen was purchased on a reagent deal
and so was cost neutral. Since its introduction it has greatly improved staining
results particularly from non-microbiology on-call staff.
5.8  Medibridge Link with NVRL
In 2013 SARI (Strategy for the Control of Antimicrobial Resistance in Ireland)
provided funding for an electronic link with the NVRL for the upload of requests
and download of results. Work on this began in late 2013 and it is hoped that after
a validation process it will go live in early 2014. This will improve turnaround times
for referred tests to the NVRL and reduce the time need to report these results. 
6.  Summary
2013 has been a good year for the Microbiology department with some key
improvements made, particularly around the area of screening and surveillance.
New agar for the screening of group B Streptococcus and Pseudomonas aeruginosa
should lead to an overall improvement in the detection of these organisms. The
Medibridge link will improve the turnaround time for tests sent to the National
Virus Reference Laboratory, however a more detailed analysis will be done in 2014
to assess if it is possible to repatriate several serology tests into the routine service
at the Rotunda to reduce the volume of blood required from patients and improve
turnaround times.
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APPENDIX 1. OVERALL TABLE OF TESTS PERFORMED IN THE MICROBIOLOGY
LABORATORY
2013                           2012                      Difference               % 
numbers Change
Tests Specimens Tests Specimens Tests Specimens Tests Specimens
MSU
Microscopy’s 12644 13723 -1079  ‐7.86
MSU Culture 12699 13790  ‐1091 -‐7.91
MSU Dipstick 4 201 -‐197  ‐98.01
Total MSU 25347 12680 27714 13761 ‐2367  ‐1081  ‐8.54  ‐7.86
First visit 8583 8356 8252 8031 331 325 4.01 4.05
Total Urine 33930 21036 35966 21792 2036  756 5.66  3.47
Pregnancy
Tests 152 152 126 126 26 26 20.63 20.63
Blood
Culture (sets) 2868 2868 2509 2509 359 359 14.31 14.31
Placenta 217 217 375 375 ‐158 ‐158  ‐42.13  ‐42.13
Total Blood
Culture 3085 3085 2884 2884 201 201 6.97 6.97
CSF Culture 232 296
CSF Gram 232 293
CSF Cell Count 225 289
CSF Diff 62 54
Total CSF 751 232 932 296 181 64 19.42 21.62
Semen
Volume 1710 1906 ‐196  ‐10.28
Semen Count 1704 1912  ‐208 ‐10.88
Semen
Motility 811 782 29 3.71
Semen
Morphology 4 0 4 100.00
Total Semen 4229 1710 4600 1912 371 202  8.07  10.56
CT PCR 2913 3109  ‐196  ‐6.30
NG PCR 2854 3094 ‐240 ‐7.76
Total PCR 5767 2913 6203 3109 436  196  7.03  6.30
IQA 843 843 926 926  83  83  8.96 8.96
MRSA 5326 2663 5720 2860 ‐394  ‐197  ‐6.89  ‐6.89
Rectal 12932 3233 14716 3679  ‐1784  ‐446 ‐12.12 ‐12.12
Total Screens 18258 5896 20436 6539 2178 643 10.66  9.83
Swabs 19762 9881 20412 10206  650  325  3.18 3.18
Sensitivities 2028 2254 226 10.03
Total 88805 45748 94739 47790 5934  2042 6.26  4.27
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INTRODUCTION
Infection control is about ensuring the safety of patients and their families that that
attend our hospital. This is achieved by maintaining an effective programme for the
prevention of hospital acquired infections and the containment of infections
brought into the hospital by staff visitors or patients in line with Health
Information and Quality Authority (HIQA) standards. The core Infection Prevention
and Control  Team (IPCT) comprises a Consultant Microbiologist (CM), 1 WTE
Assistant Director of Midwifery/Nursing (Infection Prevention and Control) and 1
WTE Infection Prevention and Control Midwife/Nurse Specialist (both referred to as
IPCM/N). The IPCM/N visits all clinical areas daily and participates in ward rounds
in the Neonatal Unit once/twice weekly and as required. The CM participates in
ward rounds in the Neonatal Unit on a weekly basis and more often when required
as well as other areas where indicated.  The IPCT liaises daily with the Microbiology
departmental staff and the CM.    
Meetings of the Infection Prevention and Control Committee
Formal meetings of the Infection Prevention and Control Committee take place
quarterly and also as required. The Terms of Reference for this Committee were
reviewed and key performance indicators identified. Progress on these will be
presented to the committee at each meeting. Much additional work relating to
Infection Prevention and Control was progressed through the Property Committee, the
Quality and Safety Committee, the Hygiene Services Committee the Neonatal Infection
Prevention and Control Working Group and the Decontamination Committee. 
INFECTION PREVENTION AND CONTROL PROGRAMME FOR 2013
The Infection Prevention and Control programme for 2013 included the following:
Education 
Monthly in service education programmes for midwifery and nursing 
staff were undertaken by the IPCMs in collaboration with others e.g., 
Decontamination Co-ordinator, Occupational Health, Infectious Diseases 
Liaison Midwife, and Health and Safety.
•   Hand Hygiene
•   Standard Precautions
•   Aseptic non-touch technique
•   Transmission Based precautions
•   Blood/body fluid exposure awareness and management
•   “Sharps” injury awareness, prevention and management
•   Use of Personal protective equipment 
•   Segregation of waste and clinical waste management
•   Management of laundry
•   Decontamination of patient equipment
•   Decontamination of Reusable Invasive Medical Devices
•   Prevention of mother-to-child transmission of blood-borne viruses
•   Management and prevention of Influenza
I N F E C T I O N  P R E V E N T I O N  A N D  C O N T R O L
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Hand hygiene Education
Improving hand hygiene compliance for healthcare workers remained a priority for
the hospital. It is recognised as the key component in the prevention of healthcare
associated infections.
An application to the HSE DNE HCAI AMR Committee for funding for a Sure Wash
machine was successful. This is a mobile hand hygiene training unit.  It uses camera
and game technology for training and assessment of hand hygiene education,
according to WHO hand hygiene protocols. Having successfully completed training
on the unit it is possible using employee ID numbers to record the training.
Education sessions were offered to all new staff at induction, at the monthly in
service days for midwifery and nursing staff at the breakfast meetings for
consultants and for non consultant hospital doctors  and on visiting clinical
areas. Open days were held for all on two occasions (in May and September). Here
staff members were educated about the WHO 5 moments for hand hygiene and
given demonstrations on the correct technique for performing hand hygiene.
They were also assessed on their technique using the ultraviolet “glo germ box”
and using the Surewash machine.
In March 2013 the HSE launched a programme for hand hygiene on their e-
learning platform HSELanD. Initially all staff in the hospital were encouraged to
log on and use this facility. From November 2013 new staff members have to
complete this programme before commencement of employment. 
Records of staff attending hand hygiene education are maintained with the
support of the HR department. Non attendees can be identified and targeted.
Since November 2013, following a request from the National Director for Quality
and Patient Safety a report is returned to the Regional Director of Performance
and Integration. This is a monthly report of two indicators namely 
• % of new healthcare staff that have received mandatory induction hand 
hygiene training.
• % of existing healthcare staff that have received mandatory hand 
hygiene training within the last two years. 
REPORT MONTH / YEAR DEC-13
For new staff: % healthcare staff that have received 
mandatory induction training hand hygiene training 75%
For existing staff: % current healthcare staff that 
have received mandatory hand hygiene training in the last 2 years 85%
Hand Hygiene Audits
Hand hygiene audits are carried out throughout the Hospital on a regular basis in
all departments; in the NICU audits take place twice per month. During 2013 it
was agreed to increase the frequency of audits done in the Delivery Suite. To
facilitate this one midwife from the department attended a training day on hand
hygiene auditing. Following this audits this midwife did education with staff and
internal audits. These audits have shown an increase in hand hygiene compliance
in Delivery Suite from 80% in May to 93% in October. 
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As part of the National hygiene audit, during the months of June and October 2013,
the IPCMs were required to measure healthcare worker compliance against 30
hand hygiene opportunities for each of seven randomly selected wards, resulting
in 210 opportunities per hospital.  
The WHO methodology for undertaking hand hygiene observational audits was
used.  Healthcare workers were observed for their compliance against the WHO '5
moments of hand hygiene':
The HSE set a target of achieving >90% compliance in 2013.
The compliance rate was 87.6% in June and 89% in October.
Multimodal plan
In October 2013 the National Director for Quality and Patient Safety requested the
development of a multimodal hygiene programme for the hospital. This was
developed by the IPC team and approved by the IPC Committee. It was based on
the WHO multimodal programme and was inclusive of hand hygiene and
hospital/hygiene standards. There were 42 quality improvement plans (QIP)s
developed which addressed areas of non compliance. A progress report on the
status of implementation of the QIP is required by the end of March 2014.
Auditing of decontamination of medical equipment 
Auditing of medical equipment in clinical areas continued in 2013. Ward managers,
infection control link midwives and care assistants are assisting the
IPC/Decontamination team when carrying out the audits. 
High risk areas are audited monthly: Neonatal Unit, Delivery Suite, Emergency
Room, Theatre and CSSD.
All other areas are considered low risk areas and are audited quarterly.
Results are available on a traffic light system and can be downloaded on the
intranet.  These results are presented at Midwife Managers’ meetings and at the
Decontamination Committee Meeting.
Ongoing Surveillance and Audit of Infection with multiple   antimicrobial
resistant organisms 
In line with best practice and in the interests of patient safety, screening for
multidrug resistant organisms (MDROs) including MRSA, VRE, and ESBLs and in
identifiable at risk groups in adults was continued. 
The surveillance screening of infants in the Neonatal Unit for carriage of MRSA or
aerobic Gram negative bacilli resistant to aminoglycosides and/or third generation
cephalosporins was carried out weekly. The findings were reviewed at meetings of the
IPC Team and the Neonatal Unit IPC team, and reported to the IPCC.  In late 2013 it was
decided that only infants admitted to the ICU area of the unit would be screened on
admission and only infants > 7 days old would be screened weekly throughout the Unit.
UNANNOUNCED VISIT
An unannounced HIQA inspection took place on 15th May. HIQA inspectors visited
the hospital to assess compliance with two of the National Standards for the 152
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Prevention and Control of Healthcare Associated Infections namely
Standard 3 – Environment and Facilities Management 
Standard 6 - Hand Hygiene
The two clinical areas inspected were the general prenatal and general postnatal
wards. Overall, the Authority found these areas to be generally clean, with some areas
for improvement identified. They acknowledged the challenges of an older listed
building Paintwork throughout the wards including radiators, walls and skirting
boards required attention. There were no designated “clean” or “dirty” utility rooms.
The findings also reported evidence of good practice in waste segregation, linen
management, and in the management of the cleaning equipment.  
The authority found evidence of good practice in relation to hand hygiene but
reported that a culture of hand hygiene is not yet operationally embedded within all
staff specialties.
The findings in the report back from HIQA were reviewed and QIPs developed that
prioritises the improvements necessary to fully comply with the standards.  The QIP
was published by the hospital on the website within six weeks of publication of the
report, as requested by HIQA.
Antimicrobial Stewardship
Antimicrobial stewardship refers to coordinated interventions designed to improve
and measure the appropriate use of antimicrobials by promoting the selection of the
optimal antimicrobial drug regimen, dose, duration of therapy, and route of
administration.  The antimicrobial stewardship team seeks to achieve optimal clinical
outcomes related to antimicrobial use, minimize toxicity and other adverse events,
reduce the costs of health care for infections, and limit the selection for antimicrobial
resistant strains.
The antimicrobial stewardship team was set up in the Rotunda Hospital in May 2011
and has members from Infection Control, Microbiology, Infectious Diseases and
Pharmacy. The team currently takes part in twice weekly antimicrobial rounds. 
Due to a staff shortage within the Pharmacy Department between April and July 2013
there was no Pharmacist available to contribute to antimicrobial stewardship rounds.
The Pharmacy department contributes antimicrobial consumption data every six
months to a national surveillance system coordinated by the Health Protection and
Surveillance Centre.
In late 2013 the Chief Pharmacist, Microbiologist and Infectious Disease Consultant
developed a business case for an Antimicrobial Pharmacist post. This business case
has been submitted by the Secretary General Manager to the HSE. The principle aim
of the business case is to facilitate the implementation of a robust, multifaceted
Antimicrobial Stewardship Programme to ensure better outcomes and safer care for
women and babies. 
Continuous Professional Development
During 2013 the IPC Team attended relevant master classes, workshops and
conferences. In addition the ADOM graduated from RCSI with an MSc in IPC Nursing
and the CMM finished her Post Graduate Diploma in IPC Nursing
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CONSULTANTS:
DR. MICHAEL GEARY DR. CAROLE BARRY
PROF. FERGAL MALONE DR. FIONNUALA BREATHNACH
DR. SHARON COOLEY DR. RONAN GLEESON
DR. BARRY GAUGHAN DR. KAREN FLOOD
MATERNAL FETAL MEDICINE FELLOW:
DR. JENNIFER DONNELLY
MIDWIFE SONOGRAPHERS:
IRENE TWOMEY    CMS DEIRDRE NOLAN   CMS
GEMMA OWENS  ACTING CMM2 HILDA O’KEEFFE (PERINATAL IRELAND 
RESEARCH SONOGRAPHER)
RADIOGRAPHERS:
MABEL BOGERABATYO MARIE FINNERTY
FIONA CODY (PERINATAL IRELAND RESEARCH SONOGRAPHER)
FETAL MEDICINE MIDWIVES:
NOLLAIG KELLIHER CMM2 JANE DALRYMPLE CMS
JOAN O’BEIRNES S/M LAURA MCBRIDE S/M
MARY DEERING CMM3  ANTENATAL INPATIENTS, DAY SERVICES, 
INCORP. FETAL MEDICINE
MEDICAL SOCIAL WORKER:
DEIRDRE KEEGAN SINEAD DEVITT
ADMINISTRATION
ANITA O’REILLY SUZANNE LARKIN MARY MAGUIRE
2013 was another busy year in the Ultrasound, Fetal Assessment (FAU) and
Prenatal Diagnosis (PND) clinics. 
The core ultrasound services in The Rotunda Hospital in 2013 were provided by
midwife sonographers Irene Twomey, Deirdre Nolan, Gemma Owens, Hilda
O’Keeffe and radiographers Marie Finnerty and Mabel Bogerabatyo and Fiona
Cody. Once again their dedication, hard work and commitment are recognised.
All patients are offered a departmental fetal anatomic survey at 20 weeks. Serial
scanning services were provided for patients attending the Diabetes, Twin and
Medical Clinics. Non routine or emergency ultrasound requisitions are
accommodated in addition to the scheduled workload.  
Fiona Cody and Hilda O’Keeffe of Perinatal Ireland contributed enormously to
the FAU this year. A total of 906 scans were performed.
U LT R A S O U N D, F E TA L  A S S E S S M E N T  &
P R E N ATA L D I AG N O S I S  C L I N I C S
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Mary Deering has been CMM3 for Antenatal Inpatients and Day Services,
incorporating Fetal Medicine since 2011. 
DEVELOPMENTS IN 2013
3 New E8 Ultrasound Machines were purchased for the unit.
CMS Irene Twomey and Radiographer Mabel Bogerabatyo commenced their
Masters in Ultrasound.
Dr. Jennifer Donnelly completed her fellowship in Feto-maternal medicine.
Radiographer Marie Finnerty emigrated  - We wish her well.
NUMBER OF OBSTETRIC SCANS
20 Week Scan Fetal Anatomic Survey 8,958
Growth Scan 7,735
Echocardiogram  179   
Others 1,296
NUMBER OF GYNAECOLOGICAL SCANS 1,514
Total 19,682  
FETAL ASSESSMENT UNIT
Dr. Gleeson, and Dr. Gaughan with CMM2 Nollaig Kelliher, S/M Joan O’Beirnes and
S/M Laura McBride provided longitudinal follow up for women with high risk
pregnancies in the Fetal Assessment Unit. This was a diverse group of patients
including women with obstetric cholestasis (67), preterm pre-labour rupture of
membranes (17), IUGR (64), multiple pregnancies (92) and breech presentation (71).
Fetal biometry, biophysical score (409), CTG (846) and serial laboratory evaluation
facilitated outpatient management.  Altogether there were 1,838 attendances.
PRENATAL DIAGNOSIS CLINIC
In 2013 1,469 new patients attended for Prenatal Diagnosis.  Drs. Geary, Barry,
Breathnach, Cooley, Flood and Prof. Malone with CMS Jane Dalrymple, CMM2 Nollaig
Kelliher, S/M Joan O’Beirnes and S/M Laura McBride operated 7 clinics per week.
There were 3,628 attendances as some patients were followed longitudinally. All
patients had an ultrasound scan.  In addition the following tests were performed:
Combined First Trimester Screening 1,151
Second Trimester Screening (Intmark) 52
Amniocentesis 163
Chorionic Villus Sampling 105
Of the 268 diagnostic procedures performed, there were 58 abnormal results
representing 21.5% of invasive tests.
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Abnormality CVS Amnio Total
Trisomy 21 8 11 19
Trisomy 18 7 9 16
Trisomy 13 1 2 3
45X 5 1 6
Triploidy 1 1 2
Mosaic 1 1 2
Translocation 2 2 4
Deletion 0 1 1
22q1.1 Microdeletion 0 1 1
Sickle Cell 1 0 1
CPS1 Deficiency 1 0 1
Ring Chromosome 0 1 1
COL2A1 Mutation 1 0 1
Total 28 30 58
Failed Culture 0 1
.4%
43 invasive procedures other than amniocentesis or CVS were performed. 
These included: 
Fetal Bladder Shunts 3
Cordocentesis 9
Intrauteine Transfusion 11
Laser Ablation (see Note Below) 20
Total 43
Dublin Fetal Surgery Group:
Since 2010, the fetal surgical teams at the National Maternity Hospital Dublin,
and the Rotunda Hospital Dublin have collaborated jointly for the management
of all cases of twin-to-twin transfusion syndrome referred to either centre. This
has resulted in a single team approach to all such cases, regardless of which of
the two hospital locations at which such patients are seen. Professor Fergal
Malone, Professor Fionnuala McAuliffe and Dr Stephen Carroll jointly perform
all such procedures.
During 2013, a total of 20 cases of severe TTTS were managed by the Dublin Fetal
Surgery Group by means of fetoscopic laser ablation of placental vessels. By the
end of 2013, our group had completed 102 cases of laser surgery for severe TTTS,
with at least one survivor occurring in 75% of cases (76/102). These results are in
line with international published experience for this complex condition.
This approach to a complex, but relatively rare, fetal problem is an excellent
example of a joint collaborative management strategy that successfully
optimises care for these patients. Patients are currently referred from obstetric
units throughout Ireland for fetoscopic laser ablation and, where appropriate
expertise is available, patients are referred back to their original obstetric centre
for subsequent fetal surveillance and delivery. It is hoped that, as referral
pathways become more established, the number of cases of fetoscopic laser
ablation will increase further156
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Major Fetal Structural Abnormality:
Excluding soft markers and chromosomal abnormalities, 210 cases of major
structural abnormalities were detected and followed.  These include:-
Cardiac 44
CNS 42
Renal 43
Abdominal/GIT 8
Skeletal 22
Multiple 15
Head / Neck incl. Cystic Hygroma 7
Cleft Lip & Palate 5
Thoracic 11
Hydrops 2
Amniotic Band 4
Conjoined Twins 1
Teratoma 2
Other 4
Total 210
Targeted fetal echocardiograms were performed in women deemed high risk
according to a specific departmental protocol or where a routine structural scan
was suspicious for a cardiac abnormality.  Dr Fionnuala Breathnach performed the
majority of fetal echocardiograms. A total of 179 targeted fetal echocardiograms
were performed within the Department in 2013, with 44/179 (25%) cases having
confirmed structural congenital heart disease. 
Where fetal congenital heart disease was identified or suspected, women were
seen at our Combined Fetal Cardiology clinic based at the Coombe Hospital, staffed
by Consultant Paediatric Cardiologist Dr. Orla Franklin and by consultants in
Maternal Fetal Medicine Prof. Sean Daly and Dr. Fionnuala Breathnach.  
Established in 2009, this collaborative clinic offers a seamless transition from
prenatal to neonatal care for infants diagnosed in-utero with congenital heart
disease.  This approach allows for individualized care, to include prenatal
counseling and formulation of delivery and perinatal care plans. This clinic
continues to expand, and caters for referrals from all maternity units in Ireland.
In November 2013, the Irish Congenital Heart Foundation was established by Drs
Franklin, Daly and Breathnach. A National Fetal Echocardiography meeting was
convened in Carton House, Maynooth and was attended by physicians and
sonographers from across the country. This study day comprised a series of talks in
addition to live scanning sessions and was hugely successful. 
In 2013, 317 patients were referred for targeted fetal echocardiogram at our
combined service. 
The table below illustrates the group of patients seen at the Combined Fetal
Cardiology clinic in 2013 who had a prenatal diagnosis of a fetal cardiac
abnormality, and therefore includes patients who delivered in the Coombe
Hospital, and those referred from other hospitals.
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Multiple Pregnancy:
Sixty five multiple pregnancies were referred to the Prenatal Diagnosis Clinic in
particular high risk circumstances.  These included:
Multiple Pregnancy
Monoamniotic Twins 2
MCDA Twins 47
TTTS 15/47
Discordant growth 12/47 
Structural anomaly 3/47
Other 17/47
Dichorionic Twins
Discordant growth 7
Structural Anomaly 2
MCTA Triplets 1
DCTA Triplets 4
TCTA Triplets 1
TCDA Triplets Discordant for Growth 1
Total 65
Excludes women undergoing laser therapy for TTTS In the Dublin Fetal Surgery Group
MCDA = Monochorionic Diamniotic;  MCTA = Monochorionic Triamniotic;  
DCTA = Dichorionic Triamniotic;                TCTA = Trichorionic Triamniotic
Additional Cases Followed in Prenatal Diagnosis Clinic:
PPROM 1st & 2nd Trimester 3
IUGR (Severe 2nd trimester) 26
Polyhydramnios 7
Oligohydramnios 2
Rhesus 3
Antibodies 17
CMV 1
Toxoplasmosis 2
Parvovirus 18
Soft Marker Normal Outcome 24
High Risk Screen Normal Outcome 58
Total 161
Major Cardiac Lesions seen at Combined Rotunda-Coombe Fetal Cardiology Clinic:
Cardiac Lesion 2011 2012 2013
Atrioventricular septal defect/ VSD 20 28 38
Hypoplastic left heart syndrome 12 7 14
Hypoplastic right heart syndrome 2 9 6
Outflow Tract Abnormalities 28 11 23
Isometric Heart Lesions 3 2 5
Arrythmia 11 11
Others 4 8 6
Total 69 76 104
We estimate that two-thirds of infants born with single-ventricle physiology in
Ireland attend our combined service for prenatal consultation.
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DR GERALDINE CONNOLLY
DEBORAH BROWN RM
Antenatal care is provided to all teenage pregnant mothers up to age 17 in the
Rotunda hospital in the teenage pregnancy clinic.  Girls who are older and
deemed vulnerable, such as those with special needs, may also attend the clinic
as we feel they may benefit from continuity of care. Comparative figures for the
past 7 years for the clinic are presented.
Number booked
2007 120
2008 132
2009 145
2010 116
2011 124
2012 110
2013 112
Primiparous Multiparous
2007 113 7
2008 123 9
2009 131 6
2010 109 7
2011 115 9
2012 100 10
2013 98 14
Onset of Labour
Spontaneous % Induction %
2007 72 26
2008 70 30
2009 68 30
2010 69 27
2011 66 24
2012 68 31
2013 66 33
Mode of Delivery %
SVD Instrumental C Section C section 
Emergency No labour
2007 64.7 20.7 12 2.6
2008 59.8 28.8 11.4 0
2009 64.2 23.3 10.9 1.6
2010 58.4 19.7 17.9 3.7
2011 63.6 20 10.9 5.5
2012 61.1 21.3 15.5 1.9
2013 62 23 15 1
T E E N A G E  P R E G N A N C Y  C L I N I C
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Epidural rates %
2007 78.5
2008 71
2009 74.4
2010 66.3
2011 68
2012 66
2013 72
Premature delivery % low birth wt %
2007 5.8 3.3
2008 7.8 6.8
2009 7.6 6.5
2010 4.7 2.8
2011 7.3 9.1
2012 2.9 4.8
2013 2 3
Chlamydia positive (%) Third degree tear (n)
2007 15 1
2008 6.4 1
2009 16 3
2010 12.2 3
2011 9.6 3
2012 14.1 2
2013 9.6 4.8
Adverse baby outcome (n)
intrauterine neonatal
2007 0 1
2008 1 0
2009 2 2
2010 0 1
2011 0 2
2012 0 1
2013 0 0
Attendance at
Antenatal Classes % Postnatal Clinic (%)
2007 52 50
2008 66 67
2009 55 37
2010 48 48
2011 54 41
2012 45 55
2013 40 49
160
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Comment
The caesarean section rate in the teenage population is 16% which is
significantly lower that the overall hospital population.  Two patients attended
the pre-natal diagnosis clinic. One had transposition of the great vessels and was
delivered liveborn at 37 weeks.  The other had non-specific abnormalities noted
at the anatomy scan with a normal amniocentesis.  She spontaneously laboured
at 22 weeks and declined post mortem.  
Attendance at the postnatal clinic was less this year and we hope to improve
this. We inserted a mirena IUS into 24% of those who attended.  Breast feeding
was initiated in 32%.   Chlamydia positive rate was 9.6% somewhat less than last
year. Two percent had premature deliveries. Three babies weighed above 4.5Kg
and 3 babies had IUGR at term.
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DR. JOHN SHEEHAN
MS. KATHLEEN O’DONOHOE
MS. LOUISE RAFFERTY
2013 was another busy year for the Mental Health Service in the Rotunda.  151
new patients were seen by D. Sheehan as well as 208 review patients in the Out-
Patient Clinic.  The Support Midwives saw 513 patients in the Health Promotion
Clinic and 1629 patients on the wards.  Pre-pregnancy counselling was offered as
well as assessment and management of perinatal mental health problems. The
midwives and Dr. Sheehan also provided a telephone consultation service
mainly to GP’s and Public Health Nurses acting as a resource for information and
services.
In April, a new Perinatal Mental Health referral form was introduced.   In June,
Ms. Louise Rafferty had an article published in Practicing Midwife on perinatal
mental health. 
Lectures were provided to doctors, medical students and midwifery students.
Training and education was provided to midwifery interns and midwives. 
Dr. Sheehan started a monthly CPD meeting for the perinatal mental health
team in 2013.
M E N T A L  H E A L T H  S E R V I C E S
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DR FIONNUALA BREATHNACH Consultant Obstetrician, 
Maternal-Fetal Medicine Specialist
DR MARIA BYRNE Consultant Endocrinologist
DR SIOBHAN BACON Specialist Registrar, Endocrinology
DR SAAD ABDULGHAFOUR Research Registrar, Endocrinology
MS JACKIE EDWARDS CMM Specialist Diabetes Midwife
MS AILEEN FLEMING Specialist Diabetes Midwife
MS CLAIRE KEARNEY Specialist Diabetes Midwife
MS LAURA HARRINGTON Senior Dietician
MS CARLA MORALES Lead Midwife for Midwifery-Led 
Gestational Diabetes Service
MS AILBHE MCCARTHY CNM1 Research
INTRODUCTION:
The Combined Obstetric Endocrine service for care of women with Diabetes
Mellitus continues to represent one of the highest-risk areas of clinical care in
this hospital. The population with pregestational type II diabetes continues to
grow, and the extent to which each subgroup with diabetes (type I, type II and
gestational diabetes) contributes to the population whose prenatal care is
conducted through this clinic is illustrated in Figure 1:
FIGURE 1: Women attending Combined Obstetric Endocrine Service 
2007-2013
C O M B I N E D  O B S T E T R I C - E N D O C R I N E
S E R V I C E  F O R  D I A B E T E S  M E L L I T U S
Recognition of the expanding numbers in the GDM/ IGT category, and of the
high-risk nature of our group with pre-existing diabetes, led to a decision in 2012
to establish a new model of care for this service. This model involves monitoring
and surveillance for diet-controlled GDM/ IGT in a midwifery-led service, with
obstetric care for these women being provided through routine antenatal clinics. 
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Attendance at the Combined Obstetric Endocrine clinic is only required for
women with pregestational diabetes (type I or type II) or with gestational
diabetes who require therapy beyond diet. Women with a history of gestational
diabetes in a prior pregnancy attend the midwifery-led unit for regular
surveillance from the first trimester of pregnancy; again with transfer to the
Combined Obstetric Endocrine service only in the event that gestational diabetes
is confirmed and is not adequately responding to dietary therapy.
A prospectively-conducted audit of the new model of care, comparing perinatal
outcomes in a consecutive cohort of diet-controlled GDM women attending the
consultant-provided Combined Obstetric-Endocrine service in 2009 with those
attending the new midwifery-led model of glycaemic surveillance has
demonstrated the following favourable outcomes, that indicate that this model
offers a safe alternative to attendance at the combined clinic (See table 1).
Furthermore, women attending the midwifery-led clinic have shorter waiting
times and report high levels of satisfaction with this strategy. Reserving the
Combined Obstetric Endocrine clinic for those with high-risk pre-existing
diabetes or insulin-dependent GDM also allows for closer maternal and fetal
surveillance for those patients at highest risk for adverse perinatal outcome.
TABLE 1: Perinatal Outcome among a prospectively-recruited cohort attending
the Combined Obstetric Endocrine Service (CLC) (2009) and a Midwifery-led
Glycaemic Surveillance Service (MLC) (2012):
Outcome MLC (%) CLC (%) p value
N 116 109
Mode of Delivery
Vaginal 77 (66.4) 58 (53.2) 0.044*
Caesarean 39 (33.6) 51 (46.8)
Elective 26 (22.4) 41 (37.6) 0.14
Emergency 13 (11.2) 10 (9.2)
Deaths
Stillbirth 1 (0.9) 0 1.00
Neonatal Death 0 0
Shoulder Dystocia 0 0
Admission to NICU 15 (12.9) 19 (16.4) 0.23
Birthweight-gm (SD) 3436 (±664) 3440 (±565) 0.60
>98th for Gestation and Gender 18 (15.5) 9 (7.8) 0.09
<9th for Gestation and Gender 6 (5.2) 1 (0.9) 0.12
Congenital Anomalies 4 (3.4) 3 (2.6) 1.00
SCREENING FOR GESTATIONAL DIABETES:
The Rotunda was not in a position to introduce the IADPSG guidelines on
screening for gestational diabetes, which endorse the criteria for diagnosis of
GDM that were used in the HAPO study, until these changes in the structure of
the clinic were introduced. These proposed thresholds for identification of GDM
would be expected to translate into a vast expansion in the number of women
who are conferred a diagnosis of gestational diabetes. The vast majority of such 
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women have minor degrees of carbohydrate intolerance, which should be
managed with dietary modification and exercise advice. Unfortunately,  the
Rotunda has one dietician on staff, and this group feels strongly that without any
provision of the resources that would be required to provide dietary consultation
and glycaemic surveillance to an additional 30% of our obstetric population, it
would compromise our existing high-risk Diabetes population if our resources
were to be spread over a wider and lower risk group. Introduction of the new
IADPSG thresholds for diagnosis of GDM proceeded in February 2014 and the
impact of this change will therefore not be reflected in this year’s report.
We are hopeful in the future that resources may be provided to allow the women
with more minor degrees of carbohydrate intolerance to avail of tailored specialist
dietetic consultation and self-glucose monitoring in pregnancy, which is widely
recognised as representing the optimal standard in pursuit of glycaemic control.
Unfortunately in 2013 the HSE withdrew temporary long-term illness card
coverage for the diagnosis of gestational diabetes, such that women who develop
GDM and require insulin must now self-fund insulin, glucometers and glucose-
strips. These costs render the condition unaffordable for a large proportion of our
patient population.  This team is advocating strongly for the HSE to reverse this
decision and invest in maternal-fetal health for substantial long-term gain.
TABLE 2: Pregestational Diabetes: Maternal Characteristics
TYPE 1 TYPE II
N 19 31
Age 30.2 ± 6.9 34.1 ± 4.7
DM duration (yrs) 15.3 ± 7.0 4.3 ± 4.3
DM Complications: (Expressed in ongoing viable pregnancies)
•Chronic hypertension 1/16 (6%) 2/21 (10%)
•Retinopathy 3/16 (19%) 2/21 (10%)
•Nephropathy 1/16 (6%) 2/21 (10%)
•Neuropathy 1/16 (6%) 0
Preeclampsia 1/16 (6%) 1/21 (5%)
Gestation at booking 9.0 ± 7.7 7.9 ± 3.4
HbA1c at booking/IFCC 65 ± 17 49 ± 14.3
HbA1c at delivery/IFCC 47 ± 8.0 41 ± 9.0
Fructosamine at booking 357 ± 59 240 ± 52
Fructosamine at delivery 228 ± 25 186 ± 23
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TABLE 3: Pregestational Diabetes: Perinatal Outcome
TYPE 1 TYPE II
N 19 31
Spontaneous Fetal Loss (<24 weeks) 3/19 (16%) 10/31 (32%)
Preterm delivery 24+0 – 36+6 weeks 9/16 (47%) 3/19 (15.8%)
Liveborn 13/16 (81%) 21/21 (100%) 
2 sets twins
Stillbirth 0 0
Neonatal death 1 (See Case Study #1) 0
Delivered Elsewhere 3 (16%) 2/19 (11%)
Caesarean Delivery 10/13* (77%) 13/19* (68%)
Gestational age at delivery 36.9 ± 1.5 37.4 ± 3.0
Birthweight (g) 3400 ± 800 3200 ± 800
Macrosomia ≥95th centile 
for gestational age 3 (23.1%) 2 (9.5%)
Shoulder dystocia 0 0
Major congenital anomaly 0 0
*Ongoing viable pregnancies delivered at the Rotunda
TABLE 4: Gestational Diabetes (GDM) And Impaired Glucose Tolerance (IGT):
Diet-controlled Diet-controlled GDM/ IGT
GDM IGT ON INSULIN
N 133 139 164
Age 33.7 ± 5.0 32.5 ± 4.9 33.9 ± 4.7
Gestational age at delivery 38.4 ± 2.9 38.9 ± 2.0 38.1 ± 2.0
Birthweight (g) 3440 ± 700 3430 ± 600 3390 ± 680
Caesarean delivery 47/119* (39%) 53/132* (40%) 79/155 (51%)
Stillbirth 1/119 (1%) (See 0 0
case study #2)
Spontaneous fetal loss <24 N/A N/A N/A
weeks 6 1
Delivered Elsewhere 10/133 (8%) 7/139 (5%) 9/164 (6%)
Preeclampsia N/A** 6 (4.3%) 3 (2.2%)
Macrosomia ≥95th centile 14 (11.9%) 17 (12.8%) 16 (9.8%)
for gestation
*Ongoing viable pregnancies delivered at the Rotunda
**Preeclampsia rate for women with GDM is not available
CASE STUDY 1:
31 y.o. Para 1+0. Type I diabetes mellitus for 15 years with known diabetic
nephropathy. Registered for prenatal care with the Combined Obstetric Diabetes
service at 5 weeks’ gestational age. IFCC at booking 71mmol/mol, fructosamine
368. IFCC at delivery 50mmol/mol, fructosamine 233. Acute placental abruption
at 36+3. Birthweight 2.84kg. Neonatal death on day 1 of life. Post mortem
findings: Severe hypoxic ischaemic encephalopathy due to placental abruption.
CASE STUDY 2:
32 y.o. Para 1+0. Previous GDM 2011 (GTT  7.1/14.3/9.1/7.5). Fetal anatomic survey
demonstrated occipital encephalocele and ventriculomegaly. Delivered at 23+4
following fetocide in another jurisdiction. Birthweight 550g.
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LAURA HARRINGTON, RD, MINDI- SENIOR DIETITIAN
In 2013 the dietitian held a total of 1083 patient visits; 671 new patients and 412
reviews. This decrease in activity from 2012 reflects the decrease in overall hospital
activity. The types of patients cared for can be classified in the table below:
Referring Service New Patient Follow-up Percentage Total Patient
Visits (in- Patient of Total Patient
and visits Patient visits
outpatients) (in-and Visits
outpatients)
Antenatal 163 69 21.4%
Diabetes 448 272 66.5 %
Gynaecology 16 10 2.4 %
Neonatology/Paeds 39 58 9.0 %
Postnatal 5 3 0.7 %
TOTAL 671 412 1083
The majority of dietetic referrals are for the following conditions:
. Antenatal: Overweight or obesity, maternal underweight, poor weight gain,
hyperemesis, multifoetal gestations, anaemia, history of eating disorder, 
Crohn’s disease and other conditions that impact on nutritional status 
• Diabetes: Gestational diabetes, type 1 and 2 diabetes in pregnancy and 
impaired glucose tolerance
• Gynaecology: Polycystic ovary syndrome and infertility linked to 
overweight/obesity or underweight
• Neonatology/Paeds: Poor weight gain, faltering growth, food 
intolerances and allergy
• Postnatal:  Poor wound healing, underweight and low intestinal transit
time (IBS/incontinence).
Diabetes referrals continue to dominate the dietetic service. The percent of the
total patient case load dedicated to diabetes has risen by 7.4% in the last 5 years.
To manage this increased demand, the dietitian set up multi-disciplinary group
education sessions for patients newly diagnosed with gestational diabetes.
The dietitian also gives presentations in the antenatal classes up to twice weekly
and presents to midwifery staff in diabetes study days yearly. 
Links are maintained with the dietitians at The Coombe Women and Infants
University Hospital and The National Maternity Hospital to create best practice
guidelines, contribute to the National Clinical Guidelines, create and update
patient education materials and encourage continuing professional education.
The current level of activity in the department does not reflect the true demand
for dietetic services. However, the dietitian endeavours to provide a quality
service within the confines of limited staffing resources. 
C L I N I C A L  N U T R I T I O N
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DR MARY HOLOHAN
At the Epilepsy Clinic in 2013 there were 128 patients seen.  For all of the patients
a delivery plan was determined and if on treatment, medication  optimised in
conjunction with the Epilepsy Specialist Nurse.  Monitoring of the therapeutic
drug levels especially has significantly assisted in patient care.  
During 2013, 106 of these patients delivered in the Rotunda Hospital with 2
patients transferring care to other unit in late pregnancy. 49 had not required
anti-convulsant treatment for some time before pregnancy and 41 patients
needed anti-epilepsy drug treatment for the duration of the pregnancy.  6
patients had discontinued treatment shortly before this index pregnancy
remaining symptom free during the pregnancy. 2 patients had first seizure during
this index pregnancy with 1 starting treatment (Levetiracetam). Seizure activity in
8 patients were associated with use of Benzodiazepines.
There was 8 complications in the group of 49 patients not on treatment. There
were 2 deliveries at 26 - 27 weeks. There were 3 cases of significant fetal growth
restriction.  APH requiring emergency delivery at term occurred in two cases. One
baby had an X linked chromosomal abnormality. 3 patients had uncomplicated
twin pregnancies.
Of the 41 patients on anti-epilepsy treatment regimes throughout pregnancy, 28
were on mono-therapy,10 required 2 medications and 3  patients were on 3
medications.  (One of these patients had an uncomplicated pregnancy on
Carbamazepine for neuralgia.) Prior to pregnancy, a patient had vagal nerve
stimulator in addition to medication - this was inactivated for the duration of
gestation.  2 of the patients had monotherapy with SodiumValproate and one
patient was on a combination of Valproate and Carbamazepine. 
There were 9 pregnancy complications in patients using anti-epilepsy
medications
- Tetralogy of Fallot on Lamotrigine 
- Ventricular Septal Defect on Lamotrigine 
- Pregnancy Induced Hypertension on Lamotrigine 
- Tachypnoea of Newborn after induction for Cholestasis on Lamotrigine 
- Trisomy 21 on Valproate 
- Preterm Delivery on Valproate 
- Talipes on Lamotrigine and Levetiracetam
- PPH of 2 litres on Valproate and Carbamazepine 
- Post Natal Depression on Levetiracetam 
In 2 patients, epilepsy was a feature of complex neurological conditions requiring
considerable multidisciplinary input. One patient on monotherapy had an
uncomplicated twin pregnancy.
E P I L E P S Y  C L I N I C
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There were no pregnancy complications in the 8 patients whose seizures related
to Benzodiazepine use.
The Irish Epilepsy Association Nurse Specialist, Sinéad Murphy, continues to
attend the Epilepsy Clinic on alternate weeks.  Sinéad had an individual
consultation with each of the patients on anti-epilepsy medications. Changing
from Sodium Valproate is actively encouraged even after first trimester in view of
the developmental challenges now linked to treatment with Valproate. The
support, advice and care plans offered in the clinic have been enhanced by the
appropriate  access by the Specialist Nurse to the electronic patient record of
patients attending Beaumont. The record is updated at patient visits and a
printed summary placed in antenatal notes.
I am very grateful to the neurology service in the Dublin hospitals for their
support in assisting with the care of the patients attending this clinic and in
particular to Professor Norman Delanty and Nurse Specialist Sinéad Murphy.
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MS CINNY CUSACK, PHYSIOTHERAPY MANAGER
The Physiotherapy Department’s mission is to provide patient centred,
innovative and evidenced based care in the management and treatment of
obstetric (pre and post natal), gynaecology and paediatric conditions. Our
current staff compliment of 3.3 WTE.
Health promotion and patient education forms a key part of our women’s health
service. This empowers women to take an active role in their preparation for
parenthood, management of pregnancy related musculoskeletal conditions,
incontinence and promotes participation in a healthy exercise programme not
just for during pregnancy but for motherhood and beyond. There have been 2
new health promotion initiatives in 2013.
THE DEVELOPMENT OF 4 EDUCATIONAL VIDEOS AIMED AT INCREASING
WOMEN’S UNDERSTANDING OF HOW AND WHEN TO DO THEIR PELVIC FLOOR
MUSCLE EXERCISES (PFME).
Early findings from the MAMMI (Maternal health And Maternal Morbidity in
Ireland) show that 1 in 5 women leak urine before pregnancy. During pregnancy,
1 in 3 leak urine and 1 in 2 leak 3 months postpartum. PFME, shown to be
preventative and curative, are recommended as the first line of treatment and
should be taught to all pregnant women (NICE guideline 2013).
In 2013, four self-help educational videos on urinary incontinence (UI) and PFME
were developed in collaboration with Deirdre Daly (Lecturer in Midwifery/HRB,
Research Fellow MAMMI study) in response to awareness that fewer than half
of pregnant women attending the Rotunda Hospital attend parenthood
preparation classes so were not taught formally how to do PFME. The videos are
designed to increase women’s knowledge of PFME and UI and will help women
take more responsibility for managing their continence. These videos will be
released in 2014 and will form part of an ongoing research evaluation of the
effectiveness of physiotherapy interventions. 
PROMOTION OF HEALTHY LIFE STYLE ADVICE FOR MANAGEMENT OF
GESTATIONAL DIABETES MELLITUS (GDM) 
The role of exercise in the management of GDM has been highlighted by the
HSE guidelines 2010 and the benefits of healthy exercises are highlighted in the
‘Exercise in pregnancy ‘Royal College of Obstetricians (RCOG) statement 4 in
2006. 30 minutes of moderate exercise on most, if not all days of the week is
encouraged for women who have no medical or obstetrical risks and is easily
monitored by the talk test. 
In 2013, a new initiative was introduced by the senior dietitian, diabetic nursing
staff and physiotherapy. A multidisciplinary group education session was
introduced for mothers with raised blood sugars or newly diagnosed with GDM.
These classes are now held on a weekly basis with additional input from the
cessation of smoking programme. 
P H Y S I O T H E R A P Y
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URINARY RETENTION GUIDELINES 2013
The urinary retention guideline was updated and published in June 2013. The
guideline was co authored by Mary O’Reilly Practice Development and Cinny
Cusack Physiotherapy manager and authorised by Dr. Mary Holohan.  The
urinary retention patients are reviewed by physiotherapists on the wards and
followed up as outpatients if required. Our role is to increase the patients
understanding of good bladder health, management of bladder retraining with
the use of frequency volume charts, fluid advice and pelvic floor exercises and
bladder emptying techniques.
OBSTETRIC PHYSIOTHERAPY - ANTENATAL 
Preparation for parenthood classes are jointly run with the parent education
midwives. The physiotherapy department gives 3 of the 6 classes.  A total of 4,849
patients commenced the course of parenthood classes in 2013. 
Class 1 promotes a healthy life style during pregnancy. This includes, exercise
guidelines, healthy bladder and bowel advice. How and when to do pelvic floor
exercises, postural and movement advice aimed at reducing back and pregnancy
related pelvic girdle pain.  The management of other pregnancy related
musculoskeletal conditions. 
Classes 2 and 6 deals with coping skills and non pharmacological methods for
managing pain during labour, the role of the pelvic floor during birth. We give
advice on baby handling and the importance of tummy time. Post natal advice
and exercises and relaxation which will improve the women’s well being during
pregnancy.
Early attendance for the class is recommended and any special needs are catered
for on an individual basis. Refresher classes are provided for multigravida mums.
Partners are welcome to attend classes 2 and 6.
INPATIENT POSTNATAL PHYSIOTHERAPY 
7,457 physiotherapy attendances were given to post natal mothers for advice and
exercises, treatment of pelvic girdle pain and mobility issues.  Our focus is on the
high risk mothers who have anal sphincter tears, caesarean section, an operative
delivery , have a baby over 4kg or who have any incontinence.
OUTPATIENT POSTNATAL PHYSIOTHERAPY
The post natal class runs weekly and is open to all postnatal patients up to 8
weeks postpartum. It is an opt in service and 285 patients plus babies attended
the classes held during 2013; an increase of 36 patients from 2012. The aim of the
class is to provide an opportunity for questions, support and advice. We review
the pelvic floor exercises and assess for a diastasis rectus abdominus so that
exercises can be progressed safely to enable the mother return to fitness and so
reduce the risk of future back pain and incontinence.
Patients suffering from post partum urinary and faecal incontinence can self
refer for physiotherapy during the first 6 months postpartum.  However, in the
first 6 weeks, they are encouraged to attend the post natal class.
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CLINICAL AUDIT ON THE PHYSIOTHERAPY MANAGEMENT OF  OBSTETRIC
ANAL SPHINCTER INJURIES. 
A clinical audit was completed and presented at the biannual audit and research
meeting and was awarded first prize. All women who sustained a third/fourth
degree tear are routinely followed up at 2 weeks and 6-8 weeks post natally.
Ongoing treatment is provided to all women who remain symptomatic. We aim to
review these women at 20 weeks gestation in a subsequent pregnancy.
GYNAECOLOGY PATIENTS
The Continence promotion Clinic is led by Dr. Mary Holohan and Cinny Cusack.
This clinic is aimed at providing specialised conservative management to women
suffering from urinary incontinence. The clinic offers a comprehensive
assessment and treatment programme including referral for physiotherapy,
medication, use of pessaries and life style advice prior to consideration for surgery.
Gynae In patients are seen following all major surgery for advice, pelvic floor and
abdominal exercises, management of reducing risk of future prolapse and safe
return to exercise. Patients requiring chest physiotherapy are also referred for
treatment. In 2013 there were a total of 217 patient treatments given, an increase on
91 from 2012. 
PELVIC GIRDLE PAIN (PGP)CLASS
All patients referred to physiotherapy with pelvic girdle pain are triaged based on
their gestation and pelvic girdle questionnaire. Patients are then given an
appointment for the pelvic girdle class or an individual appointment. The aim is to
give an appointment within 2-3 weeks of referral. Significantly urgent patients
may be seen sooner. The class provides advice on ergonomics, management of
activities of daily living, pacing and specific stabilising abdominal and pelvic floor
exercises.  Patients who may require further treatment are triaged through this
class and assessed for use of pelvic support s and walking aids.
There were 1,092 patient referred with low back pain and PGP. 591 attended a PGP
class initially.
PAEDIATRIC PATIENTS
Babies are referred to physiotherapy as inpatients for the following conditions,
Torticollis, Talipes, Erbs and Plagiocephaly. 44 babies were reviewed requiring 55
treatments. Due to current staffing levels we are unable to provide a routine input
into NICU but individual babies are referred for treatment when required .
A further 334 babies were referred as outpatients requiring 870 attendances for the
following conditions: Plagiocephaly and Torticollis 117, brachial plexus injury and
upper limb 15. Talipes and lower limb 96 and developmental delay 106. Treatment
times are limited by space issues due to the high level of gym occupancy for
classes. 
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DEPARTMENT ACTIVITY
In 2013 there were 4,544 outpatient attendances to the physiotherapy
department NOT including the preparation for parenthood classes or the
inpatients seen on the wards. The overall numbers treated in the department
have remained similar to 2012 as we are working at full capacity. 
Manual handling training is now provided by the Physiotherapy manager and
sessions are provided monthly. 
I would like to acknowledge the hard work, enthusiasm and dedication that the
Physiotherapy staff has put in over the past year. The smooth running of this
extremely busy department could not happen without the significant
contribution of the physiotherapy secretary. 
Cinny Cusack. Physiotherapy Manager. 2013
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DR MAEVE EOGAN
Introduction
The Rotunda unit is now one of 6 HSE supported SATUs around the country, with
units established in Cork, Waterford, Mullingar, Galway and Letterkenny. In 2013
the SATU at the Rotunda Hospital provided care for 310 men and women after rape
or sexual assault, a decrease of 8 patients (3%) from 2012.
Most patients (78%) presented within 7 days of an incident of sexual assault, with
9 patients disclosing long-term abuse. Early presentation is optimal in terms of
provision of appropriate care as well as collection of forensic evidence. In 19 cases,
the incident had occurred outside of Ireland. Of the 291 cases where the incident
was reported to have taken place in the Republic of Ireland, 228 of these took place
in Dublin city or county. 12 other counties were also represented in the figures. July
was the busiest month and Monday and Tuesday were equally busy days. We strive
to see all patients as soon as possible after an incident and , in 2013, 98 (32%)
patients were seen between the hours of 9pm and 8.59am, which underpins the
need for a round-the-clock service.  
The age and gender profiles of all patients is shown in Figure 2, the age range was
from 12 to 65 years. Although the remit for the Adult SATU services is for patients
over 14 years, in 2013 the unit provided care for 9 girls less than 14 years. These were
instances where acute care in a paediatric service could not be arranged.
Considerable developments in paediatric services are underway with the
anticipation that such patients can be appropriately accommodated in the future.
112 (36%) patients were students, 93 (30%) were in employment and 101 (33%)
were unemployed. The majority of patients 267 (86%) were single. 251 (81%)
patients reported a single assailant, and 107 (35%) patients reported that the
assailant was a stranger. In 20 cases the alleged assailant was reported to be an
intimate (or ex-intimate) partner, and in an additional 5 cases reported to be a 
S E X UA L  A S S AU LT  T R E AT M E N T  U N I T
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family member.  218 patients (70%) had consumed alcohol in the 12 hours prior to
the assault, 12 units of alcohol being the mean number of units ingested. That
being said, many patients had an imprecise recall of the amount of alcohol
ingested.  41 patients were unsure if a sexual assault had taken place, due to
memory loss associated with alcohol ingestion. 
Emergency contraception (EC) was given to 140 of 200 women seen with 72 hours
of an incident. An additional 6 women received EC after 72 hours, facilitated by
the licensing and availability of a new EC medication (Ulipristal Acetate) which
can be administered up to 120 hours following an incident.  There were a range of
reasons (including previous effective contraception, hysterectomy) why the
remaining patients did not require EC.  All SATU attendees were offered follow-up
screening for sexually transmitted infections.  284 men and women accepted this
offer, but only 160 actually attended for screening. Such low return rates are not
uncommon, both nationally and internationally, and have encouraged continued
provision of routine prophylaxis for Chlamydia at the time of the patient’s initial
attendance. The rates of identification of Chlamydia have fallen precipitously
since the introduction of routine prophylaxis. All patients are also offered a
course of Hepatitis B Vaccination. This policy was introduced in 2009 and I would
like to acknowledge the ongoing support of the ID Services at the Mater
University Hospital. We also offer HIV prophylaxis on-site if required following
risk assessment. In 2013 26 patients received post-exposure prophylaxis for HIV. 
Since 2009 we have been providing care for men and women who have
experienced sexual violence but who preferred not to report the incident to An
Garda Síochána. Of the 310 patients who attended the SATU, 76 (25%) patients
attended without reporting the incident to An Garda Síochána. It is a welcome
development that patients seek care and attention following an incident which
will hopefully have a positive impact on their recovery.
A postgraduate certificate in Sexual Assault Forensic Examination was run by UCD
for doctors aspiring to work in the service. This course provided training in both
adult and paediatric care provision, and educational components were delivered by
many Rotunda SATU staff. There has not been a higher diploma programme run for
nursing and midwifery staff for a number of years now, hopefully 2014 will show
progress in that regard as our service now depends greatly on an appropriately
trained cohort of clinical nurse/midwife specialists. 
51639 Rotunda Clinical Report 2013 301014 v5_Clinical Rep  30/10/2014  11:57  Page 175
Aideen Walsh completed a Masters in Science programme in Advanced
Nurse/Midwife Practice at RCSI. This will provide her with the academic qualification
to develop advanced nursing practice within the SATU. Deirdra Richardson continues
to offer the risk reduction programme to schools in the Dublin area. SATU staffs are
also actively involved in outreach education within Emergency Departments &
General Practice, Mental Health Services, Prison Services, An Garda Síochána and
Dublin Rape Crisis Centre to raise awareness and increase understanding and
recognition and to equip people better to respond to incidents of sexual violence. The
strong Interagency Links that have traditionally existed, particularly with An Garda
Síochána, Forensic Science Laboratory and Rape Crisis Centre were maintained over
this year.  The SATU Liaison group met quarterly during the year.  These meetings are
a valuable opportunity to discuss relevant issues pertaining to SATU facilities and
care and ensure that all staff from the various agencies are aware of changes and
developments, and indeed challenges, as they arise. 
The Annual Interagency Study Day took place in the Pillar Room of the Rotunda in
October 2013. This was attended by delegates from a range of agencies involved in
taking care of men and women after sexual violence. We were particularly pleased
to welcome our colleagues from Northern Ireland who showcased their recently
opened state of the art combined facility for both adults and children. This is a
model of high quality, responsive and patient focussed care we should aspire to.
We acknowledge both the Manuela Riedo Foundation and The Friends of the
Rotunda, the study day would not have taken place without their significant and
much appreciated support. 
As is highlighted annually, the SATU has, yet again, outgrown its physical space. As
a service we are confident that we will be considered for expansion and relocation
in conjunction with any on-site hospital developments.
Similar to every health care setting in this country, we remain limited by both
head count and funding restrictions. As the longest established SATU in Europe,
we continue to be proud of our heritage and ambitious for the future.
Nevertheless, we rely to a significant degree on the support of the Master, Director
of Midwifery, Management and Board of the Rotunda Hospital, and for their
ongoing and unwavering support, even in these times of immense budgetary
restrictions, we are extremely grateful. 
As we continue to negotiate this challenging environment, I acknowledge the
assistance of all SATU staff over the past year. Maintenance of a responsive 24 hour
service was possible throughout the year, due to the dedication of the unit staff. All
staff are extremely committed to providing exemplary care at all times and but for
them the SATU of the Rotunda Hospital would not be a centre of excellence. This
report highlights the significant amount of work done by a small but highly
committed team, and their availability to provide holistic care to patients at a time
of crisis is acknowledged. 
PUBLISHED PAPERS (2013)
Eogan M, McHugh A, Holohan M. The role of the Sexual Assault Centre. Best
Practice & Research Obstetrics and Gynacology 2013;27:47-58.
Walsh A, McHugh A, Eogan M. (2013) Sexual Assault services – an overview. Forum,
Journal of the Irish College of General Practitioners 2013; 30:(6) 48-49.176
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SINEAD DEVITT  (ACTING HEAD MEDICAL SOCIAL WORKER)
INTRODUCTION
In 2013, the Rotunda’s team of social workers continued to provide a comprehensive
social work service to patients, their partners and their families.  Those who used
the service had a broad range of needs and issues of concern.  These included:
bereavement, domestic violence, addiction, relationship issues, mental health
issues, underage pregnancy, the birth of a baby with special needs, child protection
issues, concealed pregnancy, crisis pregnancy and intellectual disability.
The Rotunda’s social work service is exceptionally proactive and broad in its
remit.  It operates from the rationale that addressing problems in a timely
manner can prevent their escalation and can serve to minimise the distress
experienced by patients.  To exploit the potential of preventative interventions,
there is a social worker attached to each of the hospital’s four obstetric teams and
to all the larger specialist clinics and units.  Patients are typically met during
pregnancy so that issues of concern can be identified and alleviated.
FINANCIAL ADVERSITY
Throughout 2013, it was evident that the economic crisis has impacted significantly
on patients and their families.  The cumulative effect of unemployment, budgetary
cutbacks and difficulties in obtaining social welfare support was that many
patients were faced with acute financial hardship.
In 2013, maternity benefit became liable for tax for the first time.  It was announced
in the 2013 budget that child benefit would be standardised for each child.  A higher
rate had traditionally been paid for third and subsequent children.  The
Department of Social Protection announced a restriction of emergency needs
payments, which are given to the less well-off for unforeseen spending needs.
These restrictions affected payments towards purchasing baby-related items and
had a direct impact on many patients attending the Rotunda Hospital.
These restrictions have surely contributed to the increase in calls to the Society of St
Vincent de Paul in 2013.  They reported the number of calls that the charity receives
for financial help has doubled over the last five years.  However, the profile of those
seeking help has radically changed.  Families they now visit include people in low-
paid employment, the self-employed and people in good employment with debts
they can’t handle. 
Official figures also indicate that 10% of the population, and 21% of children don’t
always have enough to eat.  Many pregnant women attending the hospital report
how a lack of financial resources contributes towards their inability to buy suitable
food.  This is very worrying as in utero malnutrition adversely impacts the health of
the fetus and leads to increased risk for future disease.  Also for patients, being
unable to consume a balanced diet, leads to increased rates of chronic diseases, such
as diabetes.
M E D I C A L  S O C I A L  W O R K
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Financial difficulties led to a marked increase in the numbers seeking help and
support from the social work department, both in terms of their money problems
and also in terms of their emotional distress and other associated difficulties. 
DEMOGRAPHICS
Figures from the Economic and Social Research Institute (ERSI) indicate that
despite the recession and a resumption of emigration, Ireland’s population
continues to grow.  In 2013, the number of deliveries in the Rotunda fell to 8,649
compared to 8,846 the previous year.  This reflects the small decline reported by
the ESRI in the number of live births during the past three years.  However, the
Irish birth rate remains the highest within the European Union, some 50% higher
than the European average.  Eurostat projects the Irish population is to increase
from 4.5 million to 6.5 million between 2010 and 2060, a 47% increase. 
Population growth can also be attributed to significant inward migration.  Many
young families and women move to Ireland to find work and contribute to Irish
society.  In 2013, 2,198 foreign nationals delivered their babies in the Rotunda
Hospital, which represented 25% of all the births that year.  These trends help
counteract the possibility of an economically unbalanced, aging population.   
There is evidence that some women may be postponing having children because
of the recession.  The average age of mothers giving birth increased by more than
a year, to 31.9 years, within the last decade.  
Ireland has become an urban society, with 60% of people living in villages, towns
and cities.  The children being born today will accelerate that trend and have
implications for transport, energy, housing, job creation and a variety of social
services.  Long term planning in healthcare, education and housing is therefore
essential. It is important to get this correct to ensure greater equality for the next
generation.
HOUSING CRISIS
In 2013, the number of private rental properties available to rent in Dublin
continued to decrease.  In November 2013, Daft.ie reported that this number had
fallen to about 1,500 whereas there were 6,700 such properties for rent the same
day 4 years previously.  The cost of renting property continued to rise across the
country, and at a quicker rate in Dublin, due to the shrinking number of
properties available.  It is of note that the State has reduced its investment in
social housing over the years and has traditionally relied on the private rented
sector to meet the housing needs of social housing applicants.  Those on the
social housing waiting list, and qualifying for Supplementary Rent Allowance
(SRA), are now often faced with landlords’ reluctance or refusal to accept SRA.
This has had a disproportionate impact on low-income households.  Focus Ireland
reported a rise in families becoming homeless.  At the end of 2013, the charity
highlighted how the number of families becoming homeless in Dublin each
month has increased from 8 to 16.  Many patients attending the Rotunda Hospital
are struggling to find suitable places to live prior to the birth of their baby.  This
is a major source of stress when many families find themselves living in poor,
inappropriate housing conditions or are in danger oflosing their home.
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Indeed, the social and economic changes which have taken place in Ireland over
recent years have given rise to many challenges for patients attending the hospital.
This has led to an increase in the number of referrals to the social work department
and has rendered the nature of our work more complex and varied.  The following
reports of social work involvement in the hospital’s specialist clinics and units
during 2013 provide a summary of the services offered by the department.
TEENAGE PREGNANCY CLINIC
In 2013, there were 113 deliveries to teenagers booked into the Teenage Clinic.  This
included 30 deliveries to teenagers who were 16 and 15 years of age.  In these cases,
a referral was always sent by the medical social worker to the appropriate HSE Child
and Family Service.  Where abuse is not suspected or alleged, but the girl or boy is
underage, the HSE will still work with An Garda Siochana to explore the young
woman’s circumstances.  They acknowledge the sensitivity required in order to
facilitate a young mother availing of all necessary services, while at the same time
satisfying relevant legal requirements.  The medical social worker also continued to
meet teenagers aged 18 or 19 who required additional support, whereas traditionally
the Teenage Clinic was for adolescents aged 17 years or under.
For many young people, their pregnancy is unplanned and the medical social
worker provides support and counselling to the young person to assist them to
come to terms with the news and to provide ongoing support and assistance
throughout the pregnancy.  Becoming a mother at any age can be a daunting
experience and young people, in particular, can feel overwhelmed about
becoming parents.  Attendance and participation in the antenatal classes is also
encouraged. The Teen Parents’ Support Programmes in the young person’s local
area offer continued support for the mother and baby following delivery.
The medical social worker attached to the Teenage Clinic works closely with the
Clinic’s specialist midwife in order to provide a holistic and consistent service.  
BEREAVEMENT SOCIAL WORKER
In 2013, the bereavement social worker offered a service to all women who had
experienced the loss of a baby through miscarriage, ectopic pregnancy, stillbirth or
neonatal death. The role of the bereavement social worker was to visit these
patients and their partners while they were in hospital or to contact them when
they went home. They were offered emotional and practical support, counselling,
advice on explaining the death of a baby to children, and follow-up care. They were
also offered counselling and support during subsequent pregnancies and after the
birth of their new baby. The follow-up care was offered both in the Rotunda and on
home visits if requested. The bereavement social worker saw 102 patients for
follow up care after their discharge from hospital and carried out 235 hours of
counselling sessions in 2013.
The bereavement social worker also coordinated and facilitated a Bereavement
Group for parents in February 2013, along with other members of the social work
team.  The evaluation from this group was very positive.  We use the feedback from
parents to restructure the group content so that it evolves with each session.
Feedback from this group was also brought to the Bereavement Working Group
Meeting. The bereavement social worker continues to build strong links with the 
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multidisciplinary team at these meetings and also with the bereavement midwife
on a daily basis to ensure optimal care for the patient and family.
The bereavement social worker represented the hospital at remembrance services
organised by A Little Lifetime Foundation, The Miscarriage Association and
Felician. These support groups offer invaluable assistance to our bereaved
patients and we aim to continue to build strong links to them in the community.
FETAL ASSESSMENT AND PRENATAL DIAGNOSIS CLINICS
2013 was a very busy year for these clinics which provide care for women with
high risk pregnancies or who have received the diagnosis of chromosomal and
major structural abnormalities.  Fetal Medicine Midwives - Nollaig Kelleher, Jane
Dalrymple, Joan O’Beirnes and Laura McBride - work closely with the medical
social worker in identifying patients who have been given difficult news about
their baby and who may need additional emotional and practical support at the
time of a diagnosis and in the weeks and months that follow. 
Getting the news that an expected baby may have a problem changes everything
for parents.  As part of the team caring for and supporting parents during this
difficult time, the medical social worker offers a confidential counselling and
support service to all patients attending the FAU.  Patients are informed of this
service around the time of their first attendance and invited to meet with the
medical social worker if they are open to doing so.  Meeting with the medical social
worker, even briefly at this time, allows patients to identify another source of
support available to them throughout their pregnancy and after their baby’s birth. 
SUBSTANCE MISUSE
2013 2012 2011 2010 2009 2008
73 81 71 71 76 76
Deliveries to substance abusing women in the Rotunda Hospital. 
In 2013 the social worker within the Danger of Viral Exposure (DOVE) Clinic met
with all women who were undertaking a drug treatment programme such as a
methadone maintenance programme, and with women who were actively using
illicit drugs. 
Women were referred to the social work department by the drug liaison midwife.
The relationship and communication between the social work department and
drug liaison midwife is vital to early intervention with women.  
The medical social worker will introduce their role to women and begin their
assessment which involves looking at the environmental, social, emotional and
physical factors in the woman’s life.  From this assessment, the medical social
worker will be better able to establish the necessary supports for her and her baby.
In 2013 the medical social worker continued to have a role in working to ensure the
welfare and safety of newborn babies.   Where necessary she reported any drug-
related child protection concerns to the Health Service Executive.  A total of 50
referrals were made to the HSE Child and Family Services in 2013 – representing
68% of women attending the clinic. 
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As a result of these concerns, the medical social worker and drug liaison midwife
attended 11 discharge meetings to discuss the care of the baby after birth.  21 Child
Protection Conferences took place in 2013.   This conference is an interagency and
inter-professional meeting within the HSE and involves facilitating the sharing
and evaluation of information between professionals and parents.  This conference
formulates a child protection plan which sets in place the actions needed to ensure
the child’s continued protection and well-being.  
In 2013, 13 babies did not return home with their biological parents immediately
after discharge –one baby was placed in care following an emergency care order,
one baby was placed in care under a voluntary care order and eleven babies were
placed in care under interim care orders.  This is an increase on the figures from the
previous year which indicate that 9 babies did not return with their parents due to
drug-related concerns following their birth.  In addition 11 mothers were required
to return home under the supervision of a non-drug using relative for a period of
time until stability was assured. 
The medical social worker continued to work as a support to all women attending
the DOVE clinic throughout her pregnancy and provided information in relation to
benefits and entitlements. 
INFECTIOUS DISEASES
Since 1st January 2012, HIV cases have been reported to the Health Protection
Surveillance Centre (HPSC) on a weekly basis using the Computerised Infectious
Disease Reporting (CIDR) system.  347 cases of HIV were notified to the HPSC in 2013
– this is an increase of 6 cases when compared to last year’s figures. 
In 2013, 6 women in the Rotunda were newly diagnosed with HIV infection at their
antenatal screening.  30 women with HIV infection delivered babies in the
Rotunda in this year. 
The medical social worker continued to adopt a non-judgemental, respectful and
anti-oppressive approach to working with all women who attended the DOVE
clinic.  She provided pre- and post- test counselling to patients and ensured women
of her availability for support throughout and after their pregnancy.  Counselling
is offered to women to assist them in processing their feelings around their new
diagnosis and in coping with the impact that this may have on their lives.  The
medical social worker has an in-depth knowledge of the community supports
available for women and during 2013 she continued to foster positive relationships
with these services in order to best meet the needs of these women.  
The medical social worker liaises closely with the Infectious Disease Midwife to
effectively meet the needs of many women.
NEONATAL UNIT
The role of the medical social worker attached to the Neonatal Unit is to help
families cope with the stressful experience of having a premature or sick baby.  The
social worker provides emotional support, information and practical assistance to
parents while their baby is in the hospital and also after their baby has been
discharged home.  In addition, bereavement support is offered to parents if their
baby dies while in neonatal care.
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The social worker liaises closely with medical and nursing colleagues to ensure that
parents receive holistic family-centred care. There is particularly close collaboration
with the NICU Discharge Co-ordinator and with community-based services and
support agencies to promote continuity of care from the hospital to the home
environment.
At a time when many families are experiencing financial difficulties, the social
worker is involved in informing parents of their welfare entitlements and in
enabling them to secure financial assistance with medical and other expenses.
Grateful appreciation is expressed to community welfare officers and to HSE offices
throughout the country for their co-operation.  
During 2013, there continued to be an increase in the number of babies transferred
from hospitals outside Dublin to the neonatal unit in the Rotunda.  These families
had to cope with the practical and emotional difficulty of commuting long
distances or of finding somewhere to stay in Dublin. The lack of accommodation for
parents, the high cost of car-parking in the city centre and the absence of adequate
financial supports for such families constitute major problems.
A positive development over the past year was the continued success of a monthly
parents’ support group which is facilitated by the medical social worker in
conjunction with representatives from the Irish Premature Babies Support
Organization.  These representatives are parents who have previously had
premature babies in the Rotunda’s neonatal unit. The objective of the group
meetings is to give parents the opportunity to support each other through the
difficult experience of having a baby in neonatal care.  They provide a safe
environment in which parents can express their feelings and share their
knowledge.  Sincere gratitude is expressed to the representatives from ‘Irish
Premature Babies’ who provided invaluable support and advice.
DOMESTIC VIOLENCE
In 2013, the Rotunda Hospital introduced a routine enquiry into domestic violence in
keeping with best national and international recommendations. Domestic violence in
pregnancy is more common than gestational diabetes and hypertension and can
actually begin or increase during pregnancy. It may lead to miscarriage, pre-term
labour, low birth weight, fetal injury and can pose a significant health risk for both the
woman and her baby.  A study carried out in the Rotunda Hospital in 2000 showed
that 12.5% (1 in 8) of a pregnant sample group experienced violence in pregnancy.  
Research demonstrates that a system of routinely asking all women during the
ante-natal period if they are experiencing domestic violence is a model that
supports women to disclose abuse and seek support. It also serves to reduce the
stigma associated with domestic violence and has the value of highlighting the
prevalence of this issue to women.  Research shows that many women were asked
about domestic violence 11-12 times before disclosing.
It is often thought that women will find it unacceptable to be asked about
experiences of abuse.  However, research carried out in the Rotunda Hospital in
2004 on the acceptability of routine enquiry indicated that 99.4% thought the
questions were acceptable and 99.6% thought it would be helpful to ask all women
attending the hospital about domestic violence.  Women are asked about domestic
violence without their partner present to ensure their safety is not compromised. 
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The medical social work team prioritise all domestic violence referrals.  It is
important to explore with the woman where she is at in the domestic violence
cycle. She could be only defining what is happening to her as an abuse or may be
at the point of leaving a relationship.  The medical social worker can assist a
woman explore her options, such as, a referral to a refuge or Woman’s Aid and a
safety plan can be discussed.  Not all domestic conflicts warrant the involvement
of statutory child protection services.  The level of risk to children is assessed by the
medical social worker with the patient.  A woman, in the majority of the cases, is
the best judge of her family’s safety. 
TRAINING - STAFF
Training Day on Stillbirth and Neonatal Loss, Centre of Midwifery Education –
05/06/13 . D. Kir
In-service Training for Midwifery Staff on Miscarriage, Stillbirth and Neonatal Loss
– 31/01/13. D. Kirk
Training for Midwifery Students on Miscarriage, Stillbirth and Neonatal Loss –
09/04/13, 08/05/13. D. Kirk
PROFESSIONAL DEVELOPMENT
D. Kirk attended a one day workshop on Anxiety: A Cognitive Behaviour
Approach.09/03/13 PCI College, Dublin
D. Kirk, Bereavement Social Worker, continued to attend quarterly meetings of
the Irish Association of Paediatric Palliative Care in 2013
ACKNOWLEDGEMENTS
The Medical Social Work team would like to acknowledge their grateful
appreciation of the following:
• The Friends of the Rotunda and the Samaritan Fund for their financial 
support;
• The various charitable organisations which respond so generously to our
requests for assistance for families in need;
• All the voluntary community-based agencies which provide invaluable 
services and expertise;
• The lab staff in the Rotunda who generously donate hampers for 
families every Christmas;
• All our co-workers throughout the hospital, especially the midwives in 
Bereavement Liaison, DOVE, Drugs Liaison, Teenage Clinic, FAU and the 
staff of NICU and POPD
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CONSULTANTS: Dr Sam Coulter-Smith, Dr Sharon Cooley (Locum), 
Dr. Karen Flood (Locum)
ADMINISTRATOR: Ms Olivia Boylan
MIDWIFERY: Care and support was provided by the midwives 
attached to the Antenatal Clinic on a rotation basis.
REGISTRARS: January to December 2013
Dr Nikhil Purandare Dr Jennifer Donnelly
Dr Allan Varghese Dr Audris Wong 
Dr Adam Mackie Dr Fergus Mc Carthy 
Dr Niamh Daly Dr Jennifer Hogan 
Dr Claire O’Connor Dr Tasneem Ramhendar
Dr Uzma Mahmood Dr Aoife Doyle
Dr Noha Bozreiba Dr Niamh Murphy
Dr Sanchila Talukdar Dr Cathy Monteith
Dr Pooja Sibartie Dr Rebecca Moore
Dr Amanda Ali
The Early Pregnancy Assessment Unit (EPAU) is a specialised clinic dedicated to
providing care to women in early pregnancy. Approximately 12-15% of women
will experience bleeding and/or pain in early pregnancy and the majority of
these patients will seek medical treatment. In 2013, this compromised 5551 new,
return and reassurance visits to the EPAU. The EPAU is an essential component of
the Rotunda Hospital and strives to deliver a service that will manage patients
in a safe, timely and supportive manner. 
Since its establishment in 2008, the EPAU has undergone changes in line with
recommendations from the Directorate of Quality and Clinical Care in the Health
Services Executive, the Royal College of Physicians of Ireland and the Institute of
Obstetricians and Gynaecologists. Further achievements in 2013 include:
• Provision of training for University College Dublin Graduate 
Certificate in Obstetric Ultrasound Module 1 for Dr Sanchila Talukdar 
and Dr. Audris Wong by Dr Sharon Cooley and Dr. Karen Flood.
• Development of standard operating procedures to streamline referrals
to the EPAU.
• Reconfiguration of appointment schedules to improve day-to-day 
efficiency.
E a r l y  P r e g n a n c y
A s s e s s m e n t  U n i t
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• Provision of support documentation for patients (also available on 
hospital intranet).
• Continued provision of Registrar training in Viewpoint® and early 
pregnancy undertaken by Dr Sharon Cooley and Dr Karen Flood.
• Continued provision of Senior House Officer training in basic 
ultrasound in conjunction with the Royal College of Physicians Basic 
Specialist Training by Dr Fionnuala Breathnach.
• Participation in regular clinical auditing of early pregnancy key 
performance indicators.
Clinical activity:
2013 (%) 2012 (%) 2011 (%)
Total number of appointments 5551     5221 5709
Total number of patients seen 4191 3106 3116
Repeat EPAU reviews 2587 (62) 2315 (80) 2214 (71)
Failure to attend for first 
appointments 145 (4) 200 (7) 114 (4)
Failure to attend for follow-up 
appointment 270 (10) 144 (6) 178 (8)
Miscarriages 1661 (30) 1551 (30) 605 (19)
Surgical management of 
miscarriage 531 32) 590 (38) 247 (41)
Expectant or medical 
management 1130 (68) 961 (62) 358 (59)
Ectopic pregnancy or pregnancy 
of unknown location 192 (4) 123 (4) 51 (2)
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CONSULTANTS: Dr Karen Flood
Dr Sharon Cooley
MIDWIFE: Patricia Fletcher
This specialised clinic offers a comprehensive service for women, and their
partners, who have had three or more consecutive miscarriages. This includes
thorough investigation of any underlying causes, provision of information and
support, with the aim of achieving a successful pregnancy. We link closely with
the counselling service, radiology and other clinics in the hospital. This clinic is
also dedicated to provide continuity of care with rapid access to review and
frequent ultrasound monitoring for women from early pregnancy until their
booking appointment.
2013 (%) 2012 (%)
Total number of patient visits 499 376
Return visits 390 (78) 292 (78)
Failure to attend for first appointments 26 (24) 18 (21)
Failure to attend for follow-up appointment 45 (12) 39 (13)
Total number of pregnant women seen 62 55
Livebirth rate 39 (63) 4 (78)
R e c u r r e n t  p r e g n a n c y  
l o s s  s e r v i c e
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MS CLAIRE O’MAHONY, CLINICAL RISK MANAGER
CLINICAL RISK & CLAIMS DEPARTMENT  
The Clinical Risk & Claims Department is responsible for the ongoing development
of a comprehensive clinical risk management programme across the hospital,
including risk identification, analysis and support in incident investigation. 
Education is delivered across the hospital highlighting incident reporting, incident
management and investigation responsibilities. The department maintains the
clinical incident management system, notifies insurers of reported incidents,
produces trend reports and provides feedback to departments and committees in
respect of incident trends.
Claims management is a key function within the the department and the risk
management team is the key point of contact for hospital solicitors and the
Clinical Indemnity Scheme (CIS) in this regard. The risk & claims team also analyse
claims data in order for learning to be implemented within the hospital.
The department has a role in the implementation of patient safety projects across the
hospital and has significant involvement in departmental patient safety meetings. 
INCIDENT REPORTING
The STARS web records 2,976 clinical events reported in 2013. This is a reduction of
1.3% from incident reporting on the previous year. Following analysis the reduction
is likely to reflect efforts put into training and communication through 2013 to
reduce unnecessary reporting or reporting that is not in line with recognised
incident reporting requirements. 
Statistics and trends in respect of incident reporting continue to be shared with the
Clinical Managers in an annual departmental report and in the quarterly reports
prior to each Departmental Patient Safety Meeting.
Clinical Risk Committee
The Clinical Risk Management Committee has responsibility for overseeing the
risk management programme in the Rotunda Hospital in relation to the
management of clinical risk. The purpose of the Clinical Risk Management
Committee is to support the Master in improving patient safety and the quality of
patient care by the analysis of clinical incidents reported.   The Hospital wishes to
promote the reporting of actual or potential risks in a blame-free culture. 
The Committee meets on a bi-monthly basis and its responsibilities include
monitoring incident trends and the progress of incident reviews and
implementation of recommendations.
Clinical  Risk Management &
Claims Department Activity
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RISK MANAGEMENT POLICY
The National Incident Management Policy was reviewed in 2013 and guidance
from this document was evaluated by the Clinical Risk Committee for
adaptation within our processes and policy. Work is ongoing in respect of
updating the hospital’s risk management policy. 
A number of improvements were implemented in 2013 in the interim. This
included the introduction of a factual accuracy check whereby draft review
reports are circulated to all individuals interviewed as part of a FAIR review,
including the patient or family and the clinicians involved in the patient’s care.
The process for communication with the patient/NOK was also further
developed in 2013 to incorporate a structured approach to patient or family
involvement in FAIR reviews and a standardised approach to information
provision in advance of this process.
Work was undertaken in Quarter 4 to develop a Rotunda Learning Notice
following an incident, inquest or claim in order to facilitate the documented
sharing of lessons following a review of an untoward event. Sharing of the
learning notices is now in place via the hospital’s intranet.
The Voluntary Hospitals Risk Management Forum “Overview of the Basics of
Risk Management” staff handbook was adopted for use within the hospital, is
referenced in the risk management policy and is available to staff via the
hospital intranet.
PATIENT SAFETY INITIATIVES FOLLOWING INCIDENT TREND ANALYSIS
Further work was implemented on the following topics following analysis of
incident trends and clinical risks:
FAIR REVIEWS/FOLLOW UP REVIEWS:
14 recommendations were made in 2013 out of reviews into clinical incidents. Of
these, 13 actions are complete. One recommendation involves a shared guideline
with another organisation. A draft guideline has been forwarded for approval
/amendment.
Recommendation Made: Number Actions Actions
complete ongoing
Promotion/Training of Existing 
Guidelines 2 2 0
SBAR/Communication 0 0 0
MEWS 0 0 0
Update to existing guideline 
required 1 1 0
New guideline/SOP required 2 1 1 
Amended process 2 2 0
Clinical Audits 
Documentation 
IT improvement 1 1 0
Totals 8 7 1
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FALLS ASSESSMENT TOOL:
Work was undertaken in 2013 in collaboration with the Practice Development
Unit in developing guidelines for falls assessment.
CONSENT:
An awareness campaign was undertaken in the form of reminders regarding
clinicians’ responsibilities pertaining to informed consent and their
responsibilities to seek written consent at an appropriate time in the patient’s
care pathway. The ACTIVATE tool is an education tool which was created by the
Rotunda Hospital in September 2012 in order to facilitate learning around
clinicians’ responsibilities in the consent process. The tool was regularly
presented at Risk Management training sessions and other forums throughout
2013 and was displayed across all ward areas and at the Patient Safety Day. It was
also incorporated within the HSE Toolbox Talks within the Dublin North East
Region. The National Consent Policy was launched in the Rotunda at a
presentation open to all staff on 20th August 2013.
TOOLBOX TALKS:
The Toolbox Talk initiative was formally launched at the Patient Safety Day on
15th May 2013 with support from HSE Dublin North East in its roll out. It
facilitates a process whereby short discussions or presentations are made by line
managers to their staff which is generally focused on one specific topic, which is
addressed in simple terms. These talks are an opportunity for staff to be briefed,
reminded and prompted in regards to applying the principles of practice in
delivering high quality safe care to patients. 
PATIENT SAFETY DAY:
The hospital’s first Patient Safety Day was held on 15th May 2013. A risk
management stand was set up with information displayed in respect of FAIR
reviews, follow-up reviews, open disclosure, never events, incident trend graphs
and shared learning from risk management data. Information leaflets and
handouts were distributed including “What to expect following a Serious
Adverse Event”, clinical abbreviation booklets and the ACTIVATE Consent tool.
NATIONAL ADVERSE EVENT MANAGEMENT SYSTEM:
The Risk Team have engaged in consultation with the CIS in respect of the
intended National Adverse Event Management System and have provided
feedback in respect of incident categories, practicalities and layout.
Following trends identified or proactive risk identification monitored by the
Clinical Risk Committee, the following measures were implemented by various
disciplines across the hospital and supported with the help of the Practice
Development Unit. Gratitude is expressed to all those who were involved in the
following improvement initiatives:
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RISK MANAGEMENT TRAINING  
146 staff members were trained in Risk Management & Documentation in 2013
along with additional attendances at specific training or feedback sessions. 
The Risk & Claims Managers continued our participation in a joint initiative
“Legal Study Day” organised by the Centre for Midwifery Education which aims
to educate clinicians in respect of risk management, key patient safety issues
and medico-legal processes. The course has been very successful to date with
good feedback from attendees and an attendance record of 127 clinicians since
the development of its commencement in May 2012. 
66 members of staff attended a joint lecture presented by the Clinical Indemnity
Scheme(CIS)/A&L Goodbody in 2013 in respect of the clinical claims process. 
CLAIMS/LEGAL:
The Voluntary Hospital Group’s “Updated Guidance preparing staff for attending
Inquests” and associated DVD was used several times during the year and
feedback was very positive in this regard.
The hospital implemented learning following the medico-legal claims process
during the year, and continues to share lessons learned via the Departmental
Patient Safety Meetings, other multi-disciplinary meetings and the Learning
Template following incidents, claims and inquests.
CLINICAL RISK & CLAIMS TEAM
I would like to thank the Clinical Risk & Claims team who are always extremely
hard-working and motivated and who all contribute in a meaningful and
effective way to the risk and claims processes within the hospital. 
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Friends of
the Rotunda
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THE FRIENDS OF THE ROTUNDA is the official fundraising arm and registered
Charity (CHY20091) of the Rotunda Hospital.
Its Main Objective is to provide a sustainable funding base for:-
➢Research into aspects of Maternal and Child Health; 
➢Additional and vital equipment and support services for the Hospital’s 
Specialist Units, Services and Clinics; and 
➢ Improved amenities for patients, their families and hospital staff.
The Charity does not receive any State funding and raises revenue each year by
actively encouraging Rotunda staff, patients, their families and friends, to
participate in fundraising activity. 
Donor Giving also provides designated funding for additional vital equipment
for the Neonatal Unit, Bereavement Support Services and improved amenities
within the Hospital that would otherwise not be provided for by the State. 
The Friends of the Rotunda Charity was formed in 1971 and incorporated as a
Limited Company by Guarantee and Not Having a Share Capital. It publishes
annual Audited Accounts that have been approved by the organisation’s external
auditors, KSi Faulkner Orr.  The Charity aims to demonstrate that it has a firm
commitment to transparency, accountability and an adherence to best practice
and performance.
The Friends’ Council is the Charity’s Governing Body and meets quarterly each year:
• Chairperson: Dr. Frances Gardiner 
• Directors: Marie Malone (Honorary Secretary), Dr. James Gardiner,
Marese Cooney and Kim Mc Cann. 
• Officers: Professor Alan Johnson, Dara Walsh, Sylvia Graham, 
Joan Dillon, and Judith Woodworth. 
The Management Executive is run by Sheila Thompson who is responsible 
for the administration and marketing & development of the organisation.
The Friends’ of the Rotunda awarded over €94,000 in grant awards during the year
to fund the following Research Projects and provide financial support for services:
• To Investigate and Characterise Modulators of Primary Haemostasis and 
Thrombin Generation in Early Onset Preeclampsia
Principal Investigators: Dr. Fionnuala Ní Áinle, Dr. Mike Geary 
and Dr. Sharon Cooley.
• The RCSI PORTO Study: YR 2 Funding
• Rotunda’s Bereavement Support Services
• Rotunda’s Sexual Assault Treatment Unit – 2013 National Conference
FUNDRAISING EVENTS THAT TOOK PLACE DURING THE YEAR INCLUDED:
• Rotunda Golf Classic – The Masters’ Cup
• Christening Party Fundraisers
• Coffee Morning Fundraisers
• Birthday Party Fundraisers
• Sponsored Walks192
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• Flora Women’s Mini Marathon to Fundraise for Rotunda Neonatal Unit
• Dublin City Marathon
• NY City Marathon
• Sale of Easter Eggs
• Coin Box Collections and Raffles
• Sale of Publications gifted to Rotunda Hospital by Artists / Authors
• Sale of Football Shirts in aid of Rotunda Research Fund 
• Sale of Christmas Cards
• Sale of Art illustrating the Rotunda Hospital
• Sale of Designer Silver Jewellery Collection
• Sale of  Memorabilia of the Rotunda Hospital
• Tango Fiesta Fundraiser
• Young European Strings Chamber Orchestra Performance in the Pillar Room
• Christmas Swim Fundraiser
• Sky Dive Fundraisers
• Friends of the Rotunda Annual Membership Subscriptions
• Charity Collaboration with ‘Ride out for Prems’ – Irish Premature Babies 
Organisation
• Charity Collaboration with Feileacain
DONATIONS
On-line payments facility for Donations was introduced in September 2009 on
the Friends’ Web Site (www.friendsoftherotunda.ie ). Revenue has since been
collected to support each of the following areas:
• Bereavement Support
• The Delivery Suite
• The Early Pregnancy Unit
• Rotunda Families in Need
• Fetal Assessment Unit
• Maternity Day Care Unit
• Neonatal Intensive Care Unit
• Rotunda Research Fund
• Sexual Assault Treatment Unit
• Essential Equipment Wish list
Additional essential equipment purchased by the Friends during the year
supported the Rotunda’s newly refurbished Neonatal Unit’s Parent’s Room.
www.MyCharity.ie now hosts the Friends of the Rotunda Charity registration on
its website. Fundraisers can set up a Fundraising Page with links to mobile and
social media connections.
CAFÉ ROTUNDA
The Hospital Shop is located within the Main Reception of the Hospital and
provides a Café and retail service to all in the Hospital. Annual rental income
from the Shop provides extra revenue for the Friends’ Charity to run its
administration costs.
51639 Rotunda Clinical Report 2013 301014 v5_Clinical Rep  30/10/2014  11:57  Page 193
Pictured above is the striking contemporary bar facility within the Pillar Room
Complex. The Venue offers Conferencing and Catering facilities and is equipped
with a PA system and Wi-Fi.
The Council of the Friends of the Rotunda wishes to extend its gratitude to all
those who organised and supported fundraising activities during 2013.
Sheila Thompson
Friends of the Rotunda 
www.friendsoftherotunda.ie
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THE HIRE OF THE PILLAR ROOM
Another substantial source of revenue in aid of Rotunda Research is generated
each year through the hire of The Pillar Room Complex as a facility for private
and corporate functions. It is also used by the Hospital as a teaching &
examinations / conference centre. Bookings are managed by the Friends of the
Rotunda office on 01 872 2377 or email friends@rotunda.ie.
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Clinical Audit Team:
DR SHARON COOLEY Clinical Audit Lead
MARY WHELAN Clinical Audit Facilitator
VALERIE JACKSON Surveillance Scientist
COLIN KIRKHAM Statistician
The Rotunda Hospital Clinical Audit Department was established in June 2011
under the quality and safety initiative of the Rotunda’s Strategic Plan 2011-2013.
Clinical audit offers a structured approach to evaluating our care against local,
national and international standards.
The Clinical Audit Department functions include:
• Education and support at all stages of the clinical audit pathway. This 
includes topic selection, researching standards, the application process, audit
tool design, data analysis and report writing.
• Assistance in maintaining clinical audit experience which is an essential 
element of professional competence. 
• Monitor all clinical audit activity within the hospital and routinely report on
same.
• Monitor local and national audit standards and appraise hospital 
performance against these standards where appropriate. 
• Promote a high standard of practice amongst clinical staff and all healthcare
workers undertaking clinical audit.
• Provide a forum for the sharing and dissemination of clinical audit work in 
the Rotunda, which is facilitated by the use of the clinical audit database, the
Biannual Rotunda Audit and Research Day and quarterly audit results 
meetings.
• Encourage presentation of audit results at inter-hospital meetings e.g. JOGS, 
SJH Annual Audit Day and TSH Biannual Audit Day.
• Forge professional links with other clinical audit units nationally.
Clinical Audit Group Weekly Meeting
The core group within the Clinical Audit Department meet weekly to discuss and
approve audit applications.
Clinical Audit Steering Group
The Clinical Audit Steering Group meets quarterly. Membership of the steering group
includes the executive management team, clinical risk department, departmental
patient safety representatives, heads of departments and allied health professionals. 
Other Internal Meetings
Clinical audit activity reports are submitted to the Quarterly meeting of the Board
of Governors, the Patient Safety Meetings and the Monthly Quality and Safety
Committee meeting. These reports include details of new audits, completed audits
and any immediate actions arising from audits. In addition, any clinical audit with
a plan that requires immediate action is highlighted to the Executive Management
Team.. 
C L I N I C A L  A U D I T
D E PA R T M E N T
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Clinical Audit Database
The database of clinical audit activity in the hospital facilitates the production of
weekly and quarterly reports on topics audited; departments and clinicians
involved, action plans and dates for re-audit. All clinical audits conducted in the
hospital are registered on the database. All health professionals who participate
in completed clinical audits that have been registered with the hospital receive
a certificate of participation in conjunction with their supervisors. 
In total 61 clinical audits were registered in 2013 (51 first audits, 7 re-audits and 3
continuous audits). 
Clinical Audit Training
The clinical audit team regularly delivers educational sessions in-house on the
clinical audit cycle across all disciplines. In 2013 there were 8 information
sessions held and a total of 68 staff members attended with representatives
from all clinical areas. In addition, external sessions are delivered to midwifery
students at Trinity College Dublin.
Clinical Audit Intranet Page
The department has developed a designated page on the hospital intranet where
the application forms, excel tool template, guide to clinical audit, key steps to
audit success, draft action plan and report template are available to download.
Annual and Monthly clinical audit reports are also available to download.
Audit and Research Day
Two successful audit and research days were held within the hospital during the
year and kindly sponsored by AbbVie. The Rotunda Medals were awarded to Dr
Naomi Burke and Ms Cinny Cusack.
Presentations at External Meetings
Ms Debbie Browne Teenage Support Midwife “An audit of the risk status of
teenagers at the booking visit and throughout pregnancy” presented at St James
Hospital 6th Annual multidisciplinary Research, Clinical Audit and Quality
Improvement Seminar. 
Dr Kate Glennon “An Audit of Postnatal Hospital Readmissions with Perineal
Infection” presented at JOGS
Dr Rebecca Moore “An audit of compliance with glucose tolerance testing among
pregnant HIV positive women on protease inhibitors” presented at JOGS
New Initiatives in 2012
• The Hospital Clinical Audit Policy document was reviewed an updated at 
the end of 2013. The new policy states “When audits extend beyond the 
agreed date of completion, an additional “grace period” of three months is 
given automatically, after which time the audit supervisor is requested to 
provide an update on the expected completion date. 
• The Clinical Audit Department now provides encrypted USB’s to audit 
leads if necessary.
• The Clinical Audit Facilitator sits on and reports to the Monthly Quality 
and Safety Committee.
• Each department was issued an audit calendar early in 2013 to 
propose/plan audit activity for the year ahead.
Conclusion
The team would like to commend the clinical staff for their enthusiasm for
clinical audit and look forward to working with them towards their clinical audit
goals in 2014.
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MASTER
Dr. S. Coulter-Smith
Secretary/ General Manager Ms P Treanor
Director of Midwifery/Nursing Ms M Philbin
MIDWIFERY
Senior Staff
Ms P Williamson (ADOM) Ms T Mc Cluskey (ADOM)
Ms F Hanrahan (ADOM) Ms M Keane (ADOM)
Ms M Brennan (Infection Prevention & Control)
Clinical Midwife Manager III 
Ms O. O’Byrne      Ms A Keenan        Ms. J. Hickey
Ms C Cannon      Ms M Deering      Ms S Finn Heaney
PARAMEDICAL HEADS OF DEPARTMENT
Chief Pharmacist Snr Physiotherapist Snr Radiographer Laboratory Manager
Ms A  Frankish/Mr B Cleary Ms C Cusack Ms S Gibson Mr J O’Loughlin
Acting Head Medical Social Worker Senior Dietitian
Ms S  Devitt/Ms P Forster Ms L Harrington
ADMINISTRATIVE HEADS OF DEPARTMENT
Patient Services Manager Ms C Ryan Hyland / Ms N Moore
Financial Controller Mr C Kenny
Human Resources Manager Mr K Slevin
Information Manager Ms L Sibley
Materials Manager Mr S Williamson
Head Librarian Ms A O’Byrne
Quality Manager Ms S Breen
Clinical Risk Manager Ms. C. O’Mahony 
Information Technology Manager Mr. N. Carberry 
SUPPORT DEPARTMENT STAFF HEADS
Support Services Manager Mr R Philpott
Technical Services Mr B Memery
Catering Officer Ms P Ryan Mohammed
Clinical Engineering Mr H Gelera
Household Services Manager Ms C L’Estrange
Head Porter Mr P Shields
CHAPLAINS
Ms A Charlton Fr D O’Reilly
Rev D Gillespie Rev A Boal
Rev J Stephens Ms G Stephens
Ms S Dawson The Dominican Community
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